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Abstract: 
At physiological oxygen concentrations ([O2]) hypoxia-inducible factor-1α (HIF-1α) is 
constantly hydroxylated and thus prepared for proteosomal degradation through the 
action of the prolyl hydroxylases (PHDs) (Jiang et al., 1996). In hypoxia, however, the 
oxygen-sensitive PHDs are inhibited and HIF-1α is stabilised. Other agents, including 
cytokines and growth factors have been shown to stabilise HIF-1α at physiological [O2] 
through different mechanisms such as activation of the phosphatidylinositol 3-kinase 
(PI3K) or mitogen-activated protein kinase pathways (Semenza, 2003). Increased 
production of reactive oxygen species (ROS) during hypoxia have also been claimed to 
stabilise HIF-1α (Chandel et al., 1998) and we have now investigated the effect of 
endogenous ROS on HIF-1α stabilisation. 
 
HIF-1α stabilisation and ROS production in human embryonic kidney (HEK 293T) 
cells were determined by immunoblotting and the use of fluorescent probes, 
respectively. γGlutamyl cysteine synthetase (γGCS) is the rate limiting enzyme of 
glutathione (GSH) biosynthesis and therefore a crucial antioxidant. We used small 
interfering RNA (siRNA) to silence this enzyme and thus impair the capacity of the 
cells to detoxify ROS.  
 
In order to determine whether mitochondria are a major source of ROS we used cells 
depleted of mitochondrial DNA (Rho0); these were characterised in vitro by monitoring 
oxygen consumption. RT-PCR was used to determine mitochondrial DNA content and 
immunoblotting to assess mitochondrial-encoded protein expression. The effects of a 
Rho0 phenotype were then assessed in relation to HIF-1α stabilisation and ROS 
production. 
 
HIF-1α is stabilised in an oxygen-dependent manner. HIF-1α stabilisation at low [O2] 
(3%), but not at 0.5% O2 is prevented by treatment with antioxidants. Silencing γGCS 
augmented free radical production in HEK 293T cells. This was associated with HIF-1α 
stabilisation at ambient [O2] (21%) and could be prevented by treatment with 
antioxidants. Rho0 cells produced less ROS than wild-type cells and did not stabilise 
HIF-1α either at low [O2] (3%) in wild-type cells or at 21% O2 in γGCS silenced cells.  
 
The data suggest that HIF-1α can be stabilised by ROS generated by the mitochondria.
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MRP   Multi drug resistance protein 
MOPS   3-(N-morpholino)propanesulfonic acid 
MPA   Metaphosphoric acid 
MtDNA  Mitochondrial DNA 
mTOR   Mammalian target of rapamycin 
NAC   N-acetyl-L-cysteine 
NaCl   Sodium chloride 
NAD   N-terminal activation domain  
NADH   Nicotinamide adenine dinucleotide 
NADPH  Nicotamide adenine dinucleotide phosphate 
NADPH oxidase Nicotamide adenine dinucleotide phosphate oxidase 
NaOH   Sodium hydroxide 
Neg. Ctl  Negative control 
NF-ĸB   Nuclear factor kappa B 
nNOS   Neuronal NOS 
NO   Nitric oxide 
NO+   Nitrosonium cation 
NO-   Nitroxylanion  
NO2-   Nitrate  
NOHA   NGhydroxy-L-arginine 
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NOS   Nitric oxide synthase 
NOS2   Nitric oxide synthase 2 
NOX   NADPH oxidase 
N-terminal  NH2 -terminus 
O2-   Superoxide 
O3   Ozone 
ODD   Oxygen dependent degradation domain 
OGC   Monocarboxylate carrier 
OH-   Hydroxyl    
O/N   Overnight 
OONO-  Peroxynitrite  
P13-kinase   Phosphoinositide 3’ kinase 
PAS   Per-arnt-sim 
PBS   Phosphate buffered saline 
PBST   Phosphate buffered saline tween 
PCR   Polymerase chain reaction 
PDGRβ  Platelet-derived growth factor β 
PDH   Pyruvate dehydrogenase 
PDK-1   Pyruvate dehydrogenase kinase 1 
PFKFB3  6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-3 
PFKL   Phosphofructokinase L 
PGF    Placental growth factor 
PGK1   Phosphoglycerate kinase 1 
PHD1   Prolyl hydroxylase domain 1 
PHD2   Prolyl hydroxylase domain 2 
PHD3   Prolyl hydroxylase domain 3 
PKC   Protein kinase C 
PKM   Pyruvate kinase M 
POLγ   Polymerase γ 
Pos. Ctl  Positve control 
PPARs   Peroxisome proliferator-activated receptors), 
Prx   Peroxiredoxin 
PTK   Protein tyrosine kinase 
PTP   Protein tyrosine phosphatase 
pVHL   Von hippel-lindau protein 
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RAS   Rat sarcoma 
RCC   Renal carcinoma cell 
RD   Regulatory domain 
RNA   Ribonucleic acid 
RNAi   RNA interference  
RNS   Reactive nitrogen species 
ROS   Reactive oxygen species 
RO·    Alkoxyl 
RO2·    Peroxyl 
Rot   Rotenone  
RT-PCR  Reverse rranscription polymerase chain reaction 
s   Seconds 
Scr   Scrambled (siRNA) 
SDF1   Stromal derived factor 1 
SDH   Succinate hydrogenase 
SDS   Sodium dodecyl sulphate 
SDS-PAGE  SDS polyacrylamide gel electrophoresis 
SEITU   S-ethyl-isothiourea 
SFM   Serum free medium   
shRNA   Small hairpin ribonucleic acid 
siRNA   Small interfering ribonucleic acid 
SOD   Superoxide dismutase 
Sp1   Specificity protein 1 
sPBS   Sterile phosphate buffered saline 
TAD   Transactivation domain 
TAE    Tris acetic acid EDTA buffer 
TCA cycle  Tricarboxylic acid cycle   
TEMED  N’N’N’N’ Tetramethyletheylenediamine 
TGF-α   Transforming growth factor-α 
TGF-β3  Transforming growth factor-β3 
TMRM  Tetramethyl rhodamine methyl ester 
TNF-α   Tumour necrosis factor-α 
TPI   Triosephosphate isomerase 
Tris   Tris(hydroxymethyl)methylamine 
Trx   Thioredoxin 
Abbreviations 
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Q   coenzyme Q 
Ub   Ubiquitin 
VEGF   Vascular endothelial growth factor 
VEGFR1  VEGF receptor 1 
VLS   Visible light spectrophy  
VO2   Oxygen consumption 
WB   Western blot 
YFP   Yellow fluorescent protein  
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Chapter one: Introduction 
 
1.1 General introduction 
Oxygen accounts for approximately 21% of the earth’s atmosphere. The evolutionary 
development of respiratory, cardiovascular and haematopoietic systems provides a 
means to capture oxygen from the environment and distribute it throughout the body. It 
is used as a substrate for oxidative phosphorylation amongst many other vital 
biochemical reactions. In 1938, Corneille Heymans was awarded the Nobel Prize in 
Physiology or Medicine for showing how blood pressure and oxygen content of the 
blood are sensed by the body and transmitted to the brain. It is the ability of cells to 
adapt to the changes in oxygen availability which provides one of the most essential 
mechanisms for survival.  
 
Hypoxia is used to describe reduced oxygen concentrations or availability, characterised 
by low partial pressure of oxygen (pO2). However, hypoxia is a relative term, for 
example the arterial pO2 in mammalian adults is ~ 13 kPa, and in the foetus it is ~ 5 kPa 
(Ward, 2008). Hypoxia is better defined as a situation in which oxygen becomes the 
limiting step in physiological and biological reactions and occurs in tissues when the 
oxygen supply fails to meet the demand of oxygen consuming cells. This includes 
physiological settings such as embryonic development and exercising muscle, as well as 
in pathophysiological conditions such as myocardial infarction, inflammation and solid 
tumour growth (Simon, 2006). 
 
Hypoxia is sensed and results in changes in the activity or expression of a large number 
of hypoxic-sensitive genes. However, only within the past few years have the molecular 
mechanisms underlying this fundamental response of cells to hypoxic stress started to 
be elucidated. 
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1.2 Hypoxia-inducible factor family 
1.2.1 Introduction 
Mammalian cells respond to hypoxia by activating the transcription factors named 
hypoxia-inducible factors (HIFs), which are expressed by virtually all cells of the body 
(Chandel and Budinger, 2007). The HIF protein is composed of a α- and a β-subunit 
(also known as aryl hydrocarbon nuclear receptor translocator, ARNT) and belongs to a 
large family of proteins termed basic-helix-loop-helix (bHLH). The HIF proteins also 
contain a Per-Arnt-Sim (PAS) domain (Figure 1) which has diverse functions, including 
a range of regulatory and sensory functions for oxygen tension and redox potential 
(Erbel et al., 2003). HIFs bind to hypoxia-response elements (HRE), consensus 
sequences in the promotor region of over one hundred genes (Table 1), which are 
known to activate the transcription of genes that allow the cell to respond to and survive 
the hypoxic environment. Genes such as those associated with angiogenesis in cancer, 
exercise and ischemia, as well as erythropoiesis, iron metabolism, glucose metabolism, 
cell survival, proliferation, apoptosis and motility.  
 
 
 HIF-1 gene targets 
Angiogenesis EG-VEGF, ENG, LEP, LRP1, TGF-β3, VEGF 
Erythropoiesis EPO 
Iron metabolism Transferrin, Transferrin receptor 
Glucose metabolism HK1, HK2, AMF, ENO1, GLUT1, GAPDH, 
LDHA, PFKFB3, PFKL, PGK1, PKM, TPI 
Cell survival ADM, EPO, IGF2, IGF-BP1, IGF-BP2, IGF-
BP3, NOS2, TGF-α, VEGF 
Cell proliferation Cyclin G2, GF2, GF-BP1, GF-BP2, GF-BP3, 
TGF-α, TGF-β3 
Apoptosis NIP3, NIX 
Motility AMF/GP, LRP1, TGF-α 
 
 
 
Table 1 – Genes that are transcriptionally activated by HIF-1 
A selection of target genes that are transcriptionally activated by HIF-1, including genes involved in 
angiogenesis, erythropoieses, iron metabolism, glucose metabolism, cell survival, cell proliferation, 
apoptosis and motility (Semenza, 2003). 
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There are three members of the HIF α-subunit, coded by different genes, as well as a 
number of mRNA splice variants, which have been described (Pouyssegur and Mechta-
Grigoriou, 2006). Primarily, research has focused on HIF-1α, however further research 
is now emerging on HIF-2α. HIF-1α and HIF-2α have 48% overall sequence homology, 
with the N-terminal region showing the highest similarity. HIF-3α is the least studied of 
the three isoforms, though it is known to be similar to HIF-1α and -2α in the bHLH-
PAS region. Yet it lacks structures for trans-activation (Bardos and Ashcroft, 2005) 
found in the C-terminus of HIF-1α and HIF-2α and has been shown to repress oxygen-
regulated gene expression (Makino et al., 2001). Database analyses have revealed that 
multiple alternatively spliced variants of HIF-3α exist, some of which contain the von 
Hippel-Lindau (VHL)-targeted oxygen-dependent degradation (ODD) domain that is 
also found in HIF-1α and -2α (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Schematic representation of the different HIFα subunits 
Functional domains are indicated by boxes and the locations of the amino acid residues relevant for HIF-
1α and HIF-2α regulation are marked. bHLH, basic helix-loop-helix domain; PAS, Per/ARNT/Sim 
domains; ODD, oxygen-dependent degradation domain; N-TAD, N-terminal activation domain; C-TAD, 
C-terminal activation domain; LZIP, leucine zipper (Bardos and Ashcroft, 2005). 
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The α-subunits are highly unstable in the presence of oxygen, while the β-subunit is 
constitutively present in the nucleus, regardless of oxygen tension. The inherent 
instability of HIF-α subunits results from successive post-translational hydroxylation 
and ubiquitination, leading to proteasomal degradation (Brahimi-Horn and Pouyssegur, 
2007). 
 
1.2.2 Hypoxia-inducible factor-1 
Hypoxia-inducible factor-1 (HIF-1) was first identified in human hepatoma (Hep3B) 
cells under reduced oxygen tension, and was found to be necessary for the activation of 
the erythropoietin gene enhancer, in hypoxic cells (Wang and Semenza, 1993). Since its 
discovery, HIF-1 has been identified as a heterodimeric transcription factor mediating 
responses to changes in tissue oxygenation, consisting of both α (100-120 kDa, 
dependent on hydroxylation status) and β subunits (~ 92 kDa) (Hellwig-Burgel et al., 
2005). HIF-1α expression and HIF-1 transcriptional activity increase exponentially as 
cellular oxygen concentrations decrease (Jiang et al., 1996). In vitro, HIF-1α protein 
expression progressively accumulates as the pO2 decreases to anoxia. The stability of 
HIF-1α in hypoxic conditions is caused by the inhibition of its proteasomal degradation 
(section 1.4). When HIF-1α has not been targeted for degradation, it translocates to the 
nucleus where it dimerises with HIF-1β partner and binds to site-specific HRE on target 
genes (Table 1). The binding of HIF-1 to HRE results in the induction or repression of 
over one hundred genes which are involved in a vast array of cellular functions (Table 
1). 
 
1.3 HIF-1 mediated adaptive responses to hypoxia 
1.3.1 Metabolic regulation 
Cells largely derive their metabolic energy for active processes from the hydrolysis of 
the high-energy phosphate bond of ATP. The most efficient metabolic pathway for the 
generation of ATP is through the oxidative metabolism of glucose. This process 
involves three distinct phases: glycolysis, the tricarboxylic acid (TCA) cycle (also 
known as the Krebs cycle or citric acid cycle) and oxidative phosphorylation.  
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1.3.1.1 Glycolysis 
The first stage of respiration is glycolysis, which occurs in the cell cytoplasm and 
involves the co-ordinated activity of ten enzymes in the conversion of glucose into 
pyruvate. The net ATP gain of glycolysis is two molecules of ATP per molecule of 
glucose metabolised. As well as generating this yield of ATP, glycolysis also generates 
two electron-carrying NADH equivalents which facilitate oxidative phosphorylation.  
 
During normoxic oxygen conditions (steady state), the primary metabolic function of 
glycolysis is to feed pyruvate into the TCA cycle. However, eukaryotic cells are able to 
shift the primary source of metabolic energy in situations of metabolic crisis, such as 
hypoxia. In such situations there is an increase in the rate of flux through the glycolytic 
pathway resulting in increased glycolytic ATP production, through HIF-dependent 
transcriptional up-regulation of the genes involves in glycolysis (Table 1).  
 
1.3.1.2 TCA cycle 
Each molecule of glucose that is metabolised through glycolysis results in the 
generation of two molecules of pyruvate. In the steady state, the majority of pyruvate 
generated is oxidised by pyruvate dehydrogenase (PDH) to form acetyl coenzyme A 
(AcCoA), which combines with oxaloacetic acid to form citric acid. This then enters the 
TCA cycle, located within the mitochondria where a series of enzymatic reactions result 
in the net generation of one molecule of ATP, three molecules of NADH and one 
molecule of FADH2 per molecule of pyruvate metabolised.  
 
The entry of pyruvate into the TCA cycle can be a regulated by the HIF pathway 
(Semenza, 2007). A fundamental adaptation during hypoxia is the shunting of pyruvate 
away from the mitochondria by the HIF-1-mediated activation of PDK1 (pyruvate 
dehydrogenase kinase 1) (Kim et al., 2006;Papandreou et al., 2006). PDK1 down 
regulates the activity of PDH (the enzyme responsible for converting pyruvate into 
AcCoA), causing a decrease in the pyruvate available for entry into the TCA cycle.  
 
The reduced delivery of substrate to the mitochondria for oxidative phosphorylation 
results in reduced ATP synthesis. This is compensated for by increased glucose uptake 
via glucose transporters. Conversion of pyruvate to lactate by the activity of glycolytic 
enzymes and lactate dehydrogenase A (LDHA), which are encoded by HIF-1 target 
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genes also increase ATP synthesis (Semenza et al., 1996;Ryan et al., 1998;Seagroves et 
al., 2001). 
 
1.3.1.3 Oxidative phosphorylation 
Oxidative phosphorylation is the process by which cells utilise over 20 electron-
carrying proteins. These are located within the mitochondrial electron transport chain 
(ETC) and are arranged in four polypeptide Complexes which generate the cellular 
energy necessary to generate ATP. This process utilises the NADH and FADH2 
generated during glycolysis and the TCA cycle as electron donor molecules. The 
mechanism underlying oxidative phosphorylation involves the transport of electrons 
from high energentic molecules such as NADH and FADH2 through a series of carrier 
molecules (i.e. cytochrome c and coenzyme Q) which donate the electrons to gradually 
lower energy levels.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Summary of protein subunits of the five respiratory chain complexes 
Depicted is a schematic of the five respiratory Complexes (I–V) embedded in the lipid bilayer of the inner 
mitochondrial membrane. Dissociable electron carriers cytochrome c (Cyt c) and coenzyme Q (Q) are 
also shown. Arrows (green) show the pathway of electrons from the various electron donors. Broken 
arrows (blue) show the sites of proton pumping from the matrix side to the cytosolic side by Complexes I, 
III, and IV. The red arrow shows the flow of protons through Complex V from the cytosolic side to the 
matrix coupled to the synthesis of ATP (Scarpulla, 2008). 
 
 
Complex I Complex III Complex IV Complex II Complex V 
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As a consenquence of this process, energy is released from the different redox reactions, 
part as heat and also as coupled to the generation of a proton gradient across the inner 
mitochondrial membrane which finally fuels the activity of ATP synthase (Complex V), 
promoting the phosphorylation of ADP to form ATP. Molecular oxygen acts as the final 
electron acceptor at Complex IV of the ETC (cytochrome c oxidase). This enzyme has a 
high affinity for molecular oxygen (Km < 1 μM) and is responsible for over 90% of the 
body’s oxygen consumption (Rolfe and Brown, 1997).  
 
As in the case of glycolysis and the TCA cycle, oxidative phosphorylation through the 
ETC can be regulated by gene products of the HIF pathway in conditions of hypoxia. 
This involves a subunit switch within the cytochrome c oxidase (CcO) (the oxygen-
binding subunit), in which the CcO4-1 regulatory subunit is replaced by the CcO4-2 
isoform. This is a result of HIF-1-mediated transcriptional activation of genes encoding 
CcO4-2 and LON, a mitochondrial protease that degrades CcO4-1 (Fukuda et al., 
2007). This subunit switch optimises the energy consumption in conditions of low 
oxygen (Fukuda et al., 2007) due to the higher affinity of CcO4-2 isoform towards 
oxygen. 
 
From the above hypoxic metabolic adaptations, the following conclusions can be drawn. 
The increase in glycolysis and decrease in respiration that occur in response to hypoxia 
do not represent a passive effect of substrate (O2) deprivation but instead represent an 
active response of the cell to counteract the reduced efficiency of energy generation by 
oxidative phosphorylation under hypoxic conditions. 
 
1.3.2 HIF-dependent regulation of erythropoiesis 
Acute blood loss, ascent to high altitudes and pneumonia each results in a reduction in 
blood oxygen content. The ensuing tissue hypoxia induces HIF-1 activity in cells 
throughout the body, including specialised cells in the kidney that produce 
erythropoietin (EPO), a glycoprotein hormone that is secreted into the blood and binds 
to its cognate receptor on erythroid progenitor cells, thereby stimulating their survival 
and differentiation (Gerber et al., 1997). HIF-1 has been shown to orchestrate 
erythropoiesis by co-ordinately regulating the expression of multiple genes, including 
transferrin (Rolfs et al., 1997), transferrin receptor (Tacchini et al., 1999), 
ceruloplasmin (Mukhopadhyay et al., 2000) and hepadin (Peyssonnaux et al., 2007). 
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These proteins are responsible for the intestinal uptake, tissue recycling and delivery of 
iron to the bone marrow for its use in the synthesis of haemoglobin. Erythropoiesis is 
impaired in Hif1a-/- (homozygous HIF-1α-null) embryos and erythropoietic defects in 
HIF-1α-deficient erythroid colonies could not be restored by cytokines, such as vascular 
endothelial growth factor (VEGF) or EPO (Yoon et al., 2006). 
 
1.3.3 HIF-dependent regulation of angiogenesis 
Erythropoiesis represents an adaptive response to systemic hypoxia, whereas 
angiogenesis describes the local tissue response to decreased oxygenation. As cells 
grow and proliferate, their oxygen consumption increases and HIF-1 activity is induced 
either as a result of growth factor mediated induction via phosphatidylinositol 3-kinase, 
(P13K) or mitogen-activated protein kinase (MAPK) pathways (Figure 6), or as a result 
of tissue hypoxia (Figure 4). HIF-1 activates the transcription of multiple factors 
encoding angiogenic growth factors and cytokines (Figure 3), including VEGF, stromal-
derived factor-1 (SDF1), placental growth factor (PGF), angiopoietin 1 and 2 and 
platelet-derived growth factor β (PDGRβ) (Forsythe et al., 1996;Kelly et al., 
2003;Ceradini et al., 2004;Bosch-Marce et al., 2007;Simon et al., 2008). These bind to 
cognate receptors on vascular endothelial and smooth muscle cells as well as on 
endothelial progenitor cells, mesenchymal stem cells and other bone marrow-derived 
angiogenic cells (Figure 3) leading to increased tissue vascularisation. 
 
Hypoxia-induced expression of HIF-1 provides a mechanism to ensure that every cell 
receives adequate perfusion in young and healthy animals. Ageing and diabetes impair 
angiogenesis (Figure 3) by inhibiting the induction of HIF-1 (Bosch-Marce et al., 
2007;Chang et al., 2007). However, this impairment in angiogenesis can be restored by 
HIF-1α gene therapy in ischemic muscle (Bosch-Marce et al., 2007) and wound tissue 
(Liu et al., 2008b) or by local administration of an iron chelator (desferrioxamine) that 
inhibits HIF-1α hydroxylases, into ischemic skin (Chang et al., 2007). 
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Figure 3 – Regulation of angiogenesis by HIF-1α 
Direct HIF-1 target genes are indicated in red, whereas genes that may be either direct or indirect 
(secondary) targets of HIF-1 are indicated in blue. The combination arrows/ blocked arrows indicate that 
the genes encoding angiopoietin (ANGPT) 1 and 2 may be activated or repressed by HIF-1 in response to 
hypoxia depending on the cell type. 
 
 
1.4 Oxygen-dependent regulation of HIF-1α stability  
HIF-1α mRNA is ubiquitously expressed, regardless of the level of oxygen tension. The 
regulation of HIF-1α protein levels in cells occurs at the level of protein stability. HIF-
1α protein accumulates under hypoxic conditions. At physiological oxygen 
concentrations, the HIF-1α protein is unstable with a half-life of less than 5 minutes. 
This rapid turnover is mediated via hydroxylation of prolyl and asparaginyl residues. 
 
1.4.1 Prolyl hydroxylation 
The HIF-1α prolyl hydroxylases are crucial for the intricate and finely tuned cellular 
oxygen-sensing system. Three mammalian prolyl hydroxylase enzymes have so far been 
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identified, termed PHD1, 2 and 3. Their activity relies absolutely on the availability of 
oxygen (in the form of dioxygen O2) and 2-oxoglutarate as substrates; ferrous iron 
(Fe2+) is also an important co-factor. Ascorbate is also required to reduce ferric iron 
(Fe3+) back to Fe2+, after oxidation reactions, in order for the PHD enzyme to be 
recycled (Counts et al., 1978). Hydroxylation of proline residues 402 and 564 of human 
HIF-1α (Hellwig-Burgel et al., 2005) in the ODD domain of HIF-1α mediates the 
binding of von Hippel-Lindau (VHL) complex; the substrate recognition component of 
an E3 ligase complex that targets HIF-1α for ubiquitination and proteasomal 
degradation (Pan et al., 2007). The leucine residue 574 mediates the recognition of HIF-
1α by VHL by recruiting a prolyl hydroxylase for the hydroxylation of Pro 564, but 
both Pro 402 and 564 can interact independently with VHL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – Schematic of HIF-1α destabilisation and stabilisation 
Schematic illustration of HIF-1α degradation at 21% oxygen, and stabilisation at 0.5% oxygen. In the 
presence of oxygen, PHD targets the α-subunit for proteasomal degradation. In the absence of sufficient 
substrate, the α-subunit binds to its β-subunit, translocating to the nucleus where a myriad of genes are 
either activated or suppressed. (Abbreviations: Fe2+, ferrous iron; 2-OG, 2-oxoglutarate; O2, oxygen; 
PHD, prolyl hydroxylases; VHL, von Hippel-Lindau; OH, hydroxylation; Ub, Ubiquitinated, HRE, 
hypoxic response element). 
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1.4.2 Asparaginyl hydroxylation 
Asparaginyl hydroxylation of HIF-1α occurs in the HIF-1α C-TAD, preventing trans-
activation. A yeast two-hybrid screen led to the identification of factor inhibiting HIF-1 
(FIH-1). FIH-1 is the asparaginyl hydroxylase that hydroxylates human HIF-1α at 
asparagine (Asn) 803. Hydroxylation of this specific asparagine residue prevents 
transcriptional activity through inhibiting the interaction with the transcriptional 
coactivator CBP/p300 [where CBP is CREB (cAMP-response-element-binding 
protein)- binding protein] (Brahimi-Horn et al., 2007) thus rendering the HIF-1α protein 
incapable of mediating transcriptional activation. Thus, hydroxylases confer a two-
pronged oxygen-dependent repression of the HIF pathway. In hypoxia, the repression 
imposed by PHDs and FIH is removed and the HIF pathway is activated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – Summary of the regulation of HIF-1α stability 
A gradient of pO2 from normoxic (left) to hypoxic/ anoxic conditions (right), highlighting the crucial 
events which occur at high pO2 verses events occurring at low pO2 (adapted from Pouyssegur et al., 
2007). 
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1.5 Oxygen-independent regulation of HIF-1α stability/ activity 
Though HIF-1α stability is most frequently associated with hypoxia, non-hypoxic 
regulation has been demonstrated. 
 
1.5.1 Pharmacological 
Iron chelators such as desferoxamine (DFX) bind free iron, such as the iron found in the 
reactive centre of the PHDs, thus are able to mimic hypoxia (Schofield and Ratcliffe, 
2005) by the reducing the availability of iron as a co-factor. Cobalt chloride (CoCl2) is 
another agent which has been used to stabilise HIF-1α in normoxic oxygen conditions 
(Chandel et al., 2001) and this may be due to competition from CoCl2 with iron. 
However, it has been claimed to ‘mimic hypoxia’ by inhibiting the interaction between 
HIF-1α and the VHL protein by direct binding to HIF-1α (Yuan et al., 2003). It has also 
been reported that transcriptional activity of erythropoitin, glycolytic enzymes and 
vascular endothelial growth factor occurs in response to CoCl2 in human heptoma cells. 
The mechanism of which was attributed to the production of reactive species generation 
via mitochondrial-independent means (Chandel et al., 1998). 
  
1.5.2 Genetic mutations 
The von Hippel–Lindau tumor suppressor protein (pVHL) is encoded by the VHL gene 
and when inactivated is associated with von Hippel–Lindau disease. Maxwell et al., 
1999 demonstrated that renal carcinoma cells (RCC) lacking VHL constitutively 
express both HIF-1α and HIF-2α as well as multiple HIF target genes. This effect is 
observed because VHL-dependent ubiquitination and proteasomal degradation of HIF-
1α and HIF-2α can no longer occur. Hypoxic regulation of HIF could be restored upon 
reintroduction of plasmids encoding the VHL polypeptide (Maxwell et al., 1999). 
 
1.5.3 Growth factors 
HIF-1α concentration can also increase in response to growth factor stimulation. 
However, HIF-dependent growth factor stimulation differs in two important respects 
from the increase in HIF-1α concentration in response to hypoxia. First, growth factor 
stimulation induces HIF-1α expression in a cell type-specific manner and secondly, 
growth factors stimulate the synthesis of HIF-1α via activation of the P13K or MAPK 
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pathways (Fukuda et al., 2002) (Figure 6) and this regulation is not at the level of 
protein stability. 
 
Figure 6 – Growth factor stimulation of                    
HIF-1α protein synthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.5.4 Metabolic intermediates 
Hydroxylation of HIF-1α is required for degradation of HIF-1α by VHL. PHDs catalyse 
HIF-1α hydroxylation using 2-oxoglutarate as a cofactor and generate succinate as an 
end product (Schofield and Ratcliffe, 2004). This mechanism indicates that increased 
levels of succinate could antagonise HIF-1α hydroxylation, leading to HIF activation. 
Indeed, this has been confirmed in cells lacking fumarate hydratase (FH) and succinate 
hydrogenase (SDH) (Pollard et al., 2005), enzymes of the TCA cycle. Loss of function 
mutations in FH and SDH lead to inherited cancer syndromes. Mutations lead to 
increased levels of both succinate and fumarate, sequential metabolites of the 
mitochondrial TCA cycle, which have been shown to inhibit PHD and to increase HIF-
1α protein levels.  
 
1.5.5 S-nitrosylation 
In murine tumours, exposure to ionising radiation stimulated the generation of NO in 
tumour associated macrophages. As a result, the HIF-1α protein is S-nitrosylated at 
Cys533 in the ODD domain, which prevents its destruction. Importantly, this 
mechanism appears to be independent of the prolyl hydroxylase-based pathway that is 
involved in oxygen-dependent regulation of HIF-1α. Selective disruption of this S-
 
 
Growth factor binding to a cognate 
receptor tyrosine kinase activates the 
phosphatidylinositol 3-kinase (PI3K) and 
mitogen-activated protein kinase 
(MAPK) pathways. The effect of growth 
factor signalling is an increase in the rate 
at which a subset of mRNAs within the 
cell (including HIF-1α mRNA) are 
translated into protein (Semenza, 2003). 
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nitrosylation significantly attenuated both radiation-induced and macrophage-induced 
activation of HIF-1α (Li et al., 2007). 
 
1.5.6 Free radicals 
Recent data has shown that free radicals play a role in the regulation of HIF-1α 
stabilisation (Klimova and Chandel, 2008). Some authors have proposed a model in 
which ROS (section 1.6) generation increases under hypoxia. As early as 1998, Chandel 
et al., reported ROS generation from the mitochondria were sufficient to trigger HIF-1α 
DNA binding activity and mRNA expression of EPO and VEGF (downstream HIF-1α 
targets) in human hepatoma cells. They later reported that during hypoxia, superoxide 
was generated at Complex III of the mitochondrial electron transport chain. This 
superoxide passes into the cytosol via anion channels where is converted to hydrogen 
peroxide (H2O2) which induces PI3K and protein phosphatase activity leading to HIF-
1α stabilisation and transcription of downstream target genes in hypoxic cells (Chandel 
et al., 2000a). Data obtained by Agani et al., 2000 demonstrated that inhibitors of the 
electron transport chain, specifically at Complex I, blocked HIF-1α expression in mice 
exposed to a hypoxic environment. These data are also supported by evidence from 
human ape xenomitochondrial cybrids (HAXC) (the introduction of mtDNA from non-
human apes into a human cells lacking mtDNA), where a decrease in HIF-1α expression 
was observed. Mitochondrial Complexes II, III, IV and V had activities 
indistinguishable from parental human or non-human primate cells. However, there was 
a 40% reduction in the activity (VMax) of the electron transport chain at Complex I 
(Agani et al., 2000), consequently there would be no ROS generated from the 
mitochondria as Complex I lies upstream of Complex III (section 1.6.2.5). 
 
Although several groups have confirmed the above data (Guzy et al., 2005;Brunelle et 
al., 2005), the generation of free radicals in hypoxia and their effect of stabilising HIF-
1α remains controversial since there is evidence to the contrary. For example, Genius 
and Fandrey, demonstrate decreased NADPH oxidase (section 1.6.2.2) ROS production 
in hypoxia (Genius and Fandrey, 2000). Another group, in 2001, demonstrated that 
HIF-1 activation does not require an active mitochondrial respiratory chain. Their data 
shows that cells without functional mitochondria (Rho0), generated by prolonged 
exposure to ethidium bromide have a normal response to hypoxia, measured at the level 
of HIF-1α stabilisation, translocation and its transcriptional activation activity. 
Furthermore, over expression of catalase (section 1.7.3), which degrades hydrogen 
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peroxide, either in the mitochondria or cytosol, fails to modify the hypoxic response, 
indicating hydrogen peroxide is not a signalling molecule in the hypoxic signalling 
cascade (Srinivas et al., 2001). 
 
Vaux et al., 2001 studied HIF-1α stabilisation and the HIF target gene, glucose-
transporter-1, in a variety of Rho0 cells or in cells which had other genetic defects in 
mitochondrial respiration. HIF induction by hypoxia was essentially normal in all cells 
tested. Hydrogen peroxide production was measured and found to be reduced in Rho0 
versus wild-type cells and further reduced by hypoxia. Furthermore, concentrations of 
rotenone that maximally inhibited respiration did not affect HIF activation by hypoxia 
(Vaux et al., 2001). These data do not support the model of ROS-induced HIF-1α 
stabilisation and indicate that a functional respiratory chain may not be necessary for the 
regulation of HIF by ROS. 
 
The demonstration of free radical generation in hypoxia, and more specifically from the 
mitochondria remains contentious, largely due to methodologies used to measure free 
radicals. The formation of ROS and RNS may be monitored using a variety of 
procedures including fluorometric and spectrophotometric methods, chemiluminescence 
and electron paramagnetic resonance (Chance et al., 1979;Pou et al., 1989;Tarpey and 
Fridovich, 2001). These methods rely on the redox properties of specific ROS and RNS, 
and therefore are prone to artefacts (or false positive results) caused by species of 
similar reactivity or by reactive intermediates produced by the probe itself (Picker and 
Fridovich, 1984;Faulkner and Fridovich, 1993;Liochev and Fridovich, 1995;Liochev 
and Fridovich, 1998). Specific inhibitory enzymes may be added to unequivocally 
identify the species (such as superoxide dismutase or catalase to eliminate superoxide or 
hydrogen peroxide, respectively) but these enzymes do not determine whether ROS are 
the primary species or rather intermediates formed in the detection reaction. For 
example, it has been reported that superoxide was produced by the enzyme glucose 
oxidase since superoxide dismutase inhibited the reduction of nitroblue tetrazolium in 
the presence of glucose, when in fact the probe was reacting with the enzymes 
prosthetic group and superoxide was formed after this reaction (al-Bekairi et al., 
1994;Liochev and Fridovich, 1995). Similar results have been demonstrated with 
luminol and lucigenin (Liochev and Fridovich, 1998). 
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Studies using visible light spectroscopy (VLS) have shown that generation of ROS 
occurs at low oxygen concentration ([O2]) (3% O2) in the murine monocytic cell line, 
RAW246.7 and that it is dependent on the redox state of the electron transport chain 
(Palacios-Callender et al., 2004), which is regulated by the interaction of NO on 
cytochrome c oxidase (Cooper and Giulivi, 2007). This has led to the suggestion that 
free-radical dependent stabilisation of HIF-1α is indeed a possible mechanism of HIF-
1α stabilisation, particularly in pathological conditions such as cancer which are known 
to be associated with particularly high free-radical generation (Quintero et al., 2006a). It 
also opens up the possibility of NO taking part in this regulation in situations in which 
the redox status of the oxidative-phosphorylation chain is reduced in the presence of 
enough oxygen to favour the generation of ROS. This might occur as a result of the 
relative ratio between [O2] and [NO] but not in hypoxia, where although the oxidative-
phosphorylation chain is reduced there might not be enough oxygen to allow free-
radical generation (Palacios-Callender et al., 2004). 
 
1.6 Free radicals 
1.6.1 Introduction 
Reactive oxygen species (ROS) are oxygen-derived small molecules, including oxygen 
radicals (superoxide (O2-·), hydroxyl (·OH), peroxyl (RO2·), and alkoxyl (RO·)) and 
certain non-radicals that are either oxidising agents and/or easily converted into radicals, 
such as hypochlorous acid (HOCl), ozone (O3), singlet oxygen (1O2) and hydrogen 
peroxide (H2O2). Nitrogen-containing oxidants, such as nitric oxide (NO), are called 
reactive nitrogen species (RNS).  
 
The presence of free radicals in biological systems was discovered more than 50 years 
ago (Commoner et al., 1954). Shortly thereafter, it was hypothesised that oxygen 
radicals could be by-products formed through enzymatic reactions in vivo (Harman, 
1956). Denham Harman described free radicals as a Pandora’s box of evils that may 
account for cellular damage, mutagenesis, and cancer and could play a role in biological 
ageing. However, one beneficial function of ROS production was also realised, namely, 
the importance of ROS in host defence, highlighted by deficiency in ROS generation 
and reduced killing ability of leukocytes. Over the last few decades, however, ROS have 
been shown to play an important role as regulatory mediators in signalling processes 
(Forman and Torres, 2002;Quintero et al., 2006b;Colombo and Moncada, 2009). 
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1.6.2 Physiological sources of ROS 
1.6.2.1 Introduction 
In mammalian cells, ROS can be formed in response to toxic reagents or as products of 
O2-utilising enzymes such as those in NADPH oxidases, xanthine oxidase, NO 
synthases (NOS) and the mitochondrial respiratory chain. 
 
1.6.2.2 Nicotamide adenine dinucleotide phosphate (NADPH)-oxidases 
 
1.6.2.2.1 Introduction 
The NADPH oxidase (NOX) family are proteins that transfer electrons across biological 
membranes and have emerged as a major source of ROS in signal transduction (Brown 
and Griendling, 2009). NADPH oxidase proteins are membrane-associated, multiunit 
enzymes that catalyse the reduction of oxygen using NADPH as an electron donor, 
producing superoxide via a single electron reduction. The electron travels from NADPH 
down an electrochemical gradient first to flavin adenine dinucleotide (FAD), then 
through the NOX heme groups, and finally across the membrane to oxygen, forming 
superoxide (Figure 7). Historically, the NADPH oxidase was known as the source of 
phagocyte respiratory burst; however, in the past 15 years NOX family members and 
the ROS they produce have been identified as important contributors to many signalling 
pathways (Brown and Griendling, 2009). 
 
1.6.2.2.2 Discovery 
The first body of research to be undertaken into NOX proteins was carried out in 
neutrophils, whilst studying the respiratory burst NADPH oxidase complex (Babior et 
al., 1973). The catalytic subunit of this protein is now known as NOX2, or gp91phox. 
This phagocytic NADPH oxidase (NOX2) enzyme actively generates superoxide, and 
plays a key role in host defence. This enzyme consists of the integral membrane 
subunits gp91phox and p22phox, which form the heme-containing catalytic core of the 
enzyme termed flavocytochrome b558 (Bedard and Krause, 2007) which are dispersed 
between the cytosol and the membranes whilst inactive. The other components of the 
NADPH complex (p47phox, p67phox, p40phox and small G-protein Rac1/2) are cytosol 
proteins. The activation of phagocytes by various stimuli triggers the phosphorylation of 
the p47phox, p67phox and p40phox cytosolic components and their translocation to the 
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plasma membrane, where they interact with flavocytochrome b558. Concomitantly, Rac2 
dissociates from its RhoGDP dissociation inhibitor, which allows it to interact with 
flavocytochrome b558 to form a binding partner for p67phox. This allows transfer of 
electrons from NADPH to oxygen resulting in the rapid elevation of superoxide levels 
(Figure 7) (Kietzmann and Gorlach, 2005).  
 
During the discovery of the phagocytic NADPH oxidase in the 1980’s, a series of 
observations suggested that similar enzyme systems existed in many other cell types 
including fibroblasts, tumour cells, endothelial cells and vascular smooth muscle cells 
(Bedard and Krause, 2007). However, new NOX family members have only been 
cloned and studied in the past decade. The first homologue of NOX2 to be cloned was 
NOX1, originally described in 1999 as MOX1 (Suh et al., 1999), and by a separate 
group as NOH-1 (Banfi et al., 2000). Dual oxidase (DUOX) enzymes (longer 
homologues of NOX2) were cloned shortly after NOX1. In 2000, NOX3 was described 
as a gp91phox homologue expressed in foetal kidney and a cancer cell line (Kikuchi et 
al., 2000). NOX3 was later determined to be primarily expressed in the inner ear in 
adults (Banfi et al., 2004a) NOX4, was discovered in the kidney (Geiszt et al., 
2000;Shiose et al., 2001), and soon afterwards was described in osteoclasts (Yang et al., 
2001). NOX5 was discovered in 2001 by two different groups (Cheng et al., 2001;Banfi 
et al., 2004b). 
 
1.6.2.2.3  Structure and activation 
Structurally, all members of the NOX family contain at least six transmembrane 
domains and cytosolic FAD and NADPH binding domains. NOX1-4 lack extra 
functional domains that NOX5 and DUOX1 /2 contain (Figure 7). A number of 
regulatory subunits have been identified for the NOX isoforms. Activation can occur as 
a result of various stimuli such as angiopoietin-1, angiotensin II (AngII), insulin, 
thrombin and VEGF. These stimuli alter the activity and/or expression of the NOX 
proteins and subunits, and ultimately the amount of ROS produced. Activation 
mechanisms for NOX1-3 are similar, and involve complex formation with regulatory 
cytosolic subunits. Regulation of NOX4 is poorly understood, but may be primarily at 
the expression level (Krause, 2004). In contrast, NOX5 and the DUOXs appears to be 
activated by calcium (Ca2+) (Banfi et al., 2001;Meziane-El-Hassani et al., 2005). 
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Figure 7 – NADPH oxidase family 
NADPH oxidase (NOX2) is a multiunit enzyme system that catalyses the NADPH-dependent reduction 
of oxygen to O2•−. NOX2 comprises a membrane-bound gp91phox/p22phox heterodimer and other subunits 
(p67phox, p47phox, p40phox and Rac), which associate with this complex in the activated enzyme. Six 
homologues (NOX1, NOX3, NOX4, NOX5, DUOX1 and DUOX2) with levels of identity with NOX2 
have been identified. NOXO1 and NOXA1, which may interact with NOX1 and NOX4, are two 
homologues of p67phox and p47phox respectively. NOX family homologues have putative NADPH- and 
flavin-binding sites, as well as functional oxidase activity that produces O2•−. NOX5, DUOX1, and 
DUOX2 also have a Ca2+-binding site, whereas DUOX1 and DUOX2 have an additional transmembrane 
and a peroxidase-like domain. 
 
1.6.2.2.4 NOX derived ROS and the relationship of NOX to other sources of ROS  
Superoxide is the primary product of NOX enzymes. Superoxide can dismutate to a 
secondary signalling molecule intermediate; hydrogen peroxide, either spontaneously or 
enzymatically via superoxide dismutase (SOD) (section 1.7.2). As a consequence, 
superoxide must be produced in very close proximity to its target to be effective as a 
signalling molecule. Superoxide is also capable of reacting with nitric oxide, forming 
highly reactive peroxynitrite. This inactivates nitric oxide, resulting in pathological 
consequences particularly in vascular endothelial cells (1.6.4.1). Superoxide also reacts 
with iron-sulphur (FeS4) clusters within proteins, which may release ferric ions (Panov 
et al., 2005). In the case of aconitase, superoxide inactivates the enzymes, leading to 
reduced mitochondrial function (Gardner et al., 1995). Superoxide is also known to 
react with protein thiols such as cysteine residues, but it has also been demonstrated that 
the reaction rate of SOD converting superoxide to hydrogen peroxide is much faster 
than the reaction rate of biothiols (Forman et al., 2004).  
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Hydrogen peroxide is more stable than superoxide and is also capable of crossing 
biological membranes. Hydrogen peroxide formation is tightly regulated by catalase, 
glutathione and peroxiredoxins (section 1.7), which convert hydrogen peroxide to water 
and other metabolites. 
 
NADPH oxidases are not the only source of ROS-producing molecules expressed 
physiologically (see below) and there appears to be a reciprocal relationship between 
many of these sources of ROS. For example, exposure of endothelial cells to oscillatory 
shear stress leads to NOX-dependent activation of xanthine oxidase (McNally et al., 
2003), while Ang II stimulation results in mitochondrial ROS production downstream 
of NOX activation (Dikalov et al., 2008). Endothelial NOS (eNOS) uncoupling has also 
been shown to be a direct result of NOX activation (Landmesser et al., 2003). It 
therefore seems that NOX enzymes play roles as initiators and integrators of redox 
signalling via cross talk with other ROS-producing enzymes (Brown and Griendling, 
2009). 
 
1.6.2.3 Xanthine oxidoreductase 
Xanthine oxidoreductase (XOR) is a meloflavoprotein enzyme that exists in two 
interconvertible, although functionally distinct forms, namely, xanthine dehydrogenase 
(XD) and xanthine oxidase (XO). Of them, only the latter generates superoxide by the 
oxidation of hypoxanthine to uric acid using molecular oxygen as the electron acceptor 
(Puddu et al., 2008). Usually levels of XO activity are un-measurable in most cell types, 
although XO may play an important role in vascular superoxide generation in 
experimental models of type I diabetes (Forbes et al., 2008). Xanthine oxidase is also 
activated by pro-inflammatory mediators and is up-regulated by NADPH oxidase 
activation. In vitro experiments with endothelial cells have shown that incubation with 
apocynin (a NAPDH oxidase inhibitor) or disruption of gp47phox gene markedly 
decreases XO expression and activity (McNally et al., 2003). 
 
1.6.2.4 Nitric oxide synthases (NOS) 
Nitric oxide (NO) is a stable, hydrophobic, diatomic radical gas, which is both lipid and 
water-soluble. It is produced by the catalytic conversion of L-arginine to L-citrulline by 
one of three nitric oxide synthase (NOS) isoforms (Palmer et al., 1987;Bredt and 
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Snyder, 1990;Pollock et al., 1991;Stuehr et al., 1991a). Each isoform requires several 
co-factors for the reaction, including nicotinamide adenine dinucleotide phosphate 
(NADPH), tetrahydrobiopterin (BH4), flavin adenine dinucleotide (FAD), 
flavinmononucleotide (FMN), calmodulin (CaM) and O2 (Knowles and Moncada, 
1994). The catalytic reaction involves two steps. L-arginine is initially hydroxylated to 
NGhydroxy-L-arginine (NOHA; (Stuehr et al., 1991b)) followed by NOHA oxidation to 
equimolar quantities of NO and L-citrulline (Lirk et al., 2002). 
 
There are three major isoforms of NOS: neuronal NOS (nNOS), endothelial NOS 
(eNOS) and inducible NOS (iNOS). They all exist as homodimers in their active form, 
share 50–60% sequence homology and show 80–90% conservation among species 
(Forstermann and Kleinert, 1995). 
 
Endothelial-derived NO is a paracrine factor that controls vascular tone, inhibits platelet 
function, prevents adhesion of leukocytes and reduces proliferation of the intima. An 
enhanced inactivation and/or reduced synthesis of NO is seen in conjunction with risk 
factors for cardiovascular disease (section 1.6.4.1). This condition, referred to as 
endothelial dysfunction, can promote vasospasm, thrombosis, vascular inflammation 
and proliferation of vascular smooth muscle cells. Vascular oxidative stress with an 
increase in ROS contributes to mechanisms of vascular dysfunction. Oxidative stress is 
mainly caused by an imbalance between the activity of pro-oxidative enzymes and anti-
oxidative enzymes, in favor of the former. Increased ROS concentrations reduce the 
amount of bioactive NO by chemical inactivation to form toxic peroxynitrite. 
Peroxynitrite in turn can uncouple eNOS to become a dysfunctional superoxide-
generating enzyme that contributes to vascular oxidative stress. Oxidative stress and 
endothelial dysfunction can promote atherogenesis (section 1.6.4.1) (Forstermann, 
2010). 
 
Inducible NO provides a primary defense mechanism against tumour cells and 
intracellular and extracellular microorganisms in macrophages (Moncada and Higgs, 
1993). The ‘high output’ NO from iNOS is cytotoxic and cytostatic and is thus 
important in combating bacterial infections. During the course of an inflammatory 
response, stimulated macrophages produce high levels of NO that surpass physiological 
concentrations and this diffuses to target cells (e.g. bacteria, fungi or tumour cells) 
where it causes DNA damage, low density lipoprotein (LDL) oxidation, isoprostane 
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formation, tyrosine nitration and inhibits mitochondrial respiration (Guzik et al., 2003). 
NO binds with iron-sulphur centres in key enzymes involved in the target’s respiratory 
chain and DNA synthesis pathway. NO target enzymes include aconitase, which is part 
of the TCA cycle, reduced nicotinamide adenine dinucleotide (NADH) dehydrogenase, 
which belongs to Complex I of the mitochondrial respiratory pathway, succinate 
dehydrogenase part of mitochondrial Complex II and ribonucleoside-diphosphate 
reductase, which is essential in DNA synthesis (Moncada and Higgs, 1993). The high 
NO levels are usually paralleled with the production of superoxide anion. Nitric oxide 
and oxygen combine forming peroxynitrite, which complements the cytotoxic effects of 
NO (Linares et al., 2001). Animal models and human clinical data have demonstrated 
the importance of iNOS and ‘high output’ NO in the development of septic shock, a 
heightened inflammatory response (Ochoa et al., 1991;Liu et al., 1993). 
 
1.6.2.5 Mitochondrial 
 
1.6.2.5.1 Introduction 
The mitochondria are the largest consumers of oxygen and the electron transport chain 
(ETC) is responsible for most of the ROS produced in human tissues (Chance et al., 
1979). Mitochondrial respiration accounts for approximately 90% of cellular oxygen 
uptake, and as much as 3% of the oxygen consumed is converted to ROS (Turrens, 
2003). This ROS production contributes to a range of pathologies and is also involved 
in redox signalling from the organelle to the rest of the cell (Droge, 2002;Balaban et al., 
2005). 
 
1.6.2.5.2 Sites of superoxide formation in the respiratory chain 
There are a variety of respiratory components, including flavoproteins, iron-sulphur 
clusters and ubisemiquinone that are thermodynamically capable of transferring one 
electron to oxygen. Moreover, most steps in the respiratory chain involve single-
electron reactions, which favours the reduction of oxygen. However, only a small 
proportion of mitochondrial electron carriers with the thermodynamic potential to 
reduce oxygen to superoxide do so (Murphy, 2009). 
 
Superoxide formation occurs on the outer mitochondrial membrane, in the matrix and 
on both sides of the inner mitochondrial membrane (Figure 8). Whilst the superoxide 
generated in the matrix is eliminated in that compartment by superoxide dismutase 
Chapter one: Introduction 
 
 47
(section 1.7.2), part of the superoxide produced in the intermembrane space may be 
carried to the cytoplasm via voltage-dependent anion channels (Han et al., 2003). The 
relative contribution of every site to the overall superoxide production varies from organ 
to organ and also depends on whether the mitochondria are actively respiring (State 3) 
or the respiratory chain is highly reduced (State 4) (Barja, 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 – Sites of superoxide formation in the respiratory chain 
Various respiratory Complexes leak electrons to oxygen producing primarily superoxide anion (O2−•). 
This species may reduce cytochrome c (in the intermembrane space), or may be converted to hydrogen 
peroxide (H2O2) and oxygen (in both the matrix and the intermembrane space). Increased steady state 
concentrations of O2−• may reduce transition metals (which in turn react with H2O2 producing hydroxyl 
radicals (OH•)) or may react with nitric oxide to form peroxynitrite. Both OH• and peroxynitrite are 
strong oxidants which indiscriminately react with nucleic acids lipids and proteins (Turrens, 2003). 
 
 
The rate of superoxide formation by the respiratory chain is controlled primarily by 
mass action, increasing both when electron flow slows down (increasing the 
concentration of electron donors) and when the concentration of oxygen increases 
(Turrens et al., 1982). The energy released as electrons flow through the respiratory 
chain is converted to a proton (H+) gradient through the inner mitochondrial membrane 
(Mitchell, 1977). This gradient in turn, dissipates through the ATP synthase (Complex 
V) and is responsible for the turning of a rotor-like protein Complex required for ATP 
synthesis (Noji and Yoshida, 2001). In the absence of ADP, the movement of protons 
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through ATP synthase ceases and the proton gradient builds up causing electron flow to 
slow down and the respiratory chain to become more reduced (State 4 respiration). As a 
result, the physiological steady state concentration of superoxide formation increases 
(Boveris et al., 1972).  
 
1.6.2.5.3 Sites of nitric oxide formation in the respiratory chain 
Two separate laboratories have discovered that the mitochondrial matrix contains a 
unique form of NOS (Ghafourifar and Richter, 1997;Giulivi et al., 1998;Alvarez et al., 
2003). It appears this formation of NO in the mitochondria may have important 
consequences, as this NO binds to haem groups from cytochromes (in particular 
cytochrome c oxidase) and inhibits respiration (Poderoso et al., 1996). In turn, this may 
stimulate superoxide formation, which in turn may react with NO forming peroxynitrite, 
a strong oxidant capable of inhibiting enzymes and affecting mitochondrial integrity 
(Cassina and Radi, 1996;Radi et al., 2002). 
 
1.6.2.5.4 Mitochondrial ROS formation during hyperoxia 
Mitochondrial production of superoxide increases with oxygen concentration. The 
proportion of oxygen converted into superoxide in vitro ([O2] = 220 μM) accounts for 
approximately 1-3% of the overall oxygen consumption. In vivo, particularly in tissues 
not exposed to atmospheric oxygen, the proportion of oxygen converted to superoxide is 
likely to be smaller since the intramitochondrial oxygen concentration is between 3 and 
30 μM (Wittenberg and Wittenberg, 1989). As oxygen concentrations increase, the rate 
of mitochondrial superoxide production increases linearly (Turrens et al., 1982). 
However, the release of hydrogen peroxide from mitochondria is biphasic, increasing at 
a faster rate above 60% oxygen (Turrens et al., 1985). The slower release of hydrogen 
peroxide at lower pO2 suggests that the mitochondrial antioxidant defences (section 
1.7.2) can compensate for sudden increases in the concentration hydrogen peroxide. 
These defences become overwhelmed at higher pO2, which explains the mitochondrial 
alterations observed in the lungs of animals exposed to oxygen concentrations above 
60% (Crapo et al., 1983).  
 
Under normobaric hyperoxic conditions, the lungs are the only organs affected by ROS, 
since they are in direct contact with atmospheric oxygen. Under hyperbaric conditions, 
however, more oxygen is dissolved in the plasma, and therefore other tissues become 
exposed to a hyperoxic environment. Under these conditions, the brain is the first organ 
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to show the effects of an increased ROS formation, resulting in convulsions (Turrens, 
2003). 
 
1.6.2.5.5 Mitochondrial ROS formation during hypoxia 
The formation of ROS should decrease with hypoxia, since mitochondrial activity is 
proportional to ROS. However the paradoxical increase in oxidative stress under 
moderately hypoxic conditions (1.5% oxygen, equivalent to an oxygen concentration of 
around 16 μM) has been reported (Schumacker, 2002;Waypa and Schumacker, 2002). 
These studies show that when cells are incubated with dichlorofluorescin, a fluorescent 
probe for ROS, hypoxia increases fluorescence in cells with functioning mitochondria 
(Chandel et al., 1998). Mutants without a functioning respiratory chain do not show this 
increase in fluorescence (Chandel et al., 1998;Schroedl et al., 2002). This response is 
eliminated when cells are made severely hypoxic (Schumacker, 2002). The proposed 
increase in ROS formation during hypoxia is paradoxical, given the high affinity of 
cytochrome c oxidase for oxygen; at low pO2 any remaining oxygen should be reduced 
to water by the terminal oxidase. However, two factors may contribute to an increase in 
mitochondrial superoxide formation. Firstly, under hypoxic conditions, low 
concentrations of NO radical may still be produced since the Km for oxygen of 
mitochondrial NOS is around 30-40 μM (Alvarez et al., 2003). Secondly, NO may bind 
and inhibit cytochrome c oxidase, resulting in an increase in its Km for oxygen and an 
increased reduction of electron carriers located upstream from the terminal oxidase 
(Cooper and Davies, 2000), favouring superoxide formation at low oxygen 
concentrations (Palacios-Callender et al., 2004). 
 
In summary, it has long been recognised that ROS such as superoxide and hydrogen 
peroxide are produced in cells either as by-products during mitochondrial electron 
transport or by several oxidoreductases. Stimulated production of ROS was first 
described in phagocytic cells such as neutrophils and macrophages and was named the 
‘respiratory burst’ due to the transient consumption of oxygen (Arnold et al., 2001). The 
production of ROS has been demonstrated in a variety of cells other than phagocytes 
and several studies have implicated ROS in physiological signalling (Bejarano et al., 
2007). 
 
Chapter one: Introduction 
 
 50
1.6.3 Physiological function of ROS 
 
1.6.3.1 Introduction 
The balance between oxidants and antioxidants is reflected in the redox state within 
cells, and is important in the regulation of gene expression. Indeed, changes in cellular 
redox state may be integrally associated with cell differentiation, progression through 
the cell cycle and ageing processes. In some instances, ROS may act as bona fide 
second messengers. Extracellular ROS can initiate cellular signalling by activation of 
growth factor and cytokine receptors in a manner that does not require the presence of 
the receptor ligands (Hayes and Lockwood, 1987;Kadota et al., 1987;Koshio et al., 
1988;Huang et al., 1996) or via generation of lipid peroxides within cell membranes 
(Suzuki et al., 1997). A variety of stimuli lead to intracellular ROS production. Tumour 
necrosis factor-α (TNF-α) provokes a rise in hydrogen peroxide production from 
mitochondria, and other ROS, via induction of NADPH oxidase (Lo and Cruz, 
1995;Garcia-Ruiz et al., 1997). Interaction of platelet-derived growth factor (PDGF) 
and epidermal growth factor (EGF) with their receptors causes a transient increase in 
hydrogen peroxide. In the case of PDGF, this increase in hydrogen peroxide has been 
shown to be essential for growth induction.  
 
The effects of NO and RNS have been shown to parallel the effects of ROS. It is widely 
recognised that nitric oxide has beneficial physiological effects such as enhancing 
vasodilatation and inhibiting formation of platelet thrombi and, therefore, is protective 
against cardiovascular disease (Li and Forstermann, 2000).  
 
1.6.3.2 NOX derived ROS 
The NOX family of proteins has been demonstrated to be essential in normal 
physiology. Expression of NADPH oxidases is ubiquitous in mammals, though the 
individual NOX isoforms have different distributions between tissues (section 1.6.2.2). 
NOX proteins have been shown to regulate many fundamental physiological processes 
including cell growth, differentiation, apoptosis, and cytoskeleton remodelling. In 
addition, they have specialised functions, such as host defence (NOX2) (Rada et al., 
2008), otoconium formation in the inner ear (NOX3) (Krause, 2004), iodination of 
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thyroid hormone (DUOX2) (Milenkovic et al., 2007), and control of vascular tone 
(NOX2) (Cave et al., 2006).  
 
More recently, NOX proteins have been implicated in oxygen sensing. During the 
discovery of the different NOX isoforms, in vitro studies showed that NOX enzymes 
were less active in hypoxia than normoxia (Gabig et al., 1979). In vivo data has 
demonstrated the production of mitochondrial ROS in low oxygen, which activates 
HIF-1α (section 1.5.6). There is also evidence to suggest NADPH oxidase-derived ROS 
(He et al., 2002) are involved in oxygen sensing, but the mechanism is unclear.  
 
1.6.3.3 Cellular signalling 
Reactive oxygen species act through different pathways of signal transduction, making 
use of signalling molecules such as calcium, protein tryrosine phosphatases (PTPs), 
protein tyrosine kinases (PTKs) and transcription factors. 
 
1.6.3.3.1 Intracellular calcium signalling 
The cytosolic free Ca2+ concentration ([Ca2+]c) is an important intracellular messenger 
system. Usually, this concentration is kept low (100 nM) by Ca2+ pumps. In response to 
various stimuli, [Ca2+]c rises to micromolar levels, which leads to the activation of Ca2+-
dependent cellular processes. The rise in [Ca2+]c occurs through Ca2+ influx across the 
plasma membrane and/or through Ca2+ release from intracellular stores. Oxidant 
induced inositol 1,4,5-triphosphate (IP3) release represents one component of the signal 
transduction pathway for Ca2+ release. IP3 promotes the release of Ca2+ ions from stores 
in the endoplasmic reticulum, thus activating protein kinase C (PKC), promoting its 
translocation to the plasma membrane. PKC phospholipase A2 (PLA2) is also activated 
and translocated to the plasma membrane in response to increased ([Ca2+]c. The 
products of PLA2 activity are arachidonic acid and its metabolites, which are primary 
mediators of immune and inflammatory responses.  
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1.6.3.3.2 Protein phosphatases 
Despite its toxicity, hydrogen peroxide is produced as a signalling molecule that 
oxidises critical cysteine residues of effectors such as protein tyrosine phosphatases 
(PTPs) in response to activation of cell surface receptors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Oxidative inactivation of protein tyrosine phosphatases by ROS 
All PTPs possess a redox-regulated cysteine, which catalyses the hydrolysis of protein phosphotyrosine 
residues by the formation of a cysteinyl-phosphate intermediate. Oxidation of this cysteine residue to 
sulfenic acid (RSOH) by H2O2 renders PTP completely inactive. Since the oxidation of PTP is reversible, 
PTPs exist in two forms; an active state with a reduced cysteine or an inactive state with an oxidised 
cysteine. Inactivation of PTP is associated with increased activation of protein tyrosine kinases (PTK) and 
mitogen-activated protein kinases (MAPK). 
 
PTPs are involved in the regulation of cell proliferation, differentiation, survival, 
metabolism, and motility by controlling the phosphorylation state of numerous signal-
transducing proteins. The catalytic domain of PTPs contains a conserved region with a 
single cysteine residue, which are susceptible to oxidative inactivation. Mutation or 
oxidation of this cysteine renders the enzymes inactive (Chiarugi and Cirri, 2003). 
Inactivation of PTP is associated with increased activation of protein tyrosine kinases 
(PTK) and mitogen-activated protein kinases (MAPK). 
 
Until recently, it had remained unclear how, even in the presence of the abundant 
detoxification enzymes peroxiredoxin (Prx) I and II (section 1.7.6), hydrogen peroxide 
can accumulate in the cytosol to a concentration sufficient for it to modify target 
H2O2
Oxidation
Reduction
PTP-cysteine-S-
• Reduced
• Active
PTP-cysteine-SOH
• Oxidised
• Inactive
H2O
PTK PTK
MAPK MAPK
Cell growth, apoptosis, survival
Chapter one: Introduction 
 
 53
proteins. Woo et al., 2010 show that PrxI associated with membranes is transiently 
phosphorylated on tyrosine-194 and thereby inactivated both in cells stimulated via 
growth factor or immune receptors in vitro and those at the margin of healing cutaneous 
wounds in mice. The localised inactivation of PrxI allows for transient accumulation of 
hydrogen peroxide around membranes, where signalling components are concentrated, 
while preventing the toxic accumulation of hydrogen peroxide elsewhere. In contrast, 
PrxII was inactivated not by phosphorylation but rather by hyper-oxidation of its 
catalytic cysteine during sustained oxidative stress (Woo et al., 2010). 
 
1.6.3.3.3 Protein kinases 
Numerous studies (Bauskin et al., 1991;Devary et al., 1992;Abe et al., 1997;Kurata, 
2000) have found that oxidant treatment of cells produces elevations in protein 
phosphorylation and various protein kinases. The p38 mitogen-activated protein kinases 
(MAPK) are one of the most extensively studied families of protein kinases. There is 
evidence for activation of the MAPK system by NADPH oxidases, specifically NOX4 
(Brown and Griendling, 2009). This is thought to be due to the activation of signalling 
pathways upstream of ERK1/2 kinase, or it may be an indirect effect due to the 
inhibition of phosphatase activity by ROS (Figure 9) (Touyz, 2004). 
 
Another important kinase signalling pathway involves protein kinase C (PKC). PKC is 
not a single enzyme, rather PKC arises from a family of at least 12 related enzymes. The 
mechanism of activation involves lipids, calcium and PKC phosphorylation (Newton, 
1997). Reactive oxygen species have also been demonstrated to activate members of the 
PKC family (Newton, 1995;Nishizuka, 1995). Treatment of cells with hydrogen 
peroxide stimulates PKC activity (Larsson and Cerutti, 1989;Whisler et al., 1995). 
Hydrogen peroxide can induce tyrosine phosphorylation of PKC, enhancing its activity 
(Konishi et al., 1997). PKCs also contain structural motifs that are susceptible to redox 
modification. Selective oxidation within the amino-terminal domain, which contains a 
zinc-thiolate structure, can activate PKC (Gopalakrishna and Anderson, 1989). 
Conversely, oxidative modification within the carboxyl terminal domain inactivates 
PKC (Gopalakrishna and Anderson, 1989). Hence, PKC is subject to dual redox 
regulation, with lower levels of ROS stimulating its activity but higher levels inhibiting 
it (Gopalakrishna and Anderson, 1991;Jackson et al., 2002).  
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1.6.3.3.4 Transcirption factor, NF-κB  
There is experimental evidence that links NF-κB activity to cellular redox status (Li and 
Karin, 1999). NF-κB regulates the transcription of a host of genes including acute phase 
genes, cytokines and cell surface receptors (Baeuerle and Baltimore, 1996;Baeuerle and 
Henkel, 2003;Epstein et al., 2009). Hydrogen peroxide treatment of many cell types 
activates NF-κB (Schreck et al., 1991;Meyer et al., 1993;Manna et al., 1998;Wang et 
al., 1998) and in some systems antioxidants have been demonstrated to reduce or block 
NF-κB activation (Schreck et al., 1991;Meyer et al., 1993;Manna et al., 1998). 
However, hydrogen peroxide does not stimulate NF-κB activation in all cells suggesting 
that it is not a general mediator of NF-κB activation process (Anderson et al., 1994). 
Various other stimuli including pro-inflammatory cytokines and bacterial endotoxins 
have been shown to activate NF-κB (Li and Karin, 1999). It has been suggested that 
intracellular ROS levels may be involved in the stimulatory mechanism since treatment 
with these agents increases intracellular ROS levels, and antioxidant treatment can 
prevent NF-κB activation by these agents (Beg et al., 1993;Manna et al., 1998). 
 
Cells may respond to changes in environmental exposure to oxidative stress and to 
endogenous free radical production by increasing or decreasing cell proliferation, 
changing immune response or by induction of apoptotic cell death. In contrast, extreme 
levels of oxidative stress may give rise to necrotic cell death. 
 
1.6.4 Pathophysiological function of ROS 
 
1.6.4.1 Cardiovascular disease 
Oxidative stress in vascular disease (specifically a relative overproduction of ROS), 
contributes markedly to endothelial dysfunction. In the state of oxidative stress, the 
production of ROS exceeds the available antioxidant defence systems. In the case of 
NO, as a consequence, its bioavailability is reduced. A dominant mechanism reducing 
bioavailability of vascular NO related to it rapid oxidative inactivation by the ROS 
superoxide. In addition, there is evidence that persisting oxidative stress will render 
eNOS dysfunctional such that it no longer produces NO, but superoxide (Forstermann, 
2010). Risk factors for cardiovascular disease include hypertension (Li et al., 2006), 
diabetes mellitus (Hink et al., 2001), hyperchloesterlemia (Warnholtz et al., 1999) and 
atherosclerosis (Sorescu et al., 2002). These risk factors lead to a dramatic increase in 
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ROS in the vascular wall, a situation that culminates into oxidative stress. There are 
several enzymes that can potentially produce ROS in the vessel wall. Four major 
sources include NOX, xanthine oxidase, dysfunctional eNOS and enzymes of the ETC 
(section 1.6.2).  
 
Several isoforms of superoxide-producing NOX oxidases exist in vascular wall. 
Evidence for an inactivation of NOX in the vasculature has been provided in animal 
models of vascular disease such as angiotensin II-induced hypertension (Fukui et al., 
1997;Matsuno et al., 2005), genetic hypertension (Li et al., 2006), diabetes mellitus 
(Hink et al., 2001) and hyperchloesterlemia (Warnholtz et al., 1999). In atherosclerotic 
arteries, there is also evidence for increased expression of NADPH oxidase subunits 
gp91phox (NOX2) and NOX4 (Sorescu et al., 2002); angiotensin II leads to an 
overexpression of NOX1 (Matsuno et al., 2005). A confirmation of the role of NOX-
derived ROS in hypertension and atherosclerosis came from studies with genetic 
disruption of subunits of the enzyme. Knockout of p47phox subunit reduced blood 
pressure responses to angiotensin II and diminished atherogenesis in apolipoprotein E 
(apoE) -/- mice (Barry-Lane et al., 2001;Landmesser et al., 2002). 
 
Xanthine oxidase readily donates electrons to molecular oxygen, thereby producing 
superoxide. Oxypurinol, an inhibitor of XO, has been shown to reduce superoxide 
production and improve endothelium-dependent vascular relaxations to acetylcholine in 
blood vessels from hyperlipidemic animals (Ohara et al., 1993). This suggests a 
contribution of XO to endothelial dysfunction in early hyperchloesterlemia. The source 
of XO is not entirely clear, but increased levels of cholesterol have been shown to 
stimulate the release of the enzyme from the liver into the circulation. The circulating 
XO can then associate with endothelial glycosaminoglycans (White et al., 1996).  
 
Superoxide production from the mitochondria is largely generated from two locations 
within the respiratory chain. However, the amount of superoxide released from the 
mitochondria also depends on the activity of Mn-containing superoxide dismutase-2 
(SOD, section 1.7.2) located in the mitochondrial matrix. There is evidence to suggest 
that some cardiovascular diseases are associated with mitochondrial dysfunction 
(Ramachandran et al., 2002) and that mitochondrial ROS production may be linked to 
the development of early atherosclerotic lesions (Ballinger et al., 2002). Mitochondrial 
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dysfunction, arising from SOD2 deficiency, increases mitochondrial DNA (mtDNA) 
damage and accelerates atherosclerosis in apoE -/- mice (Ohashi et al., 2006). 
 
Nitric oxide synthase (NOS) enzymes contain four redox active prosthetic groups 
(FAD, FMN, heme and BH4) that, in principle, could pass electrons to oxygen (Heinzel 
et al., 1992;Masters et al., 1996;Xia et al., 1998;Pou et al., 1999). Electron transfer to 
NOS enzymes needs to be tightly controlled to prevent uncoupling of oxygen reduction 
from nitric oxide synthesis that will turn a functional NOS into a dysfunctional 
superoxide generating enzyme (Stuehr et al., 2001). Evidence for eNOS uncoupling has 
been obtained in peroxynitrite-treated rat aorta (Laursen et al., 2001), in endothelial 
cells treated with low-density lipoprotein (Pritchard, Jr. et al., 1995), and in isolated 
blood vessels from animals with pathphysiological conditions such as stroke prone 
spontaneously hypertensive rats (Kerr et al., 1999), deoxycorticosterone acetate 
(DOCA)- salt hypertension (Mollnau et al., 2002) or streptozotocin-induced diabetes 
(Hink et al., 2001).  
 
1.6.4.2 Cancer 
A hallmark of solid cancer growth is hypoxia. Unregulated cellular proliferation leads to 
formation of cellular masses that extend beyond the resting vasculature, resulting in 
oxygen and nutrient deprivation. The resulting hypoxia triggers a number of critical 
adaptations that enable cancer cell survival, including apoptosis suppression, altered 
glucose metabolism, and an angiogenic phenotype. There is also evidence to suggest 
that oxygen depletion stimulates mitochondria to increase ROS production, with 
subsequent activation of signalling pathways, such as hypoxia inducible factor (HIF)-1α 
(section 1.5.6) that promote cancer cell survival and tumour growth.  
 
Considerable interest has focused on cancers, where the involvement of ROS as 
regulators of cell proliferation and apoptosis is clearly an important factor. ROS-
mediated DNA damage has long been thought to play a role in carcinogenesis initiation 
and malignant transformation (Valko et al., 2006). Hydroxyl radicals, for example react 
with pyrimidines, purines and chromatin protein, resulting in base modifications, 
genomic instability, and alterations in gene expression. Mitochondrial DNA is a 
particularly vulnerable target because of its proximity to the ETC constituents, and is an 
important variable in carcinogenesis (Singh, 2006). Pathological sources of 
transforming ROS include chronic inflammation secondary to infections or chronic 
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chemical irritants such as tobacco smoke and asbestos (Knaapen et al., 2004). 
Transformed cells commonly lack cell cycle checkpoints and over-express oncogene 
growth factors and their tyrosine kinase receptors that drive cell proliferation, ultimately 
leading to tumour formation and chronic hypoxia (Hanahan and Weinberg, 2000).  
 
Several tyrosine kinase receptors have been shown to signal via ROS-dependent 
mechanisms (Bae et al., 1997). Both the epidermal growth factor (EGF) receptor and 
platelet-derived growth factors (PDGF) receptor signal in part through hydrogen 
peroxide generation (Figure 10). Ligand-induced receptor dimerisation activates 
phosphatidylinositol 3-kinase (PI3K), resulting in inositol 1,4,5-triphosphate (IP3) 
activation of Rac, which, in turn, activates NADPH oxidase (NOX) complex to produce 
superoxide and downstream signalling through superoxide and hydrogen peroxide. 
Hydrogen peroxide modulates signal transduction through its oxidation of the catalytic 
cysteine of protein tyrosine phosphatases, such as PTEN, preventing inactivation of 
tyrosine kinase signalling through activator protein-1 and Akt (Wang et al., 2000) 
(Figure 10). Hydrogen peroxide-mediated inhibition of protein phosphatases contributes 
to both cellular proliferation and apoptosis suppression and links oncogene over-
expression, a hallmark of cancers, with ROS-mediated signalling (Benhar et al., 2002). 
With a few as 300 malignant cells, this can drive cell proliferation beyond the carrying 
capacity of the resting vasculature, producing a hypoxic environment that switches on 
angiogenesis (Li et al., 2000). 
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Figure 10 – Tyrosine kinase signalling (in                
part) through hydrogen peroxide 
Tyrosine kinase receptor signalling is 
amplified by ROS via inhibition of PTEN, 
stimulating cell proliferation and 
suppressing apoptosis. 
 
 
 
 
There is also experimental data from Vaquero et al, 2004 demonstrating that pancreatic 
cancer cells produce ROS, which is stimulated by growth factors (Vaquero et al., 2004). 
The authors demonstrate that inhibition of ROS with antioxidants tiron and NAC or 
with the NADPH oxidase inhibitor, DPI, stimulated apoptosis. They also showed that 
inhibition of ROS with NOX4 antisense over-expression decreased ROS levels and 
stimulated apoptosis. They suggest ROS (most likely generated from NOX4), promote 
survival and act as anti-apoptotic factors in pancreatic cancer cells. Evidence from 
Quintero et al., 2006a has also demonstrated ROS generation in human head and neck 
carcinoma cells in normoxia (21% oxygen), and this was associated with the 
stabilisation of HIF-1α. Treatment with antioxidants prevented the accumulation of 
HIF-1α in these cells.  
 
1.6.4.3 Diabetes 
The hallmarks of type II diabetes include pancreatic β-cell dysfunction and insulin 
resistance. Under diabetic conditions, chronic hyperglycemia and subsequent 
augmentation of ROS deteriorate β-cell function and increase insulin resistance which 
leads to the aggravation of type II diabetes. There are several sources of ROS in cells 
(as previously described) including the ETC in mitochondria and membrane bound 
NADPH oxidase that during diabetic conditions augment ROS production. Acute 
exposure of β-cells to high glucose concentrations stimulates insulin gene expression, 
but chronic exposure has adverse effects on β-cell function. However, chronic 
hyperglycemia causes impairment of insulin biosynthesis and secretion. In the diabetic 
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state, hyperglycemia per se and subsequent ROS production decrease insulin gene 
expression and secretion and finally bring about apoptosis (Kaneto et al., 2010). 
Pancreatic β-cells are also rather vulnerable to ROS as they have a low expression of 
antioxidant enzymes such as catalase and glutathione (Lenzen et al., 1996;Tiedge et al., 
1997) thus the removal of deleterious β-cell ROS is inadequate in diabetic conditions. It 
has been shown that when β-cell-derived cell lines or rat-isolated islets were exposed to 
ROS, insulin gene promoter activity and mRNA expression were suppressed (Kaneto et 
al., 1999;Kaneto et al., 2001). 
 
While the majority of research has concentrated on cardiovascular disease and cancer, 
ROS have been implicated in an array of disorders such as diabetes, degenerative 
neurological disorders including Alzheimer’s and Parkinson’s diseases, autoimmune 
disorders including rheumatoid arthritis and eye disorders including macular 
degeneration (Droge, 2002).  
 
The effects of oxidative stress depend on the cell type, the level of oxidative stress 
experienced, and the protective mechanisms in place in that cell type. Modifications of 
redox-regulated processes may play a role in these conditions. Also the sensitivity of 
cells to oxidative stress depends largely on their intrinsic antioxidant systems, in 
particular the levels of glutathione (GSH) within the cell. 
 
1.7 Antioxidant defence systems 
1.7.1 Introduction 
Antioxidants are substances that, at relatively low concentrations, compete with other 
oxidisable substrates and thus act to significantly delay or inhibit the oxidation of these 
substances (Halliwell and Gutteridge, 1989). In biological systems, these include free 
radical scavenging enzymes such as superoxide dismutase (SOD), and abundant radical 
scavenging chemicals such as glutathione (section 1.7.7). Living cells and tissues have a 
number of mechanisms for re-establishing redox homeostasis after exposure to 
increased free radicals (ROS or RNS) (Droge, 2002). A major mechanism of redox 
homeostasis is based on the ROS-mediated induction of redox sensitive signal cascades 
that lead to increased expression of antioxidant enzymes. 
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1.7.2 Superoxide dismutase  
The formation of ROS is kept under tight control by various antioxidant systems. 
Within the mitochondria, superoxide is enzymatically converted to hydrogen peroxide 
by a family of metalloenzymes called superoxide dismutases (SOD) (Fridovich, 1995). 
Since superoxide may either reduce transition metals, which in turn can react with 
hydrogen peroxide producing hydroxyl radicals or spontaneously react with NO to 
produce peroxynitrite, it is important to maintain steady-state concentration of 
superoxide at the lowest possible level (Turrens, 2003).  
 
There are three mammalian SOD isoforms which include the copper and zinc-
containing SOD (CuZnSOD/ SOD1) (McCord and Fridovich, 1969a), the manganese-
containing SOD (MnSOD/ SOD2) (Weisiger and Fridovich, 1973), and the secreted 
extracellular SOD (ECSOD/ SOD3) (Marklund, 1982). CuZnSOD is composed of two 
identical 16 kDa subunits, each containing one Cu and one Zn atom, and is located in 
the cytosol and nucleus of all cell types (McCord and Fridovich, 1969a). The steady-
state concentration of superoxide in the mitochondrial intermembrane space is 
controlled by CuZnSOD (Okado-Matsumoto and Fridovich, 2001). MnSOD is 
composed of four identical 22 kDa Mn-containing subunits and is found in the 
mitochondrial matrix (Weisiger and Fridovich, 1973) and thus eliminates the superoxide 
formed in the matrix or on the inner side of the inner membrane. The expression of 
MnSOD is further induced by agents that cause oxidative stress, including radiation and 
hyperoxia, in a process mediated by the oxidative activation of NF-κB (Warner et al., 
1996;Tsan et al., 2001;Murley et al., 2001). ECSOD is, unlike the other isoforms, a 
glycoprotein and is composed of four 30 kDa subunits, each containing a Cu and a Zn 
atom. It is secreted by a few distinct cell types (Marklund, 1990) and is primarily 
located in the interstitial matrix of tissues and the glycocalyx of cell surfaces anchored 
to heparan sulfate proteoglycans (Marklund, 1984;Karlsson and Marklund, 1989). A 
small fraction of the ECSOD in the body is found in extracellular fluids such as plasma, 
lymph, synovial fluid, and cerebrospinal fluid (Marklund et al., 1982;Karlsson and 
Marklund, 1988). 
 
In acute and chronic inflammation, the production of superoxide is increased at a rate 
that overwhelms the capacity of the endogenous SOD enzyme defence system to 
detoxify them, resulting in superoxide-mediated cellular damage (McCord and 
Fridovich, 1969b). 
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1.7.3 Catalase 
The enzyme catalase, catalyzes the decomposition of two molecules of hydrogen 
peroxide to water and oxygen (2H2O2 → 2H2O + O2) and is exclusively localised in 
peroxisomes (Woo et al., 2010). The overall biological importance of catalase is not 
completely clear. Homozygous catalase knockout mice develop normally and show no 
abnormalities, indicating that this enzyme is not essential for animal life (Liu et al., 
2008a). Over-expression of catalase, however, has protective effects in the 
cardiovascular system such as delayed development of atherosclerosis (Yang et al., 
2004) and inhibition of angiotensis II-induced aortic wall hypertrophy (Zhang et al., 
2005). Catalase gene expression in micro-organisms is generally controlled either by 
sensors of ROS or by growth phase control mechanisms (Chelikani et al., 2004).  
 
1.7.4 Heme oxygenase 
Heme oxygenase (HO) catalyzes the first step in heme breakdown to generate equimolar 
quantities of carbon monoxide, biliverdin, and free ferrous iron. There is evidence to 
suggest that HO can protect against vascular remodelling and atherogenesis (Stocker 
and Perrella, 2006). HO is induced by oxidative stress. The proposed mechanisms by 
which HO may protect cells include its abilities to degrade the pro-oxidative heme to 
biliverdin. This gets subsequently converted to bilirubin, which has radical-scavenging 
properties. Moreover, bilirubin seems to directly inhibit functional NOX and can also 
interrupt assembly and activation of the enzyme (Jiang et al., 2006). In addition, a 
decrease in heme content caused by HO limits heme availability for maturation of the 
NOX2 subunit of NADPH oxidase, preventing assembly of a functional enzyme and in 
turn reduces cellular ROS generation (Taille et al., 2004).  
 
1.7.5 Thioredoxin  
Thioredoxin (Trx) is a multifunctional low-molecular weight protein containing an 
active thiol/disulfide site and possessing oxidoreductase activity. The major Trx 
isoforms are cytosolic TrxI and mitochondrial TrxII. Human TrxI is substantially 
localised in cytoplasm, but is also found in the cell nucleus and blood plasma. TrxII is 
primarily synthesised in the form of a precursor protein which has a N-terminal 60-
amnio acid sequences eliminated in the course of post-translational proteolysis to form 
TrxII and its transported into the mitochondria (Kalinina et al., 2008). Both TrxI and 
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TrxII can be localised not only within cells, but also in the intracellular space 
(Soderberg et al., 2000). Different cell types including tumour cells secrete TrxI (Powis 
et al., 2000), with secretion appearing not to be sensitive to oxidation (Tanudji et al., 
2003). However, the secretion process can change in the presence of various xenobiotics 
including alkylating agents (Kalinina et al., 2008). Trx has been recognised as a critical 
protective system acting via direct (antioxidant) and indirect (regulation of signal 
transduction) effects (Yamawaki et al., 2003). Trx is present in endothelial cells and 
vascular smooth muscle cells. It appears to exert most of its ROS-scavenging properties 
through Trx peroxidase, which uses endogenous thiol (SH) groups as reducing 
equivalents. Trx reduces the oxidised form of Trx peroxidase and the reduced Trx 
peroxidase scavenges ROS. 
 
1.7.6 Peroxiredoxins 
Peroxiredoxin (Prx) -I to IV belong to the 2-Cys (cysteine) Prx subfamily of Prx 
enzymes, which exist as homodimers and reduce hydrogen peroxide with the use of 
reducing equivalents provided by Trx (Rhee et al., 2005). PrxI and PrxII are localised to 
the cytosol, whereas PrxIII and PrxIV are restricted to the mitochondria and the 
endoplasmic reticulum, respectively. PrxI and PrxII are also abundant, constituting a 
total of 0.2% to 1% of soluble protein in cultured mammalian cells (Chae et al., 1999). 
Prx enzymes are efficient in eliminating low concentrations of hydrogen peroxide 
because of their low Km values for the substrate (Chae et al., 1999).  
 
1.7.7 Glutathione 
 
1.7.7.1 Introduction 
Glutathione was discovered over a century ago as an abundant thiol containing 
compound present at millimolar (mM) concentrations in cells and tissues. The central 
function of GSH in detoxification and protection against oxidants was recognised about 
50 years ago (Mills, 1957). It serves as a short-term storage form of the amino acid 
cysteine, as a nucleophile for efficient detoxification of reactive electrophiles, and as an 
antioxidant.  
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1.7.7.2 Biosynthesis, degradation and transport of GSH 
Glutathione concentrations, rates of synthesis and rates of turnover vary greatly from 
one tissue to another. This impacts on how rapidly GSH is depleted from a cell and how 
rapidly a cell can recover after a chemical insult (Potter and Tran, 1993).  
 
GSH is synthesised by two sequential, ATP-dependent reactions in the cytoplasm 
catalysed by γ-glutamylcysteine synthetase (γGCS) and glutathione synthetase 
(Krzywanski et al., 2004) (Figure 11). The majority of the biosynthetic activity resides 
in the cytoplasm with little if any activity in other organelles, including the 
mitochondria (Griffith and Meister, 1985). The degradation of GSH is mediated by a 
separate pathway which, in contrast to the synthetic pathway exhibits a discrete tissue 
distribution (Hinchman and Ballatori, 1990). The initial step in the breakdown of GSH 
involves the cleavage of the γ-glutamylpeptide bond by γ-glutamyltransferase (GGT), 
which is distinctly localised to the luminal membranes of epithelial cells such as the 
renal proximal tubule and enterocytes (Lash, 2006). 
 
Glutathione is transported out of cells by several multi-drug resistance proteins (MRP) 
(Ballatori et al., 2005) and is transported into the mitochondria by dicarboxylate carrier 
(DIC) and a monocarboxylate carrier (OGCP) (Lash, 2006). 
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Figure 11 – Biosynthesis of glutathione 
Glutathione is a powerful antioxidant defence system within mammalian cells. GSH is catalysed de novo 
in two ATP-dependent reactions. γGCS catalyses the first and rate limiting step in GSH biosynthesis. 
Reduced GSH donates electrons for the reduction of hydrogen peroxide. 
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1.7.7.3 Role of glutathione in detoxifying ROS  
The main function of GSH is to protect cells from the toxic effects of reactive oxygen 
compounds, therefore acting as an endogenous antioxidant. Glutathione effectively 
scavenges free radicals and other reactive species such as hydroxyl radicals, 
peroxynitrite and H2O2 directly and indirectly through enzymatic reactions. In such 
reactions, GSH is oxidised to form GSSG, which is then reduced to GSH by NADPH-
dependent glutathione reductase (Droge, 2002) (Figure 12). In addition, GSH maintains 
intracellular sulfhydryl-containing proteins in their reduced and active form by GSH-
dependent reduction of H2O2 and other peroxides, mediated by glutathione peroxidases. 
Or by the action of thiol-disulfide exchange reactions which are mediated by thiol 
transferases to form oxidised glutathione (GSSG) (Lash, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 – Oxidation and reduction of glutathione 
Schematic drawing showing the reactions of GSH thiol transferases, free radicals, GSH peroxidases and 
GSH reductase. The structures of both reduced and oxidised glutathione are also shown. (Adapted from 
(Meister, 1988). 
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1.7.7.4 Role of mitochondrial GSH in defence against oxidative damage 
In mitochondria, GSH plays a key role in the protection against oxidative damage to 
mitochondrial components. Indeed, the oxidative damage to mitochondrial DNA that 
occurs upon ageing increases with age in mitochondria from liver, kidney and brain of 
rats (Vijg, 1999). Changes in [GSH]:[GSSG] redox status would indicate that 
mitochondrial antioxidant systems could not cope with the oxidant species being 
generated. 
 
The GSH content found in the mitochondria is different, and is regulated in different 
ways, to that of cytosolic GSH, implying two separate GSH pools. As briefly mentioned 
previously, there is no synthesis of GSH in mitochondria. Rather, GSH is imported from 
the cytosol. The role of mitochondria in ageing attributed to free-radical damage of 
mitochondria function was first described in 1980 (Miquel et al., 1980). Indeed, Miquel 
and colleagues highlighted that mitochondria are important sources of free radicals in 
ageing, and that mitochondrial components are essential targets of free radical damage. 
Changes of total cellular GSH upon ageing are only modest. Interestingly, changes in 
mitochondrial GSH are much more marked. Oxidised GSH levels in mitochondria from 
the brain of old animals have been observed to be at least four times higher than those in 
young animals (de la Asuncion et al., 1996). Furthermore, changes in the redox state of 
GSH in mitochondria correlate with changes in oxidative damage of mitochondrial 
DNA. There is evidence to suggest, late onset administration of dietary antioxidants, 
such as thiol-containing compounds or vitamins C and E, prevents oxidation of GSH 
and oxidative damage to mitochondrial DNA (Pallardo et al., 1998). 
 
1.7.7.5 Disruption of the GSH system in disease 
GSH/GSSG is the most important redox couple and plays crucial roles in antioxidant 
defence, nutrient metabolism and the regulation of pathways essential for whole body 
homeostasis. GSH deficiency contributes to oxidative stress in the pathogenesis of 
many diseases. 
 
Glutamate plays a regulatory role in GSH synthesis through two mechanisms, firstly, in 
the uptake of cysteine and secondly, in the prevention of GSH inhibition of GCS. When 
extracellular glutamate concentrations are high, as in patients with advanced cancer, 
HIV infection and brain injury, cysteine uptake is competitively inhibited by glutamate, 
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resulting in a decrease in GSH synthesis (Tapiero et al., 2002), leading to increased 
oxidative stress. Glycine availability can be reduced in response to protein malnutrition, 
sepsis and inflammatory stimuli (Grimble et al., 1992). When hepatic glycine oxidation 
is enhanced in response to high levels of glycagon in diabetes (Mabrouk et al., 1998), 
this amino acid may become a limiting factor for GSH synthesis, which in turn can lead 
to an increase in oxidative stress. 
 
As well as conditions influenced by the availability of the key compounds involved in 
GSH synthesis, genetic mutations also exist which affect the metabolism of GSH. 
Humans with inborn deficiencies of γ-glutamylcysteine synthase, GSH synthetase, 
GSSG reductase or GSH peroxidases have been reported (Meister, 1988). Patients 
exhibiting such deficiencies often have defective brain function, and an increased 
sensitivity to oxidative stress leading to haemolysis (Meister, 1988). 
 
Diaz-Hernandez et al., 2007 developed an endogenous model of oxidative stress in 
neurons from rats, using RNA interference (RNAi) to selectively knock down 
glutamate-cysteine ligase (GCL) (also known as γGCS). As described above, this is the 
rate-limiting enzyme of glutathione biosynthesis. Interference with glutathione 
biosynthesis in primary neurons by RNAi induced free radical production, and 
consequently triggered neuronal apoptotic death. The results from this paper provide in 
vitro data demonstrating the importance of GSH biosynthesis in protecting cells from 
the harmful effects of excessive free radical production.   
 
In summary, glutathione plays an important role in antioxidant defence, nutrient 
metabolism and regulation of cellular events (including gene expression, DNA and 
protein synthesis, cell proliferation and apoptosis). GSH deficiency contributes to 
oxidative stress, which plays a key role in ageing and in the pathogenesis of many 
diseases (including Alzheimer disease, Parkinson’s disease, HIV, brain injury, cancer 
and diabetes) (Droge, 2002). 
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1.8 Current study 
1.8.1 Overview  
In normoxia, the hypoxia-inducible factor-1α (HIF-1α) is constantly hydroxylated and 
thus prepared for proteosomal degradation through the action of the oxygen-sensitive 
prolyl hydroxylases (PHDs) (Jiang et al., 1996). Hence, HIF-1α stabilisation is most 
frequently determined by the concentration of oxygen regulating the activity of the 
PHDs. As a consequence, in hypoxia, PHDs are inhibited and HIF-1α is stabilised. 
There is, however, as previously described in this chapter, numerous oxygen-
independent mechanisms of HIF-1α regulation. There is compelling evidence in the 
literature to suggest a role for ROS in stabilising HIF-1α. It was originally suggested 
that ROS in hypoxia were responsible for this action (Chandel et al., 2000a). However 
the data are conflicting, as both an increase and decrease in ROS in hypoxia have been 
reported in various cell types. It is therefore important to determine a definitive role for 
ROS in the stabilisation of HIF-1α. 
 
1.8.2 Study aims 
The aims of the current study were to: 
 
1. Demonstrate oxygen-dependent stabilisation of HIF-1α in human embryonic 
kidney (HEK) 293T cells 
2. Determine whether oxygen-independent mechanisms of HIF-1α stabilisation 
exist in HEK 293T cells or other cell types 
3. Validate an in vitro model which generates free radicals in normoxia and study 
the effects of endogenously generated ROS on HIF-1α stabilisation 
4. Investigate the cellular source of ROS involved in HIF-1α stabilisation  
 
 
 
Chapter two: Experimental procedures 
 
 69
 
 
 
 
 
Chapter two: 
Experimental procedures 
Chapter two: Experimental procedures 
 
 70
Chapter two: Experimental procedures 
 
2.1 Cells 
2.1.1 Human embryonic kidney 293T cells 
For part of this study human embryonic kidney (HEK 293T) cells were used. These 
cells were obtained from within the Wolfson Institute for Biomedical Research, 
University College London. HEK 293T is a cell line originally derived from human 
embryonic kidney, commonly used for both academic and industrial research (Graham 
et al., 1977). The use of human embryonic kidney cells has become one of the most 
popular ways for expression/silencing of recombinant proteins. There are a variety of 
transfection protocols to deliver/reduce recombinant genes to these cells, and for the 
technique employed in this study, HEK 293T is recommended. Cells were cultured on 
tissue culture flasks and plates (Falcon, UK). 
 
2.1.2 D890N HEK 293T cells 
HEK 293T cells stably transfected with an inducible catalytically deficient isoform of 
mitochondrial DNA POLγ (D890N) were kindly provided by Johannes Spelbrink, 
Institute of Medical Technology and Tampere University Hospital, Tampere, Finland. 
Cells were cultured on tissue culture flasks and plates (Falcon, UK). 
 
2.1.3 J774.A1 murine macrophages 
A mouse macrophage (MΦ) carcinoma cell line was also used in this study. The murine 
MΦ cell line J774.A1 was chosen because they are known to represent a good model for 
experiments evaluating inflammatory responses. Cells were maintained in suspension in 
stirrer bottles (Techne) and were obtained from ATCC (TIB-67). 
 
2.1.4 H157 human head and neck squamous cancer cells 
Human head and neck squamous cell lines (H157) were also used in some experiments. 
These cells were generously provided by Professor E.K. Parkinson, Institute of 
Dentistry, Queen Mary’s Medical and Dental School, London, UK. They were selected 
because of their high expression of nitric oxide synthases (NOS). Cells were grown in 
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standard keratinocyte growth medium (KGM) which comprised α-MEM (minimal 
essential media, containing Earls Salts, L-glutamine without ribonucleosides). Other 
cell culture reagents as specified were obtained from Sigma and Invitrogen, UK. 
 
2.2 Cell culture 
2.2.1 Culturing cells from liquid nitrogen 
Cell culture medium was warmed in a water bath at 37˚C. Then an aliquot of cells were 
removed from liquid nitrogen and thawed quickly in a water bath (37˚C). The cells were 
then transferred to a 15 ml falcon tube and resuspended in 3-5 ml cell culture medium. 
For HEK (293T/ D890N) and H157, cells were then transferred to a sterile 75 cm2 
tissue culture plastic flask containing 10 ml cell culture medium; J774.A1 were 
transferred into a 250 ml stirrer bottle and placed on a magnetic platform. Cells were 
then cultured in a humidified incubator at 37˚C and 5% CO2. Media was replaced after 
24 h and cells were sub-cultured once 80-90% confluence was achieved.  
 
2.2.2 HEK 293T, HEK D890N and H157 passaging 
HEK 293T were grown and maintained in cell culture medium, DMEM (GIBCO) 
containing 10% (v/v) FCS (New Zealand origin, GIBCO) supplemented with 100 IU/L 
penicillin and 100 μg/L streptomycin (Invitrogen, UK). HEK D890N were grown and 
maintained in DMEM containing 10% (v/v) FCS (New Zealand Origin) supplemented 
with 200 μg/ml hygromycin (Invitrogen), 15 μg/ml blasticidin (Calbiochem), 50 μg/ml 
uridine (Sigma) and 1 mM pyruvate (Sigma). H157 were grown and maintained in α-
MEM containing 10% (v/v) FCS (New Zealand origin) supplemented with 100 IU/L 
penicillin and 100 μg/L streptomycin, 8 × 104 mol/L adenine, 5 μg/ml insulin, 1 × 10-10 
mol/L cholera toxin, 0.5 μg/ml hydrocortisone and 10 ng/ml epidermal growth factor. 
Typically, old medium was removed and cells rinsed with 10 ml sterile PBS (sPBS) 
then incubated with approximately 2 ml 1 × trypsin-EDTA, 37˚C for 5 min, followed by 
neutralisation using trypsin neutralising solution (TNS) purchased from Sigma, UK. 
Confirmation of cell detachment was obtained using an inverted light microscope 
(Axiovert25, Carl Zeiss, MicroImaging Inc., Hertfordshire, UK). Cells were then 
pelleted by centrifugation (800 × g, 10 min), the supernatant was removed carefully and 
the cell pellet resuspended in fresh medium. Cells were then seeded 1 in 10 into 75 cm2 
flasks in a final volume of 10 ml cell culture medium. Routinely, cell number and 
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viability were assessed using trypan blue exclusion. Equal volumes of cell suspension 
and trypan blue (Life Technologies) were mixed and a small volume (approximately 20 
μl) was transferred to a haemocytometer. Cells were counted under an inverted 
microscope with unstained cells counted as viable and blue cells counted as dead. Cells 
were used experimentally if viability was above 95%.  
 
2.2.3 Preparation of Rho0 media for H157 cells 
Uridine (purchased from Sigma) was added to double-distilled water (ddH2O) to make 
up a final concentration of 10 mg/mL, this was filtered though a 0.45 m Nalgene 
syringe filter (purchased from Fisher Scientific UK Ltd) to make a sterile stock. 
Pyruvate (purchased from Sigma) was also added to ddH2O to make a final 
concentration of 1M and then filtered though a 0.45 m Nalgene syringe filter to make a 
sterile stock. Ethidium Bromide 10 mg/mL aqueous solution (Sigma) was filtered 
though a 0.45 m Nalgene syringe filter and then added to ddH2O to make a 10 μg/mL 
sterile stock solution, which was kept in a foil covered 15 mL Falcon tube to protect it 
from light. Uridine and pyruvate stock was added to the media to give a final 
concentration of 50 μg/mL and 1 mM respectively.  
 
Rho0 cells were generated by adding ethidium bromide stock to the Rho0 media 
(complete H157 media plus uridine and pyruvate) to reach a final concentration of     
200 ng/mL. Ethidium bromide is a toxic mutagenic compound and all work with this 
reagent was carried out with appropriate protective clothing in a ventilated hood. The 
respective media was changed every 2–3 days. 
 
2.2.4 J774.A1 passaging 
J774.A1 murine macrophages were grown and maintained in cell culture medium, 
DMEM (GIBCO, UK) containing 10% (v/v) FCS (New Zealand origin, GIBCO) 
supplemented with 100 IU/L penicillin, 100 μg/L streptomycin, 25 mM D-glucose, 2 
mM L-glutamine. J774.A1 cells are grown in suspension, and are simply removed from 
culture, pelleted by centrifugation (800 × g, 10 min) and the supernatant removed before 
resuspending the cell pellet in fresh medium. Cells were then either seeded and allowed 
to adhere onto 10 cm2 tissue culture plates in a final volume of 10 ml cell culture 
medium or suspended back into an appropriate volume of media in a magnetic stirrer 
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bottle. Routinely cell number and viability were assessed using trypan blue exclusion 
(2.2.2). 
 
2.2.5 Storing cells in liquid nitrogen 
A flask of confluent cells was rinsed with 10 ml sPBS and incubated with 2 ml 1 × 
trypsin-EDTA (37˚C, 5 min). The cells were then removed with an additional 5-10 ml 
of cell culture medium to a 50 ml falcon tube and pelleted by centrifugation (800 × g, 5 
min). The supernatant was removed and discarded without disturbing the pellet and 
cells resuspended in supplemented DMEM. 10% DMSO was added to the cell 
suspension just prior to freezing. Approximately 1 ml cell suspension was then 
transferred to a 1.5 ml cryogenic vial. Cryogenic cells were then kept on ice in the 
fridge (4˚C) for 10 min; transferred to –20˚C for 2 h; and then removed to –80˚C 
overnight. Following at least 24 h incubation under this condition, vials were transferred 
to liquid nitrogen for long-term preservation of the cells. Alternatively, cryogenic cells 
were placed in a cryogenic 1˚C freezing container (Nalgene), and stored at –80˚C, until 
transferred to liquid nitrogen.  
 
2.2.6 Preparation of cell lysates 
In order to use proteomic techniques, the proteins obtained from cell lysates need to be 
solubilised. To lyse cells the medium is removed and the cells were rinsed at least twice 
with copious ice cold PBS. Then between 100-500 µl (depending on tissue culture 
plastic being used) of Novagen cytobuster protein extraction reagent (Merck Chemicals 
Ltd) containing protease inhibitors (Roche Diagnostics), was added and the lysate was 
scraped and collected. The lysate was then left on ice for 10 min, followed by 
centrifugation (13,000 × g, 15 min, 4˚C). The supernatant was then collected, and stored 
at –20˚C. 
 
2.3 Protein quantification 
2.3.1 Bicinchoninic acid (BCA) kit 
Protein concentrations were determined using the bicinchoninic acid based BCA protein 
assay kit (Pierce). Total protein was quantified by its reaction with Cu2+ reducing it to 
Cu1+ in an alkaline medium known as the biuret reaction. The colourimetric change is 
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brought about by the reaction of biocinchoninic acid with Cu1+ and the protein 
concentrations are determined based on a standard curve produced from a series of 
dilutions of known concentrations (0, 0.0625, 0.125, 0.25, 0.5, 1.0 and 2.0) using the 
purified protein bovine serum albumin.  
 
20 µl sample or standard were mixed with 180 µl working reagent (made in a 50:1 ratio 
of reagents A:B) and loaded in triplicate into wells of a 96 well plate, and incubated for 
30 min at 37˚C. Absorbance was measured at 562 nm (Molecular Devices, SpectraMax 
Plus) and was plotted of the absorbance of the standards against the protein 
concentration in µg/ml. From the equation of this standard curve the concentrations of 
the total protein of the samples was calculated. 
 
2.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
2.4.1 Sample preparation for SDS-PAGE 
Following protein quantification by the BCA assay (2.3.1) samples were diluted 
accordingly with loading buffer (5 ×). The samples were then heated at 100˚C in a 
heating block (Grant Instruments, Cambridge, UK) for 10 min, and then centrifuged at 
10,000 × g for 1 min at 4˚C. Samples were then loaded onto the gel for separation or 
stored at –20˚C for future analysis.  
 
2.4.2 SDS-PAGE 
Protein samples were routinely analysed by SDS-PAGE. This technique separates 
proteins according to their molecular mass. Total protein were analysed by 
electrophoresis in pre-cast SDS-PAGE 4-15% Tris.HCL gradient gels (BioRAD, 
Hertfordshire, UK). The gel was placed into the BioRAD mini trans-blot cell gel tank 
system, and the comb removed. The buffer reservoir was then filled with SDS running 
buffer (section 2.16.5). Samples were electrophoresed against 15 µl of a pre-stained 
protein marker, (New England Biolabs) towards the anode at a constant voltage of 120 
V, usually for 65 min, or until the dye front reached the bottom of the gel. 
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2.5 Western blotting 
2.5.1 Western blot transfer 
Western blotting was performed using a standard transfer tank. Four pieces of Whatman 
paper (gel sized), 2 fibre pads and nitrocellulose membrane (GE Healthcare) were 
soaked in transfer buffer (section 2.16.5) (per gel). After electrophoresis, a sandwich of 
filter paper, nitrocellulose, SDS-PAGE gel and fibre pads was built up on the positive 
side of the gel holder cassette. The gel holder cassettes were placed into the electrode 
module and the tank was filled with transfer buffer. The transfer was carried out at 100 
V for 75 min at 4˚C. 
 
2.5.2 Immunoblotting (detection) 
Following transfer, the nitrocellulose membrane (GE Healthcare) was usually stained 
with 1% ponceau S solution (Sigma) to visualise transferred proteins and then washed 
three times in distilled water and finally with TBS. Membranes were then incubated in 
10% dried skimmed milk (Marvel, Premier International Food Ltd, Spalding, 
Lincolnshire, UK) in PBS/Tween 20 (20% 10 × PBS without calcium and magnesium 
(Life Technologies), 0.001% polyoxyethylenesorbitan monolaurate (Tween 20) from 
Sigma in distilled water) for 1 h at room temperature or overnight at 4˚C with constant 
shaking. The blot was then washed 5 times in PBS/Tween 20 for 5-10 min with shaking, 
followed by incubation with primary antibody at the appropriate concentration (table 
2.16.6) diluted in 1% dried skimmed milk PBS/Tween 20 with constant agitation for the 
appropriate time (table 2.16.6). Following incubation with the primary antibody the blot 
was washed 5 times in PBS/Tween 20 for 5-10 min with shaking. After sufficient 
washing the blot was then incubated with secondary antibody diluted in 1% dried 
skimmed milk in PBS/Tween 20 conjugated to HRP at 1:2000 for 1 h at room 
temperature. The membrane was then rinsed in PBS/Tween 20 (5 times, 5-10 min each 
wash) and the proteins were visualised using enhanced chemiluminescence (ECL) 
(Amersham Pharmacia). ECL reagents were mixed immediately before use, applied 
evenly over the membrane and incubated for 3 min. Excess ECL was drained off the 
membrane, which was then wrapped in Saran wrap, ensuring air bubbles were removed. 
Blots were then exposed to hyperfilm ECL in an autradiography hypercassette (GE 
Healthcare) and developed using an automated developer (Compact X4, Xograph, 
Whiltshire, UK). The images were scanned and analysed quantitatively by densitometry 
Chapter two: Experimental procedures 
 
 76
(AlphaImager Imaging System, AlphaEase FC software version 4; AlphaInnotech, San 
Leandro, California, USA). 
 
2.6 Immunoprecipitation 
γGCS was silenced in 293T cells using siRNA against γGCS (see section 2.9.3). Protein 
A Sepharose magnetic beads (Immunoprecipitation Kit – Dynabeads Protein A, 
Invitrogen) were prepared following the manufacturer’s guidelines, and then incubated 
with anti-ubiquitin (10 µg Dako, raised in rabbit) for 10 min at room temperature. To 
immunoprecipitate HIF-1α, cell lysates (500 μg) were incubated with the bead/Ab 
complex for 2 h at room temperature on a rotating wheel. Beads were then washed four 
times in 200 μl washing buffer (provided in kit). Immunoprecipitated proteins were 
eluted by heating at 70°C for 10 min in 20 μl elution buffer (provided in kit) and 10 μl 
SDS loading buffer. Proteins were detected using antibodies raised in a different species 
to avoid cross reactivity with the immunoprecipitated complexes. 
 
2.7 Cloning γGCS siRNA sequences into pFIV-H1/U6 vector 
Molecular cloning is a technique which allows the isolation and multiplication of a 
specific DNA sequence (gene or cDNA). These DNA fragments can be amplified by 
using plasmids in vivo in bacterial cells. Plasmid vectors are bacterial extra-
chromosomal elements that allow the replication and selection of a DNA of interest. 
The pFIV-H1/U6 vector (System Biosciences, USA) was used to over-express a siRNA 
sequence against the γGCS. This vector drives the generation of dsRNA by opposing 
promoters H1 and U6. The pFIV-H1/U6 cloning vector is provided in a ready-to-ligate 
linearised form that has been digested with the BbsI restriction enzyme. The pFIV-
H1/U6 vector contains two unique 5’ overhangs which facilitate directional cloning 
with minimal self-ligation background.  
 
2.7.1 Selection of siRNA sequences 
The selection of γGCS sequences was performed on the coding domain sequence (CDS) 
of the mRNA for γGCS (Accession number NM_001498) using the RNAi consortium 
(TRE) information available on sigma.com.  
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2.7.2 Annealing of siRNA oligonucleotides 
Prior to DNA ligation, both forward and reverse γGCS primers require annealing. The 
siRNA oligonucleotides were dissolved in deionised water to reach a final concentration 
of 1 μg/μl. The annealing reaction is assembled on ice in a 50 μl total volume. Each 
reaction contained 2.5 μl sense and anti-sense siRNA oligonucleotides, 25 μl 2 × 
annealing buffer (20 mM tris, pH 7.8; 100 mM NaCl; 0.2 mM EDTA) and 20 μl 
deionised water. The reaction mixture was heated to 95˚C for 5 min in a PCR heating 
block, which was then left to cool until at room temperature. Once room temperature 
was reached, the annealed oligonucleotides were stored at –20˚C. 
 
2.7.3 Phosphorylation of template siRNA 
Each phosphorylation reaction (one per experimental siRNA template) was built on ice, 
in a 10 μl reaction volume. The reactions contained 1 μl annealed double stranded (ds) 
template oligonucleotide, 1 μl 10 × T4 polynueclotide kinase buffer, 1 μl 10 mM ATP, 
6 μl deionised water and 1 μl T4 polynucleotide kinase 10 U/μl, (New England 
Biolabs). Reactions were incubated at 37˚C for 30 min. The reaction was stopped by 
heating the mixture at 70˚C for 10 min.  
 
2.7.4 DNA ligation into pFIV-H1/U6 siRNA vector 
Ligation reactions were incubated on ice in a final volume of 10 μl for each 
phosphorylated siRNA template. Ligation reactions contained 2.5 μl linearised pFIV-
H1/U6 vector (20 ng/μl), 1 μl phosphorylated ds siRNA template DNA (product from 
2.7.3), 1 μl 10 × T4 DNA ligase buffer, 4.5 μl deionised water and 1 μl T4 DNA ligase 
diluted to 5 U/μl with 1 × reaction buffer (New England Biolabs). The reaction mixture 
was incubated at 16˚C for 2-4 h in a PCR block. The ligations were tested using 10 μl of 
the reaction to transform TOP10 E. coli.  
2.7.5 Bacterial transformation 
Competent TOP10 E. coli (50 μl aliquot) were thawed on ice before 50-100 ng of 
plasmid DNA was added. The cells were incubated on ice for 30 minutes, heat shocked 
for 30 s at 42˚C (in a water bath) and then placed back on ice for 2 min. SOC broth (200 
μl) was then added to the cells and then incubated at 37°C, 220 rpm for 1 h. Then 100 μl 
of the transformed cells were then spread onto Luria-Bertani (LB) agar plates containing 
100 µg/ml ampicillin and plates were incubated overnight at 37°C. 
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2.7.6 Identification of positive clones 
Following overnight incubation at 37˚C, well-separated colonies were selected from 
each plate and grown in 2 ml LB broth with 100 μg/ml ampicillin at 37˚C for 2 h on an 
orbital shaker. After this time, 1 μl of each bacterial culture was screened for insert 
using PCR, and the remaining bacterial culture was incubated overnight. Cells were 
then pelleted and mini-prepped (2.8.1). 
 
2.7.7 Polymerase chain reaction (PCR) 
Bacterial colonies were screened using PCR. For each PCR, a master mix was made in a 
25 μl final volume. Each PCR contained dNTPs (10 mM), appropriate buffer (1 ×), Mg-
2+ (1.5 mM), PCR enzyme (2 IU) and U6 and H1 forward/ reverse primers (0.2 mM). 
Double distilled water (ddH2O) was then added to make the reaction volume up to 25 μl 
and mixed thoroughly. Reactions were started by the addition by 1 μl template (bacterial 
culture). Samples were then subject to the following PCR protocol: 95˚C, 2 minutes; 25 
cycles of: A) 95˚C, 20 seconds (denaturing), B) 58˚C, 20 seconds (annealing 
temperature), C) 68˚C, 30 seconds (extension) and finally 68˚C, 20 minutes. The PCR 
products were then resolved on a 1% agarose gel, as described below in 2.7.8. 
 
2.7.8 Agarose gel electrophoresis 
DNA samples were analysed by agarose gel electrophoresis to separate the DNA 
according to its size. A 0.8 to 1% agarose solution was made in 1 × TAE running buffer 
and dissolved by heating in the microwave. To visualise DNA, 1 × (from 10,000 × 
stock) syber safe DNA gel stain (Invitrogen) was added. Samples for electrophoresis 
were prepared in TAE loading buffer and run along with 0.5 µg/ml of a known 
molecular weight DNA ladder (New England Biolabs). Samples were then resolved at 
50 mA for 40 min to 1 h. To image the DNA the gel was visualised and photographed 
using the AlphaImager imaging system as described in 2.5.2. 
 
2.8 Plasmid purification 
2.8.1 Mini-prep (Qiagen mini-prep kit) 
Transformed TOP10 E. coli competent cells were inoculated into 2-5 ml LB broth, 
supplemented with 100 µg/ml ampicillin and incubated at 37°C overnight at 220 rpm. 
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Bacteria from 1 ml of the culture were harvested by centrifugation at 13,000 rpm in a 
Micro centrifuge (MSE) for 1 minute at 4˚C. The supernatant was then removed and 
discarded using precept disinfectant tablets. Following the manufacturers guide 
(Qiagen) the pellet was then resuspended in 250 µl Solution I (section 2.16.2) via 
vortex, lysed with 250 µl of Solution II (section 2.16.2), and incubated for 5 min at 
room temperature. 350 µl of ice cold Solution III (section 2.16.2) was then added and 
mixed by inversion to precipitate the DNA. Cell debris was pelleted by centrifugation at 
13,000 rpm for 10 min and the supernatant removed to a mini column (Qiagen). DNA 
was absorbed to the column matrix, washed and eluted to a new tube as indicated in the 
manufacturer’s handbook. 
 
2.8.2 Maxi-prep (Qiagen fast-speed kit) 
Transformed TOP10 E. coli were inoculated into 2 ml LB broth, supplemented with 100 
µg/ml ampicillin and incubated at 37°C for 8 h at 220 rpm. Then 1 ml culture was 
inoculated into 200 ml LB broth with 100 µg/ml ampicillin and incubated at 37°C 
overnight in an orbital shaker at 220 rpm. The bacteria were harvested by centrifugation 
at 6000 × g, 4°C for 30 min. Following the manufacturers guide (Qiagen), the pellet was 
resuspended via vortex in 10 ml P1 buffer (section 2.16.2) and lysed with 10 ml P2 
buffer (section 2.16.2), via gentle mixing by inversion 4-6 times and incubated for 5 
min at room temperature. Genomic DNA and membranes were precipitated by the 
addition of 10 ml chilled P3 buffer (section 2.16.2), which was mixed by inversion 4-6 
times and incubated for 10 min in a filtering column. Eluate was applied to a column 
and was then loaded onto an anionic exchange column (Qiagen tip 500) which had been 
equilibrated with 10 ml buffer QBT (section 2.16.2) before the sample was allowed to 
drip through. The column was then washed with 60 ml buffer QC (section 2.16.2) and 
the DNA eluted with 15 ml buffer QF (section 2.16.2). The DNA was then precipitated 
by the addition of 10.5 ml room temperature isopropanol, mixed and incubated at room 
temperature for 10 min. The DNA sample was then concentrated with a filter (Qiagen 
Kit), washed with 2 ml 70% (v/v) ethanol and eluted in a new tube using 1 ml elution 
buffer (QF buffer). DNA was quantified by Nanodrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Inc, USA) and stored at -20˚C until required.  
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Primer Sequence Tm (ºC)
H1 5' -CTG GGA AAT CAC CAT AAA CGT GAA  - 3' 55
U6 5' -GCT TAC CGT AAC TTG AAA GTA TTT CG  - 3' 55
2.8.3 Sequencing  
100 ng/μl of each γGCS pFIV plasmid were used per sequencing reaction, with 5 pmol/ 
μl of either H1 or U6 primer.  
 
 
 
 
Sequence data was generated with ABI3730XL sequencer. Samples were cycle-
sequenced by Scientific Support Services (Wolfson Institute for Biomedical Research, 
UCL) using BigDye® 3.1 Chemistry, and standard thermal cycling conditions. Chromas 
Lite Version 2.01 sequence software was used to analyse and display each DNA 
sequence. 
 
2.9 Eukaryotic cell transformation 
2.9.1 Lipofectamine transformation  
HEK 293T cells were seeded one day prior to transfection in 2 ml HEK 293T cell 
culture medium without antibiotics to achieve ~ 90% confluence overnight. For a 6 well 
tissue culture plate, 4 μg DNA (per well) was diluted with 1 ml OptiMEM (Gibco, UK) 
serum free media without antibiotics. An additional 1 ml OptiMEM serum free media 
without antibiotics was used to dilute 40 μl Lipofectamine and this was incubated for 5 
min at room temperature. DNA and Lipofectamine solutions were then combined and 
incubated for 20-30 min at room temperature. After incubation the mixed solution was 
added to the plate containing HEK 293T cells and the culture medium, and this was 
incubated for 24 h at 37˚C. After this time the medium was then replaced with complete 
HEK T294 media. Approximately 48 h after transfection, cells are split using 1 ml 1 × 
trypsin-EDTA per well and re-seeded in a 75 cm2 tissue culture flask containing 10 ml 
HEK 293T cell culture media with antibiotic selection at 0.5 μg/ml puromycin. HEK 
293T cells were viewed for expression between 5-10 days after selection. 
 
2.9.2 Preparation of synthetic small interfering RNA (siRNA)  
For synthetic siRNA transformation experiments an RNA free environment must be 
obtained by careful washing of the working area and equipment with RNase zap 
(Sigma). Then the siRNA (AllStars Negative siRNA conjugated to Alexa Fluor 555 
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(Qiagen) and ON-TARGETplus SMARTpool siRNA against human γGCS or NADPH 
oxidase 2 (NOX2) purchased from Dharmacon RNA Technologies) requires 
reconstitution in siRNA resuspension buffer (Qiagen), at an appropriate stock 
concentration (20 μM). AllStars Negative siRNA is then heated for 1 minute at 90°C, 
followed by incubation at 37°C for 60 minutes. The γGCS/ NOX2 siRNA is simply 
mixed for 30 minutes on an orbital shaker at room temperature. After this, the 
experiment is initiated or siRNA is stored at – 80˚C in 25 μl aliquots. 
 
2.9.3 Gene silencing in 293T HEK with synthetic siRNA 
Gene specific siRNA was purchased in order to generate a knockdown of the target 
gene (either γGCS or NOX2) and non-targeting AllStars siRNA (scrambled siRNA) 
was used as a negative control (used in all experimental designs performed). At least 24 
h prior to gene silencing, 293T HEK were grown in media without antibiotics. For all 
siRNA gene- silencing experiments reverse transformation was used. This involves 
preparing the complexes inside the cell culture plastic wells prior to the addition of the 
cells contained in media (antibiotic free). Transfection of 293T HEK was performed 
using Lipofectamine RNAiMAX Transfection Reagent (Invitrogen). 5 nmol siRNA (per 
well) was diluted with 250 μl OptiMEM (Gibco, UK) serum free media without 
antibiotics. An additional 250 μl OptiMEM serum free media without antibiotics was 
used to dilute 5 μl Lipofectamine RNAiMAX and this was incubated for 5 min at room 
temperature. siRNA and Lipofectamine RNAiMAX solutions were then combined and 
incubated for 20-30 min at room temperature. During this 20-30 minute incubation 
period, cell suspensions were obtained by proteolysis with 1 × trypsin-EDTA. Cells 
were rinsed with 10 ml sterile PBS (sPBS) then incubated with approximately 2 ml 1 × 
trypsin-EDTA, 37˚C for 5 min. Insurance of cell detachment was observed under an 
inverted light microscope (Axiovert25, Carl Zeiss, MicroImaging Inc., Hertfordshire, 
UK). Cells were then pelleted by centrifugation (800 × g, 10 min), the supernatant was 
removed carefully and the cell pellet resuspended in 10 ml fresh antibiotic free media. 
Cells were checked for cell number and viability using trypan blue exclusion (section 
2.2.2). Cells were resuspended in media without antibiotics at 0.5 × 106 /ml. Once the 
20-30 minute liposome formation has ended, 500 μl siRNA complexes are added to 
each well (of a 6 well plate) and the plate is then gently rocked to ensure equal 
distribution. Then 2 ml of cell suspension (to a 6 well plate) is added to each well, 
rocked gently and incubated at 37˚C for 12 h. After this time the medium was then 
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replaced with complete HEK T294 media. Cell lysates were obtained as described in 
section 2.2.6. Following transfection, the efficiency was determined by flow cytometry. 
Cell acquisition and analysis was carried out in the CyAN flow cytometer, (Dako 
Becton-Dickinson). A minimum of 10,000 cell events was counted for each sample and 
non-staining samples were used for control. 
 
2.10 Reverse transcription polymerase chain reaction (RT-PCR) 
2.10.1 RNA isolation 
Total ribonucleic acid (RNA) was isolated from cells using TRIzol reagent (Invitrogen). 
Briefly, 4-5 × 106 cells were lysed with 1 ml TRIzol then scraped and the lysate 
removed into a 50 ml universal tube and incubated for 5 min at room temperature. 
Chloroform was then added (0.5 ml per 1 ml TRIzol) and the tube shaken for 15 s by 
hand and then incubated for 2-3 min at room temperature. The emulsion formed was 
then separated by centrifugation (5000 × g, 4˚C, 15 min). Using RNase free solutions 
and equipment (pipette tips and centrifuge tubes), the upper aqueous phase was 
removed in 0.5 ml aliquots to a 1.5 ml centrifuge tubes. To each tube 0.5 ml isopropyl 
alcohol was added and incubated for 10 min at room temperature before centrifugation 
(13,000 × g, 10 min). The RNA pellet was washed with 1 ml 70% (v/v) ethanol, by 
centrifugation at 13,000 × g, 2 min. The pellet was air-dried for approximately 5 min 
and resuspended in 500 μl dH2O. 
 
2.10.2  RNA integrity 
RNA concentration and purity were determined using a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, USA). The concentration 
was determined by measuring absorbance at 260 nm (A260). The ratio between 260 nm 
and 280 nm, and 260 nm and 230 nm indicate the purity of the RNA. Values of 
A260/A280 ratio should be approximately 2.0 (Glasel, 1995; Manchester, 1995) and 
A260/A230 ratio should be in the range of 1.8 – 2.2 for pure RNA according to the 
manufacturer’s instructions. 
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2.10.3 cDNA synthesis  
For each sample of RNA to be analysed, 4 wells were prepared (3 positive and 1 
negative) on a standard 96-well PCR plate. To each well, the following were added: 1 
μg RNA, 1 μg OligoDT12-18 primer (Invitrogen) and RNase-free PCR grade water to 
reach a final volume of 10 μL per well. The reaction was heated to 65˚C for 5 minutes 
in a Primus 96 plus thermocycler (MWG Biotech, Milton Keynes, UK). The reaction 
mix was then placed on ice for 2-3 minutes. The following were added to each well: 4 
μL 5 × first strand buffer, 1 μL 0.1 M DL-Dithiotheitol (DTT), 2 μL 10 mM 
deoxynucleotide triphosphate (dNTP) mix and 1 μL 40 unites per μL Rnase-out (all 
from Invitrogen). 1 μL Superscript II reverse transcriptase (Invitrogen) was added to 
each of the positive control wells. 1 μL PCR grade water was added to each negative 
control well. The reaction mix plate was then incubated at 42˚C for 60 minutes, then 
70˚C for 15 minutes in a Primus 96 plus thermocycler. After this, 80 μL PCR grade 
water was added to each well, giving a total volume of 100 μL per well. Using a 
mulitchannel pipette, 10 μL from each column (of 4 wells) was transferred to a new 
optical-grade 96-well PCR plate for each gene of interest to be analysed by PCR. The 
cDNA was either used immediately for qPCR or placed at – 80˚C for long-term storage. 
 
2.10.4 Real-time quantitative PCR (qPCR) 
To reach a final reaction volume of 25 μL the following were added to each well: 12.5 
μL SYBR Green Jumpstart Taq ReadyMix (Sigma), 0.5 μL reference dye (supplied with 
SYBR Green Jumpstart Taq ReadyMix kit), 0.2 μM forward primer, 0.2 μM reverse 
primer and 1 μL PCR grade water. The Eppendorf Realplex4 Mastercycler was used to 
perform the PCR reaction. SYBR was used as the internal control and after an initial 
step of 50˚C for 2 minutes followed by 96˚C for 2 minutes the programme ran for 45 
cycles (90˚C for 15 seconds, followed by 60˚C for 20 seconds). The data was acquired 
with Eppendorf Realplex4 Mastercycler software and exported to Excel for analysis. 
Gene copy number was calculated using serial dilutions of standard DNA. Each value 
was corrected for background by subtracting the negative control. Corrected values 
were then expressed as a percentage of the control gene (either β-actin or 18S). 
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2.11 Biochemical assays 
2.11.1 Measurement of reactive oxygen species  
2.11.1.1 Using 2’-7’dichlorofluorescin (DCFH) 
To measure reactive oxygen species (ROS) the probe, 5-(and-6)-chloromethyl-2’,7’-
dicholorodihydrofluorescien diacetate, acetyl ester (CM-H2DCFDA) (Molecular probes, 
Invitrogen) was used. CM-H2DCFDA is a cell permeable indicator for reactive oxygen 
species which is retained inside the cells after cleavage of acetate moiety by esterases. 
This compound then reacts with intracellular ROS changing its fluorescent properties 
which can be quantified. Shortly before performing the experiment, the CM-H2DCFDA 
is reconstituted in 100% ethanol to make a stock concentration of 20 μM. Cells were 
then washed twice in sPBS (37°C), and incubated with the ROS indicator in phenol free 
media for 30 minutes. Due to the dye’s susceptibility to photo-oxidation, care was taken 
to avoid light exposure, and hence low light conditions were used where possible. After 
the 30 minute incubation, the media was removed and the cells washed twice in PBS. 
To measure ROS using flow cytometry, cells were collected in 1 × trypsin-EDTA, 37°C 
for 5 min and then neutralised using an equal volume of TNS. Cells were then pelleted 
by centrifugation (800 × g, 10 min), the supernatant was removed and the cell pellet was 
homogenised in approximately 1 ml PBS. Cell acquisition and analysis was carried out 
in the CyAN flow cytometer, (Dako Becton-Dickinson). A minimum of 10,000 cell 
events was counted for each sample and non-staining samples were used for control.  
 
To measure ROS using a fluorometer cells were seeded in a black-edged 96 well plate 
at 10,000 cells per well. Cells were seeded in phenol free media, in quadruple wells and 
left overnight to adhere. The following day cells washed twice in sPBS (37°C), and 
incubated with the ROS indicator in phenol free media for 30 minutes (covered with foil 
to reduce excessive light exposure). The probe was then removed and the cells washed 
twice in sPBS (37°C) before adding media containing defined treatments. Cells without 
the probe were used as negative controls to correct for background fluorescence. The 
plate was then placed in a Victor 2, 1420 Multi label counter, in a pre-warmed reading 
chamber (37˚C). Excitation and emission was measured at 488 nm and 520 nm, 
respectively (Wallac Victor 2, 1420 Multi label counter, Perkin Elmer). Sequential 
readings were taken every 10 minutes for up to 1 hour. At the end of the experiment 
protein concentration (see section 2.3) was determined to ensure equal loading of cells.  
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2.11.1.2 Using HyPer 
HyPer consists of yellow fluorescent protein (YFP) inserted into the regulatory domain 
of the prokaryotic H2O2-sensing protein, OxyR (Belousov et al., 2006). Cells were 
transfected with the plasmid carrying HyPer using Lipofectamine transfection reagent 
following the protocol previously described in section 2.9.1. HyPer-transfected cells 
exhibiting yellow florescent protein (YFP) positive staining were then selected using 
fluorescence-activated cell sorting (FACS), as the plasmid has no antibiotic selection in 
mammalian cells. FACS analysis was performed by Scientific Support Services 
(Wolfson Institute for Biomedical Research, UCL) using a MoFlow high-speed cell 
sorter. HyPer was kindly provided by Dr A Galkin, Wolfson Institute for Biomedical 
Research, UCL, London, UK. Following sorting, HyPer transfected cells were 
incubated with defined treatments and cell acquisition and analysis was carried out in 
the CyAN flow cytometer, (Dako Becton-Dickinson). A minimum of 10,000 cell events 
was counted for each sample and non-staining samples were used for control. 
 
2.11.2 Nitrite quantification  
The amount of nitric oxide (NO) was estimated by measuring nitrite (NO2-) levels in the 
extracellular medium using the Griess reagent kit (Molecular Probes, Leiden, 
Netherlands). Total nitrite was quantified by the conversion of sulfanilic acid to a 
diazonium salt by the reaction with nitrite in acid solution. The diazonium salt is then 
coupled to N-(1-naphthyl)ethylenediamine, forming an azo dye that brings about a 
colourimetric change which is spectorophotometrically detected. Nitrite concentrations 
were determined based on a standard curve produced from a series of dilutions of 
known concentrations of NO2-. 50 µl of sample or standard were mixed with 50 µl 
Griess reagent. Assays were performed in triplicate in a 96-well plate, and incubated for 
10 minutes in the dark at room temperature. Absorbance was measured at 540 nm and 
620 nm (Molecular Devices, SpectraMax Plus). 
 
2.11.3 Lactate quantification 
Lactate concentration was determined using a lactate oxidase-based assay (Trinity 
Biotech Ltd). Total lactate was quantified by the conversion of lactic acid to pyruvate 
and hydrogen peroxide (H2O2) by lactate oxidase. In the presence of the H2O2 formed, 
peroxidase catalyzes the oxidative condensation of the chromogen precursors to produce 
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a coloured dye with an absorption maximum at 540 nm. The increase in absorbance at 
540 nm is directly proportional to the lactate concentration in the sample. 5 µl sample 
was added to a 96 well plate in triplicate, followed by 100 µl lactate reagent. The plate 
is then shaken briefly on a shaker table and then incubated in the dark for 10 minutes. 
Absorbance was measured at 540 nm (Molecular Devices, SpectraMax Plus). 
 
2.11.4 Measurement of total glutathione 
Total cellular glutathione (GSH) was measured in HEK 293T cells using a colorimetric 
assay GSH-400 kit (Oxis Research, Portland, USA). Glutathione was measured via a 
two-step chemical reaction which first involves the formation of thioethers between 4-
chloro-1 –methyl-7-trifluromethyl-quinolinium methylsulfate (R1) and all mercaptans 
(RSH) present in the samples. The second step involves a β-elimation reaction which 
takes places under alkaline conditions, allowing for the transformation of the thioethers 
obtained from GSH into a chromophoric thione which has a maximal absorbance 
wavelength at 400 nm. Samples were collected in approximately 2 ml 1 × trypsin-
EDTA, 37°C for 5 min. Cells were then pelleted by centrifugation (800 × g, 10 min), 
the supernatant was removed and the cell pellet was homogenised in 500 µl 
Metaphosphoric acid (MPA). Cells were then centrifuged at 3000 × g for 10 minutes, 
and the clear upper aqueous layer was collected. Then both samples and standards were 
prepared in a 900 µl final volume. 50 µl solution R1 was added, mixed thoroughly, 
followed by the addition of 50 µl solution R2, and mixed thoroughly again. The samples 
were then incubated at 25°C for 10 minutes in the dark. Absorbance was measured at 
400 nm (Varian, Cary 4000 UV-Vis Spectrophotometer). 
 
2.12 Visible light spectroscopy (VLS) 
2.12.1 Principle 
The visible light spectroscopy system (VLS, Figure 13) was used to monitor 
continuously the oxygen consumption (VO2) of respiring cell and changes in the redox 
state of cytochrome aa3 in cytochrome c oxidase (CcO) during respiration towards 
anoxia (Hollis et al., 2003). The VLS system measures light absorbed by cytochromes 
aa3 in the CcO. Changes in the cytochrome redox state are determined by multi-
wavelength least squares fitting of the oxidised minus reduced cytochrome absorption 
spectra (Hollis et al., 2003). 
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Figure 13 – Schematic of VLS instrumentation 
The VLS system measures light absorbed by cytochromes aa3 in the CcO. Changes in the cytochrome 
redox state are determined by multi-wavelength least squares fitting of the oxidised minus reduced 
cytochrome absorption spectra (Hollis et al., 2003). 
 
2.12.2 Oxygen calibration and measurement corrections 
The Clark-type O2 electrode is capable of measuring a current that is proportional to the 
partial pressure of O2 (pO2) in the sample. The current is converted to a voltage and 
input to the analogue-to-digital converter, which is sampled at a rate of 2 Hz by the 
acquisition software. The software converts the measured voltage to oxygen 
concentration [O2] using values determined from the calibration procedure described 
fully by Hollis et al., 2003. The rate of O2 consumption (VO2) in the chamber is also 
calculated on-line from the differential of [O2] with respect to time, determined from a 
20-data-point fourth order polynomial (i.e. fitting over a period of 10 s). The conversion 
of the O2 electrode output to [O2] involves a two-point calibration procedure, performed 
daily in 1 ml of the medium the cells are suspended in during their subsequent 
measurement in the chamber. For full details on VLS calibration and measurement 
corrections please refer to Hollis et al., 2003. In this study, VLS calibration, 
measurement corrections, cell counting post VLS measurements and data analysis were 
performed by Miriam Palacios-Callender or/and Nanci Frakich. 
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2.12.3 VLS cell culture and protocol 
Cells were cultured in sterile 175 cm2 tissue culture plastic flasks containing 50 ml 
appropriate cell culture medium (section 2.2.2). Cell culture media was then removed 
and the cells were rinsed twice with copious sterile PBS (sPBS) containing 25 mM 
HEPES. Cells were then incubated with approximately 5 ml 1 × trypsin-EDTA, 37˚C 
for 5 min, followed by neutralisation using trypsin neutralising solution (TNS) 
purchased from Sigma, UK. Confirmation of cell detachment was obtained using an 
inverted light microscope (Axiovert25, Carl Zeiss, MicroImaging Inc., Hertfordshire, 
UK). Cells were then harvested by centrifugation (800 × g, 10 min), the supernatant was 
removed carefully and the cell pellet resuspended in medium without phenol red dye (to 
avoid interference with the optical technique) to a final concentration of 2-3 × 107 
cells/ml. Cell counting and determination of viability at this point was carried out using 
Trypan blue exclusion method. After harvesting, cells were placed into a 50 ml Falcon 
tube and incubated at 37°C in a water bath for 40-60 minutes prior to measurement, 
gently resuspending every 15-20 minutes. At the time of measurement 1 ml of cells was 
placed into the respiration chamber and kept in suspension by stirring with a magnetic 
glass bar at 750 rpm, sealing the cells from the atmosphere with the plunger. At the end 
of each experiment, the cells were collected from the chamber and placed on ice for 
further determination of cell number. 
 
2.13 Electron microscopy 
Cells for electron microscopy (EM) were adhered for 1 hour to a 4 cm2 glass cover slip. 
Cells were then gently washed with 2 ml PBS and fixed by incubation with 3% 
paraformaldehyde, 1.5% glutamine, 100 mM sodium cacodylate buffer, 5 mM CaCl2 
and 2.5% sucrose at room temperature for 10 minutes. Cells were then visualised and 
images taken using an electron microscope by M Turmaine, Division of Biosciences, 
University College London. 
 
2.14 Immunofluorescence and confocal microscopy 
D890N HEK 293T cells were seeded at a density of 0.1 × 106 cells/ 0.8 cm2 growth area 
of a chamber cover glass (Lab-Tek, Nunc, Langenselbold, Germany) and incubated 12 h 
before confocal imagery. The medium was then removed, and the cells were rinsed 
twice with sPBS. Then 20 μg/ ml Hoechst 33342 plus 20 nM TMRM was added and 
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cells were incubated for 15 minutes in the dark. Confocal microscopic images were 
taken with Ultra VIEW ERS Live cell microscope (Perkin Elmer) with a × 63 oil 
immersion objective. The cells were kept at 37°C during the entire imaging period by a 
thermostatic chamber encasing the microscopic stage. Data acquisition and fluorescence 
analysis were carried out using Ultra VIEW software. Whole cell fluorescence was 
analysed by marking the individual cells in the field. Background fluorescence of a 
region without cells/ cell debris was subtracted from fluorescence values. 
 
The mitochondrial membrane potential (ΔΨm) of control (untreated) and induced 
(doxycycline (DC) treated) D890N HEK cells was evaluated 10 days after DC induction 
by inhibiting the respiratory chain at Complex I using 1 μM rotenone. The kinetic action 
of rotenone on ΔΨm was studied by recording the TMRM fluorescence in time-lapse 
experiments. Steady-state TMRM fluorescence was recorded for approximately 2 
minutes to obtain a stable fluorescence signal. Subsequently, rotenone was added and 
the signal was recorded for approximately 30 s. The ΔΨm was collapsed by the addition 
of 25 μM FCCP and TMRM fluorescence recorded for approximately a further 3 
minutes. 
 
2.15 Data analysis and statistics  
Statistical analyses were performed using either Excel (Microsoft Office) or GraphPad 
Prism 5 software packages. Densitometric analyses were performed using AlphaEase 
FC software version 4 (AlphaInnotech). Exposed films were illuminated with 
transilluminating white light and an image was captured using a motorised lens camera 
(focal length: 8.0 ~ 48 mm, maximum aperture ratio: 1:1.2, 6x zoom) with flat field 
calibration to easily correct for non-uniformities in light gathering. The captured image 
was then analysed using FC software version 4 utilising 256 gray scale values. The 
software captures an integrated density value which is the sum of the gray levels of all 
the pixels within the boundaries of each band and then subtracts a background value 
computed as a mean of 16 lowest intensity points within the assigned boundaries. All 
data are plotted graphically as mean values, with vertical bars representing standard 
error of the mean (SEM). A Student’s t-test was used to compare differences between 
two data groups. One-way ANOVA was used to assess differences between individual 
experimental conditions when multiple comparisons were being made to a control. For 
all statistical analyses a probability (P) value, *, of <0.05 was considered significant. 
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2.16 Materials and reagents  
2.16.1 Eukaryotic cell culture 
HEK 293T cell culture medium: DMEM (41965-039), 10% (v/v) FCS, 100 IU/L 
penicillin, 100 μg/L streptomycin 
HEK 293T serum free medium (SFM): DMEM (41965-039), 100 IU/L penicillin, 100 
μg/L streptomycin 
HEK 293T phenol free medium (PFM): DMEM (21063-029), 10% (v/v) FCS, 100 
IU/L penicillin, 100 μg/L streptomycin 
D890N HEK 293T cell culture medium: DMEM (41965-039), 10% (v/v) FCS, 200 
μg/ml hygromycin, 15 μg/ml blasticidin, 50 μg/ml uridine,1 mM pyruvate  
D890N HEK 293T induction (Rho0) cell culture medium: DMEM (41965-039), 10% 
(v/v) FCS, 200 μg/ml hygromycin, 15 μg/ml blasticidin, 50 μg/ml uridine, 1 mM 
pyruvate, 250 ng/ml doxycycline 
H157 cell culture medium: α-MEM (22571-038), 10% FCS, 100 IU/L penicillin, 100 
μg/L streptomycin, 1.8 × 104 mol/L adenine, 5 μg/ml insulin, 1 × 10-10 mol/L cholera 
toxin, 0.5 μg/ml hydrocortisone and 10 ng/ml epidermal growth factor 
H157 (Rho0) cell culture medium: α-MEM (22571-038), 10% FCS, 100 IU/L 
penicillin, 100 μg/L streptomycin, 1.8 × 104 mol/L adenine, 5 μg/ml insulin, 1 × 10-10 
mol/L cholera toxin, 0.5 μg/ml hydrocortisone and 10 ng/ml epidermal growth factor, 
50 μg/ml uridine, 50 μg/ml pyruvate, 200 ng/ml ethidium bromide 
J774.A1 cell culture medium: DMEM (11960), 10% (v/v) FCS, 25 mM D-glucose, 2 
mM L-glutamine, 100 IU/L penicillin, 100 μg/L streptomycin 
 
Transfection medium: OpiMEM (31985047_464548114) 
Trypsin EDTA: 0.05% EDTA 
Cryo-buffer: 10% (v/v) dimethyl sulphoxide (DMSO), 90% (v/v) DMEM 
 
Dulbecco’s Modified Eagle Medium (DMEM) and other cell culture reagents, as 
specified, were obtained from Invitrogen, UK. Heat inactivated foetal calf serum (FCS) 
was of New Zealand Origin supplied by GIBCO (10691-145). 
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2.16.2 Bacterial cell culture and cloning 
Luria bertani (LB) broth: 1% (w/v) bacto-peptone, 0.5% (w/v) yeast extract, 0.5% 
(w/v) NaCl 
LB agar: LB broth, 1% (w/v) agar 
Qiagen mini-prep solutions: 
Solution I: 50 mM glucose, 10 mM EDTA, 25 mM Tris.HCL pH 8.0 
Solution II: 1% (w/v) SDS, 0.2 M NaOH 
Solution III: 3 M potassium acetate, 11.5% glacial acetic acid 
Qiagen maxi-prep solutions: 
Qiagen buffer P1 (resuspension buffer): 50mM Tris.HCL pH 8.0, 10mM EDTA, 100 
µg/ml RNase 
Qiagen buffer P2 (lysis buffer): 200 mM NaOH, 1% (w/v) SDS  
Qiagen buffer P3 (neutralisation buffer): 3 M potassium acetate pH 5.5 
Qiagen buffer QBT (equilibrium buffer): 750 mM NaCl, 50 mM MOPS pH 7.0, 15% 
(v/v) isopropanol, 0.15% (v/v) triton X-100  
Qiagen buffer QC (wash buffer): 1 M NaCl, 50 mM MOPS pH 7.0, 15% (v/v) 
isopropanol  
Qiagen buffer QF (elution buffer): 1.25 M NaCl, 50 mM Tris.HCL pH 8.5, 15% (v/v) 
isopropanol 
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2.16.3 Treatments 
Table 2 – Treatments used, concentrations and suppliers 
Treatment  Mode of action Concentration Supplier Cat no. 
Ascorbic acid ^ Antioxidant 1 mM Sigma A-5960 
Cobalt chloride  * HIF-1α stabiliser 300 μM Sigma C-2644 
Doxycycline * Antibiotic 250 ng/ml Sigma D9891 
Ethidium 
bromide 
* DNA replication 
inhibitor 
200 ng/ml Invitrogen 15585-011 
FCCP ¬ Un coupler of 
OXPHOS 
25 μM Sigma C2920 
Hoeschst 33342 ¬ Fluorescent nuclear 
stain 
20 μg/ml Invitrogen H3570 
Lipopolysacchar
ide 
# Bacterial endotoxin 10 ng/ml Difco 0901 
Menadione * Pro-oxidant 160 μM Sigma M2518 
MG132 * Proteasome 
inhibitor 
10 μM Sigma C2211 
Mouse IFNγ # Cytokine 10 IU/ml Insight Biotech 
Ltd 
IB-1092 
N-acetyl-L-
cysteine  
^ Antioxidant 2.5 mM  Sigma A8199 
NG-monomethy-
L-arginine  
^ NOS inhibitor 1 mM Axxora Ltd ALX-106-
001-G001 
S-ethyl 
isothiourea 
# iNOS inhibitor 500 μM Caymen Chemical 1071-37-0 
Rotenone ¬ Complex I inhibitor 1 μM Sigma R8875 
TMRM ¬ Mitochondrial 
membrane potential 
fluorescent marker 
20 nM Invitrogen T668 
 
* Concentration detemined through dose response curves performed during thesis 
Concentration from published literature: ^ (Quitero et al., 2006a), # (Garedew and Moncada, 2008) and ¬ 
(Garedew et al., 2010) 
 
2.16.4 Hypoxic chamber 
Some of the experiments described were carried out at different oxygen concentrations. 
Hypoxia was achieved by incubation of cells at 37°C in an oxygen-controlled hypoxic 
chamber (Coy Laboratory Products Inc, Ann Arbor, Michigan). Oxygen concentrations 
were maintained using a 5% CO2/Nitrogen 200 BAR compressed gas cylinder (BOC 
Limited, Surrey). 
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2.16.5 Electrophoresis 
SDS running buffer (1 ×): 50 mM Tris Base, 0.384 M glycine, 0.1% SDS in distilled 
water 
SDS loading buffer (2 ×): 4 % SDS, 20% glycerol, 1.5 M Tris.HCL pH 6.8, 10% β-
mercaptoethanol up to 10 ml dH2O, bromophenol blue 
Transfer buffer: 25 mM Tris Base, 192 mM glycine, 20% methanol, made up to 1 litre 
with distilled water 
Tris acetate EDTA (TAE) buffer (50 ×): 2 M Tris, 25 mM sodium acetate, 50 mM 
EDTA pH 7.6 
TAE loading buffer: 200 mM Tris, 25 mM sodium acetate, 5 mM EDTA pH 7.6, 80% 
glycerol, bromophenol blue 
 
Western blot transfer membrane nitrocellulose was obtained from Amersham 
Biosciences, UK. Enhanced chemiluminescence (ECL) detection reagents were 
obtained from Pierce, UK and Hyperfilm ECL film was obtained from Amersham 
Biosciences, UK. Protein quantification was performed using bicinchoninic acid (BCA) 
kit, obtained from Sigma, UK.  
 
2.16.6 Antibodies 
Table 3 – Antibodies used, working dilutions, suppliers and targets 
 
 
 
 
 
Antigen Clone Supplier Cat no. Dilution Incubation 
time 
α-tubulin Monoclonal Abcam Ab7291 1:10,000 30 min 
CcO Monoclonal BD Biosciences 556433 1:5000 O/N 
γGCS Polyclonal Santa Cruz Biotechnolgy Sc-28965 1:1000 O/N 
HIF-1α Monoclonal BD Biosciences 610958 1:2000 O/N 
Hydroxyated 
HIF-1α 
Polyclonal CoValab P564 1:2000 O/N 
Mouse IgG Polyclonal Dako P0260 1: 2000 1 hour 
NOX-2 Polyclonal Millipore 07-024 1:2000 O/N 
Ubiquitin Polyclonal Dako Z0458 10 μg 2 hours 
Rabbit IgG Polyclonal Vector Laboratories P1-1000 1:2000 1 hour 
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2.16.7  Primers 
Table 4 – Human primers used for real-time qPCR 
 
Gene Direction Sequence 5’ to 3’ 
18S Forward 
Reverse 
CGC CGC TAG AGG TGA AAT TC 
TTG GCA AAT GCT TTC GCT C 
Catalase Forward 
Reverse 
CAA AAT GCT TCA GGG CCG 
TAA TTG GGT CCC AGG CGA 
COX1 Forward 
Reverse 
ATT TAG CTG ACT CGC CAC ACT CCA 
TAG GCC GAG AAA GTG TTG TGG GAA 
β-actin Forward 
Reverse 
TGT GCC ATC TAC GAG GGG TAT GC 
GGT ACA TGG TGG TGC CGC CAG ACA 
γGCS  Forward 
Reverse 
GCA CAT CTA CCA CGC CGT C 
CCA CCT CATCGC CCC AC 
HIF-1α Forward 
Reverse 
CCA GTT ACG TTC CTT CGA TCA GT 
TTT GAG GAC TTG CGC TTT CA 
MnSOD Forward 
Reverse 
GGT GGT GGT CAT ATC AAT CAT AGC 
GCT TCC AGC AAC TCC CCT TT 
NfKB Forward 
Reverse 
CGA GCT CCG GAG CAG TGA CA 
GTA AAG CTG AGT TTG CGG AAG G 
NOX1 Forward 
Reverse 
TTC ACC AAT TCC CAG GAT TGA AGT GGA TGG TC 
GAC CTG TCA CGA TGT CAG TGG CCT TGT CAA 
NOX2 Forward 
Reverse 
GTC ACA CCC TTC GCA TCC ATT CTC AAG TCA GT 
CTG AGA CTC ATC CCA GCC AGT GAG GTA G 
NOX4 Forward 
Reverse 
CTG GAG GAG CTG GCT CGC CAA CGA AG 
GTG ATC ATG AGG AAT AGC ACC ACC ACC ATG CAG 
NOX5 Forward 
Reverse 
GTC GCT CTG CTG CTG CTG CTC CTC T 
TGA TGG TGA AGG GGT GCC ACT CAT AGC 
NrF2 Forward 
Reverse 
AAA CCA GTG GAT CTG CCA AC 
GAC CGG GAA TAT CAG GAA CA 
Thioredoxin Forward 
Reverse 
TGG TGT GGG CCT TGC AA 
TCA AGG AAT ATC ACG TTG GAA TAC TT 
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Chapter three: Mechanisms of HIF-1α stabilisation 
 
3.1 Introduction 
At physiological [O2] hypoxia-inducible factor-1α (HIF-1α) is constantly hydroxylated 
and thus prepared for proteosomal degradation through the action of the prolyl 
hydroxylases (PHDs) (Jiang et al., 1996). In hypoxia however, the oxygen-sensitive 
PHDs are inhibited and HIF-1α is stabilised. Other agents, including cytokines and 
growth factors have been shown to stabilise HIF-1α at physiological [O2] through 
different mechanisms such as activation of the phosphatidylinositol 3-kinase (PI3K) or 
mitogen-activated protein kinase pathways (Semenza, 2003) (see introduction 1.5.3). 
Increased production of reactive oxygen species (ROS) at low [O2] have also been 
claimed to stabilise HIF-1α (Chandel et al., 1998). 
 
Studies described in this chapter investigate the hypothesis that free radicals stabilise 
HIF-1α both in normoxia and low oxygen conditions. This was evaluated by examining 
the effect of pro-oxidant agents and antioxidants on HIF-1α protein expression. 
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3.2 Oxygen-dependent stabilisation of HIF-1α 
3.2.1 Response of HIF-1α to decreasing oxygen 
To verify that HIF-1α becomes stable when cells are exposed to decreasing oxygen 
concentrations, HEK 293T cells were incubated at 21%, 3% or 0.5% oxygen for 24 
hours. Low [O2] (3% oxygen) and hypoxic oxygen conditions (0.5% oxygen) were 
achieved in a humidified variable aerobic workstation. Cell lysates were prepared, 
separated by SDS-PAGE and analysed by Western blot. α-tubulin served as a loading 
control. Figure 14 shows that incubation of cells at decreasing oxygen concentrations 
for 24 hours results in oxygen-dependent stabilisation of HIF-1α. HIF-1α stabilisation 
increased significantly as the oxygen concentrations decreased from 21% to 3% and 
from 3% to 0.5%. 
 
3.2.2 Effect of cobalt chloride on HIF-1α stabilisation  
Cobalt chloride (CoCl2) has been reported to result in HIF-1α stabilisation in normoxic 
oxygen conditions (Chandel et al., 2001). Thus we decided to utilise this agent as a 
positive control for the detection of HIF-1α. To determine the optimal concentration of 
CoCl2 in which to study HIF-1α stabilisation, cells were incubated with different 
concentrations of CoCl2 for 4 hours at 21% oxygen. Figure 15 shows that the 
stabilisation of HIF-1α with CoCl2 was dose-dependent, with the most significant 
stabilisation occurring at 160 μM CoCl2. 
 
3.2.3 Time course of HIF-1α stabilisation 
The next objective was to study the kinetics of HIF-1α stabilisation. Cells were 
incubated at 3% or 0.5% oxygen for 1, 2, 4 and 24 hours and compared to cells 
incubated at 21% oxygen for 4 h in the presence of CoCl2. Figure 16 shows that the 
most efficient stabilisation of HIF-1α was achieved after 4 h incubation with CoCl2 at 
21% O2 (24 h incubation did not have a greater effect; data not shown). Stabilisation of 
HIF-1α in hypoxia (0.5% oxygen) was time-dependent with the maximum effect 
observed at 4 h, similar to CoCl2. On the other hand a modest, time-dependent 
stabilisation could be observed at 3% [O2]. This was time-dependent with the maximum 
effect achieved at 24 h. 
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Figure 14 – HIF-1α stabilisation increases as the oxygen concentration decreases 
HEK 293T cells were incubated at 21%, 3% or 0.5% oxygen (O2) for 24 h. Cell lysates were subject to 
SDS-PAGE and analysed by Western blot with an anti-HIF-1α antibody (A) and quantified by 
densitometry (B). The corresponding densitometry values were normalised with α-tubulin and results are 
shown relative to 21% oxygen control. The values represent the mean + SEM from 5 independent 
experiments; * represents a significant difference (p < 0.05) from 21% O2 control values and ^ represents 
a significant difference (p < 0.05) from 3% O2. One representative blot is shown. 
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Figure 15 – HIF-1α stabilisation under increasing concentrations of CoCl2 
Cells were incubated at 21% oxygen for 4 h with different concentrations of cobalt chloride (CoCl2, -160 
µM). Protein expression was analysed by Western blot (A) and quantified by densitometry (B). The 
corresponding densitometry values were normalised with α-tubulin and are shown relative to control. The 
values represent the mean + SEM from 3 independent experiments; * p < 0.05 versus control. One 
representative blot is shown. 
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Figure 16 – Kinetics of HIF-1α stabilisation at 3% and 0.5% oxygen 
Cells were incubated at 21%, 3% and 0.5% oxygen for 1-24 h. Cobalt chloride (CoCl2, 160 μM) served as 
a positive control. Protein expression was analysed by Western blot (A) and quantified by densitometry 
(B). The corresponding densitometry values were normalised with α-tubulin and results are shown 
relative to 21% oxygen control. The values represent the mean + SEM from 3 independent experiments; * 
p < 0.05. One representative blot is shown. 
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3.3 Oxygen-independent stabilisation of HIF-1α  
3.3.1 Optimisation of 2’-7’-dicholorodihydrofluorescin (DCFH) to measure ROS 
in HEK 293T cells 
In order to study the stabilisation of HIF-1α by pro-oxidant agents, first the ability of 
these compounds to produce ROS was evaluated. 2’-7’-dicholorodihydrofluorescin 
(DCFH) is widely used to measure oxidative stress in cells. However, artefacts caused 
by auto-oxidation of the probe can lead to false positive results (Picker and Fridovich, 
1984;Faulkner and Fridovich, 1993;Liochev and Fridovich, 1995;Liochev and 
Fridovich, 1998). For this reason, experiments were initially performed to determine the 
fluorescence that can be attributed to ROS production. In order to distinguish between 
reactive intermediates produced by the probe and actual free radical formation, 
menadione (2-methyl-1,4-naphthoquinone; vitamin K3) was used as positive control 
due its association with the excessive generation of ROS such as superoxide, singlet 
oxygen, and hydrogen peroxide (Chung et al., 1999). Cells were treated either with 
antioxidants to suppress ROS-derived fluorescence or with menadione to induce ROS. 
Two treatment groups were studied. Samples were either incubated with the treatments 
in the presence of DCFH (30 minutes) or the treatments were added immediately 
following the 30-minute DCFH incubation. To establish the level of background 
fluorescence originating from the probe, DCFH was also incubated in the absence or 
presence of cells.  
 
There was no significant difference in DCF fluorescence when treatments are incubated 
with DCFH or post-DCFH incubation (Figure 17). There is also no significant 
difference between DCF fluorescence in cell negative treated groups and cell positive 
treated groups, suggesting in these cells, DCFH does not undergo auto-oxidation.  
 
To determine the limit of detection of DCFH, cells were treated with menadione for 30 
minutes (0-500 μM) and fluorescence was measured with excitation at 490 nm and 
emission at 520 nm. The results shown in Figure 18 demonstrate a clear dose-response 
effect of DCF fluorescence towards menadione-derived ROS. The lowest concentration 
of menadione required to detect DCF fluorescence is 40 μM. The first significant 
increase in DCF fluorescence is observed with 80 μM menadione. 
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Figure 17 – DCF fluorescence in the absence and presence of cells 
To establish the level of background fluorescence originating from auto-oxidation of the probe, 20 μM 
DCFH was incubated in the absence or presence of cells for 30 minutes. Cells were also treated with 
antioxidants (NAC 2.5 mM plus ascorbic acid 1 mM) or menadione 160 μM in the presence of DCFH or 
post-DCFH incubation. ROS was then measured using a fluorometer with excitation and emission 
measured at 490 nm and 520 nm, respectively. The values represent the mean + SEM from 3 independent 
experiments; * represents a significant difference (p < 0.05) from all corresponding treatment groups. 
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Figure 18 – DCF fluorescence dose response  
Cells were treated with 0-500 μM menadione for 1 h and fluorescence analysed using a cytometer. Data 
represent the mean + SEM from 3 independent experiments, * represents a significant difference (p < 
0.05) from control, and ^ represents a significant difference from 80 μM menadione. 
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3.3.2 Effect of menadione on HIF-1α stabilisation 
We next examined whether menadione, under the same conditions that induced ROS in 
cells (1 h, 0-160 μM, Figure 18) affects HIF-1α stabilisation. Menadione produced a 
concentration-dependent increase in HIF-1α stabilisation, with the most significant 
increase seen with 160 µM menadione (Figure 19), which corresponds to the highest 
ROS fluorescence in Figure 18. Cells were also treated with 160 µM menadione for 
shorter incubation periods (10-60 minutes) (incubation for longer than 1 h resulted in 
cell death). Stabilisation of HIF-1α was time-dependent, with the most significant 
increase observed at 60 minutes (Figure 20). 
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Figure 19 – Menadione induced HIF-1α expression in HEK 293T cells 
Cells were incubated at 21% oxygen for 1 h with menadione (0-160 µM). Protein expression was 
analysed by Western blot (A) and quantified by densitometry (B). The corresponding densitometry values 
were normalised with α-tubulin and are shown relative to control. The values represent + SEM from 3 
independent experiments; * p < 0.05 versus control. One representative blot is shown.  
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Figure 20 – Effect of menadione on HIF-1α stabilisation  
Cells were incubated at 21% oxygen for up to 1 h with 160 μM menadione (0-60 minutes). Protein 
expression was analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and are shown relative to control. The values 
represent + SEM from 3 independent experiments; * p < 0.05 versus control. One representative blot is 
shown. 
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3.3.3 Effect of antioxidants on HIF-1α stabilisation following treatment with 
menadione 
Since treatment with menadione resulted in both ROS production and HIF-1α 
stabilisation, experiments were conducted using antioxidants to investigate the possible 
role of reactive oxygen species in menadione-induced HIF-1α stabilisation. Cells were 
treated with 160 µM menadione for 1 h in the presence or absence of an antioxidant 
(AO) mix, N-Acetyl-L-cysteine (NAC) at 2.5 mM plus ascorbic acid at 1 mM. Figure 
21 shows menadione-induced HIF-1α stabilisation was reversed by treatment with 
antioxidants. 
 
3.3.4 Synergism between menadione and hypoxia on HIF-1α stabilisation 
Treatment with menadione (160 µM, 60 minutes) revealed an increase in ROS 
production and HIF-1α stabilisation which can be prevented by antioxidants. This result 
provides a connection between menadione and ROS production, and ROS production 
and HIF-1α stabilisation. Since the aim of my investigations was to establish, if any, a 
role of ROS in hypoxic HIF-1α stabilisation the effect of menadione in hypoxia (0.5% 
oxygen) was evaluated. Stabilisation of HIF-1α in hypoxia was significantly increased 
after 1 h incubation with menadione (Figure 22), and this effect was similar to that 
observed at 21% O2 after CoCl2 treatment (Figure 22). 
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Figure 21 – Effect of antioxidants on menadione-induced HIF-1α stabilisation 
Cells were incubated at 21% oxygen for 1 h with 160 µM menadione in the presence or absence of 
antioxidants (AO; NAC 2.5 mM plus ascorbic acid 1 mM). Protein expression was analysed by Western 
blot (A) and quantified by densitometry (B). The corresponding densitometry values were normalised 
with α-tubulin and are shown relative to control. The values represent + SEM from 3 independent 
experiments; * p < 0.05 versus menadione alone treated cells. One representative blot is shown. 
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Figure 22 – Effect of menadione on HIF-1α stabilisation in hypoxia 
Cells were incubated at 21% and 0.5% oxygen for 2 h in the presence or absence of 160 µM menadione 
(Mena) for 1 h. Cobalt chloride (CoCl2, 160 μM) served as a positive control. Protein expression was 
analysed by Western blot (A) and quantified by densitometry (B). The corresponding densitometry values 
were normalised with α-tubulin and are shown relative to control. The values represent + SEM from 3 
independent experiments; * p < 0.05 versus control. One representative blot is shown. 
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3.3.5  Effect of antioxidants on HIF-1α stabilisation following treatment with 
cobalt chloride 
Since treatment with CoCl2 induces ROS (Chandel et al., 1998) and our own data has 
shown CoCl2-induced HIF-1α stabilisation, (Figure 15) experiments were conducted 
using antioxidants to investigate the possible role of reactive oxygen species. Cells were 
treated with 160 µM CoCl2 for 4 h in the presence or absence of an AO mix. Figure 23 
shows that CoCl2-induced HIF-1α stabilisation was reversed by treatment with 
antioxidants. 
 
3.3.6 Synergism between CoCl2 and hypoxia on HIF-1α stabilisation 
Treatment with CoCl2 (160 µM, 4 h) demonstrated an increase in HIF-1α stabilisation at 
ambient [O2], the effect of CoCl2 in hypoxia (0.5% oxygen) was assessed, to further 
investigate the potential role for ROS-mediated HIF-1α stabilisation in hypoxia, as done 
in section 3.3.4. CoCl2 increased HIF-1α stabilisation in a dose-dependent manner 
(Figure 24). 
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Figure 23 – Effect of antioxidants on CoCl2-induced HIF-1α stabilisation 
Cells were incubated at 21% oxygen for 4 h with cobalt chloride (CoCl2, 160 µM) in the presence or 
absence of antioxidants (AO; NAC 2.5 mM plus ascorbic acid 1 mM). Protein expression was analysed 
by Western blot (A) and quantified by densitometry (B). The corresponding densitometry values were 
normalised with α-tubulin and are shown relative to control. The values represent the mean + SEM from 
3 independent experiments; * p < 0.05 versus CoCl2 treatment. One representative blot is shown. 
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Figure 24 – Effect of CoCl2 on HIF-1α stabilisation in hypoxia  
Cells were incubated at 21% and 0.5% oxygen for 4 h. Cells at 0.5% oxygen were incubated with 
different concentrations of cobalt chloride (CoCl2, 0-160 µM). Protein expression was analysed by 
Western blot (A) and quantified by densitometry (B). The corresponding densitometry values were 
normalised with α-tubulin and are shown relative to control. The values represent the mean + SEM from 
3 independent experiments; * p < 0.05. One representative blot is shown. 
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3.4 Antioxidants destabilise HIF-1α at 3% oxygen 
3.4.1 Modulation of HIF-1α by antioxidants in HEK 293T cells 
To investigate whether ROS are involved in the stabilisation of HIF-1α at low [O2] we 
incubated cells at 3% and 0.5% oxygen for 24 h and 2 h respectively. This was done in 
the presence or absence of antioxidants (AO, NAC plus ascorbic acid) for 4 h and 
samples prepared. Figure 25 shows that HIF-1α stabilisation was reversed by 
antioxidant treatment at 3% O2, with no effect at 0.5% O2. 
3.4.2 Effect of S-methylglutathione on HIF-1α stabilisation 
Next we examined the effect of methylglutathione (a glutathione donor) on HIF-1α 
stabilisation at 3% oxygen only. As previous data (Figure 25) demonstrated that at this 
oxygen concentration, HIF-1α stabilisation could be prevented using antioxidants. A 
methylated form of glutathione was used as an alternative to NAC plus ascorbic acid as 
it enhances cell permeability. Cells were incubated at 3% oxygen for 24, treated with 
methylglutathione (0-100 µM) for the final 4 h and HIF-1α protein stabilisation was 
determined. Methylglutathione produced a dose-dependent decrease in HIF-1α 
stabilisation with the maximal effect observed at 50 µM (Figure 26). 
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Figure 25 – Effect of antioxidants on HIF-1α stabilisation  
Cells were incubated at 3% and 0.5% oxygen for 24 h or 2 h respectively, with or without antioxidants 
(AO; 2.5 mM NAC plus 1 mM ascorbic acid). Cobalt chloride (CoCl2, 160 μM) severed as a positive 
control. Protein expression was analysed by Western blot (A) and quantified by densitometry (B). The 
corresponding densitometry values were normalised with α-tubulin and are shown relative to control. The 
values represent + SEM from 3 independent experiments; * p < 0.05 versus 3% control. (ns, not 
significant). One representative blot is shown. 
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Figure 26 – Effect of S-methylgluathione on HIF-1α stabilisation 
Cells were incubated at 21% and 3% oxygen for 4 h with or without methylgluathione (Met.GSH, -100 
µM). Cobalt chloride (CoCl2, 160 μM) served as a positive control. Protein expression was analysed by 
Western blot (A) and quantified by densitometry (B). The corresponding densitometry values were 
normalised with α-tubulin and are shown relative to control. The values represent + SEM from 3 
independent experiments; * p < 0.05 versus 3% control. One representative blot is shown. 
 
 
3%  21%  
0                5               10             50  Ctl            CoCl2 Met.GSH (µM) 
(A) 
(B) 
Chapter three: Mechanisms of HIF-1α stabilisation 
 117
3.5 Modulation of HIF-1α in human head and neck squamous 
carcinoma cells 
HIF-1α activates the transcription of genes that are involved in crucial aspects of cancer 
biology including angiogenesis, cell survival, glucose metabolism and invasion 
(Semenza, 2003). The stabilisation of HIF-1α in cancer has a number of origins that 
allows it to engage in transcriptional activity at normoxic [O2], including hypoxia 
(Wang and Semenza, 1993), genetic mutations (Maxwell et al., 1999) and an increase in 
TCA cycle intermediates succinate and fumarate (Koivunen et al., 2007). More recently 
it has also been suggested that the accumulation of ROS leads to the impairment of HIF-
1α degradation (Gerald et al., 2004). Experiments from our own group have previously 
demonstrated that NO was involved in the stabilisation of HIF-1α in head and neck 
squamous carcinoma (H157) cells and this was attributed to the high expression of NOS 
in these cells (Quintero et al., 2006a). 
 
3.5.1 NOS-dependent stabilisation of HIF-1α in cancer cells at 3% oxygen 
In order to confirm this data, cells were incubated at 3% and 0.5% oxygen and treated 
with either L-NMMA (a non-specific nitric oxide synthase (NOS) inhibitor) or 
antioxidants. Cell lysates were prepared using the protocol described in 3.2 and samples 
prepared in the same way. Figure 27 shows that at 3% oxygen both L-NNMA and 
antioxidants significantly inhibit HIF-1α stabilisation. Stabilisation of HIF-1α at 0.5% 
oxygen is not affected by treatment with L-NNMA or antioxidants.  
 
3.5.2 Effect of antioxidants on HIF-1α stabilisation in cancer cells at 21% oxygen 
In non-cancerous cells, HIF-1α stabilisation is prevented in normoxic conditions by 
proteasomal degradation. However, H157 cancerous cells stabilise HIF-1α in normoxia 
(Quintero et al., 2006a). Therefore, experiments using H157 carcinoma cells at 21% 
oxygen, treated with either L-NMMA or antioxidants were performed to decrease levels 
of ROS or NO and to investigate the effect on HIF-1α stabilisation. Figure 28 shows 
that whereas treatment with antioxidants significantly inhibited HIF-1α stabilisation,   
L-NMMA had no effect on HIF-1α stabilisation at 21% oxygen. 
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Figure 27 – Modulation of HIF-1α stabilisation in H157 cells at 3% oxygen 
H157 carcinoma cells were incubated at 3% and 0.5% oxygen for 4 h with or without antioxidants (AO; 
2.5 mM NAC plus 1 mM ascorbic acid) or 1 mM L-NMMA (non-specific NOS inhibitor). Protein 
expression was analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and are shown relative to 3% oxygen control. The 
values represent + SEM from 3 independent experiments; * p < 0.05 versus 3% control. One 
representative blot is shown. 
 
 
Control AO L-NMMA Control AO L-NMMA 
3% 0.5%
α-tubulin 
(A) 
(B) 
HIF-1α 
[O2] 
Chapter three: Mechanisms of HIF-1α stabilisation 
 119
HIF-1α 
α-tubulin 
Co
ntr
ol AO
L-N
MM
A
0
1
2
3
4
5
6
*
R
el
at
iv
e 
Va
lu
e 
to
C
on
tr
ol
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 – Modulation of HIF-1α stabilisation in H157 cells at 21% oxygen 
H157 carcinoma cells were incubated at 21% oxygen with or without antioxidants (AO; 2.5 mM NAC 
plus 1 mM ascorbic acid) or 1 mM L-NMMA (a non-specific NOS inhibitor). Protein expression was 
analysed by Western blot (A) and quantified by densitometry (B). The corresponding densitometry values 
were normalised with α-tubulin and are shown relative to control. The values represent + SEM from 3 
independent experiments; * p < 0.05 versus control. One representative blot is shown. 
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3.6 Stabilisation of HIF-1α in activated murine macrophages 
Peyssonnaux et al, 2005 reported that bacterial infection and inflammation led to the 
stabilisation of HIF-1α in macrophages (MΦ) in a hypoxia-independent mechanism. As 
it is known that MΦ produce high concentrations of NO upon activation (Stuehr and 
Nathan, 1989;Garedew and Moncada, 2008) experiments were designed to study the 
effect of NO on HIF-1α stabilisation in normoxia. 
 
3.6.1 NO-dependent stabilisation of HIF-1α in J774.A1 MΦ 
J774.A1 macrophages (MΦ) were seeded on tissue culture plastic for 24 h prior to 
activation with interferon (IFN)γ (10 U/ml) and lipopolysaccharide (LPS, 10 ng/ml). 
One set of cells was co-treated with the NOS inhibitor S-ethyl isothiourea (SEITU, 500 
µM). Non-activated cells were used as controls. At different time points (0, 1.5, 3, 6 and 
12 h) cell lysates for activated and non-activated J774.A1 MΦ were prepared and HIF-
1α protein expression was determined by Western blot. In parallel, lactate and nitrite 
accumulation were also determined, as markers for glycolytic and iNOS activity 
respectively. 
 
Lactate accumulation increased in a time-dependent manner in both groups following 
activation (Figure 29, (A)). Figure 29 (B) shows there was a significant increase in 
nitrite accumulation 6 h after activation compared to control, with SEITU treated cells 
showing no increase in nitrite accumulation over the whole time course. Figure 30 
shows that HIF-1α protein transiently stabilises within 1.5 h following activation. By    
3 h, HIF-1α protein reverts back to the concentration of non-activated controls. 
However, after 6 h MΦ activation, HIF-1α protein concentrations increased, and 
continued to do so until the final 12 h time point (Figure 30) Co-treatment with SEITU 
had no effect on the early transient stabilisation of HIF-1α but prevented its 
accumulation at the latter time points (Figure 30). 
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Figure 29 – Time course of lactate and nitrite accumulation in activated MΦ  
MΦ were activated with LPS (10 ng/ml) and IFNγ (10 U/ml). A subset of cells was also co-treated with 
SEITU (500 μM). Lactate (A) and nitrite (B) accumulation in the cell culture medium was determined by 
chemiluminescence. The values represent + SEM from 3 independent experiments, * p < 0.05 versus 
control. 
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Figure 30 – Effect of MΦ activation on the stabilisation of HIF-1α  
MΦ were plated and non-activated (control), activated with a positive control cobalt chloride (CoCl2, 160 
μM), or activated with LPS (10 ng/ml) and IFNγ (10 U/ml). A subset of the latter cells was also co-treated 
with SEITU (500 μM). Cells were incubated for 12 h at 21% oxygen, lysed and subject to SDS-PAGE. 
Protein expression was analysed by Western blot and quantified by densitometry. The corresponding 
densitometry values were normalised with α-tubulin and are shown relative to CoCl2 treated non-
activated MΦ control cells. The values represent + SEM from 3 independent experiments, * p < 0.05 
versus non-activated control MΦ cells.  
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3.6.2 The effect of antioxidants on HIF-1α stabilisation in J774.A1 MΦ 
To investigate whether ROS were involved in the early (1.5 h) stabilisation of HIF1-α, 
MΦ were seeded and activated as described above, with a subset of cells treated with 
antioxidants. HIF-1α protein stabilisation, lactate and nitrate accumulation was 
determined.  
 
Lactate accumulation increased in a time-dependent manner in both groups following 
activation (Figure 31, (A)). Figure 31 (B) shows there was an increase in nitrite 
accumulation 6 h after activation compared to control, with antioxidant treated cells 
showing a similar increase in nitrite accumulation over the whole time course. Figure 32 
shows HIF-1α stabilisation was significantly inhibited by antioxidants at 1.5 h post-
activation but there was no effect in the latter time points. 
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Figure 31 – Time course of lactate and nitrite accumulation in activated MΦ  
MΦ were activated with LPS (10 ng/ml) and IFNγ (10 U/ml). A subset of cells was also co-treated with 
antioxidants (AO; 2.5 mM NAC plus 1 mM ascorbic acid). Lactate (A) and nitrite (B) accumulation in the 
cell culture medium was determined by chemiluminescence. The values represent + SEM from 3 
independent experiments, ns, not significant.  
 
(A) 
(B) 
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Figure 32 – Effect of antioxidants on HIF-1α stabilisation in activated MΦ  
MΦ were plated and non-activated (control), activated with a positive control cobalt chloride (CoCl2, 160 
μM), or activated with LPS (10 ng/ml) and IFNγ (10 U/ml). A subset of cells were also co-treated with 
antioxidants (AO; 2.5 mM NAC plus 1 mM ascorbic acid). Cells were incubated for 12 h at 21% oxygen, 
lysed and subject to SDS-PAGE. Protein expression was analysed by Western blot and quantified by 
densitometry. The corresponding densitometry values were normalised with α-tubulin and are shown 
relative to CoCl2 treated non-activated MΦ control cells. The values represent + SEM from 3 independent 
experiments, * p < 0.05 versus activated MΦ at 1.5 h.  
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3.7 Summary of key results 
Decreasing [O2] causes HIF-1α stabilisation in HEK 293T cells. In these cells we also 
observed menadione- and CoCl2-induced HIF-1α stabilisation at ambient [O2] in a 
concentration-dependent manner. Accordingly, antioxidants and L-NMMA prevented 
HIF-1α stabilisation at 3% oxygen both in HEK 293T cells and head and neck 
carcinoma cells. Activation of MΦ led to HIF-1α stabilisation in a biphasic manner, 
with early stabilisation attributed to ROS and late stabilisation to NO. 
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Chapter four: ROS-dependent HIF-1α stabilisation in 
normoxia 
4.1 Introduction 
Findings in chapter three indicate that HIF-1α stabilisation can be mediated by reactive 
oxygen species (ROS). We therefore set out to investigate the effect of endogenous 
ROS on HIF-1α stabilisation. Studies described in this chapter explore the hypothesis 
that endogenous ROS stabilise HIF-α at ambient oxygen concentrations (21%). Diaz-
Hernandez et al., 2007 demonstrate that impairment in glutathione (GSH) biosynthesis 
induces free radical production in primary cortical neurons. γGlutamyl cysteine 
synthetase (γGCS) is the rate limiting enzyme of glutathione (GSH) biosynthesis and is 
therefore a crucial antioxidant. Silencing γGCS using small interfering RNA (siRNA) 
promoted hydroethidine (HE) fluorescence (a marker for ROS) which was prevented by 
tempol (100μM) and enhanced by H2O2 (500μM) (Diaz-Hernandez et al., 2007). We 
therefore implemented the same strategy to further investigate the effect of endogenous 
ROS production on HIF-1α stabilisation in HEK 293T cells. 
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4.2 Expression vector pFIV and cloning of γGCS constructs 
Short double-stranded RNAs can be used to silence genes in mammalian cells (Fire et 
al., 1998). Template siRNAs can be cloned into a siRNA expression vector (such as 
pFIV), transfected and subsequently expressed in cells. This method of gene silencing 
by endogenous expression of siRNA effectors aims to provide long term silencing of the 
target gene, with a stable knockdown phenotype for functional evaluation studies. The 
expression vector pFIV (Figure 33) was obtained from System Biosciences, USA with 
the intention to silence γGCS in HEK 293T cells.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33 – Plasmid map of pFIV cloning and expression vector 
Sequence features of pFIV: CMV-5’ LTR 1-415, CMV promoter 1394-1745, puromycin-resistant marker 
1753-2352, H1 RNA promoter 3051-3141, U6 RNA promotor 3194-3436, ampicillin resistant gene 5103-
5963 (System Biosciences, USA). 
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Five different human γGCS sequences were selected using Sigma Aldrich predictor 
software (Figure 34). Confirmation of the cloning was done by sequencing (Figure 36) 
in house by Scientific Support Services, Wolfson Institute for Biomedical Research, 
UCL.  
 
 
 
 
 
 
 
 
 
 
Figure 34 – Diagram of CDS sequence of γGCS and table of individual sequences 
CDS sequence of human γGCS (3717 bp) showing the sites of each sequence used to generate siRNA 
against human γGCS. Each of the five different sequences is shown in the table.  
 
The plasmid was then transformed into bacterial cells and the ampicillin resistant 
colonies selected for screening by PCR. PCR, with primers flanking the plasmid 
location sites was used to confirm cloned fragment sizes. The result yielded from the 
screening of the γGCS products was successful, as it showed the expected fragment 
sizes (190 bp) (Figure 35). With the results obtained from the screening and sequencing, 
attempts were made to achieve a successful knock-down/silencing of γGCS in HEK 
293T cells. 
 Selected γGCS Sequences 
1 5’ ATCCATGTAAATATGATCCGG 3’ 
2 5’ TAGTTATTGTTCTTCAATGGC 3’ 
3 5’ AAATCCAATTTGTAGGAAAGG 3’ 
4 5’ AAGGTAAGAGTTCAGAATTGG 3’ 
5 5’ AATGTCTGACACATAGCCTCG 3’ 
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Figure 35 – Screening of γGCS cloning products 
Expression of five γGCS constructs in duplicate (a and b). Products of expected size were obtained for all 
γGCS constructs (except 4b) of approximately 190 base pairs. Human cDNA was used for a positive 
control (lane +). Template DNA was omitted for negative control (lane -). PCR products were subjected 
to electrophoresis on a 1% agarose gel. 
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Figure 36 – Sequencing data for plasmid DNA containing γGCS cloning products 
Sequence data generated with ABI3730XL sequencer. 100 ng/μl of each γGCS pFIV plasmid (1-5) was 
used per sequencing reaction. Samples were cycle-sequenced using BigDye® 3.1 Chemistry, and 
standard thermal cycling conditions. Chromas Lite Version 2.01 sequence scanner software was used to 
analyse and display each DNA sequence. 
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4.3 Silencing of γGCS in HEK 293T cells 
To test the functionality of the γGCS siRNA, HEK 293T cells were transfected with the 
plasmid and efficiency of the knock-down was assessed by measuring protein levels as 
well as cellular GSH content. 
 
4.3.1 Inhibition of γGCS protein in HEK 293T cells 
Cells were transformed using Lipofectamine transfection reagent as described in 
experimental procedures section 2.9.1. A sub-set of cells was also co-transfected with a 
construct expressing the green fluorescent protein (GFP) marker, to ascertain a positive 
visual transfection in these cells (Figure 37).  
 
Following transfection, cells were grown until confluence was reached. Since the pFIV 
plasmid carried a puromycin-resistant maker, transfected cells could be selected using 
media containing the appropriate antibiotic. Therefore to determine the optimal 
antibiotic concentration in which to maintain transfected cells, cells were grown in 
selection media containing 0-4 μg/ml puromycin. Cell viability was quantified using 
trypan blue exclusion. Figure 38 shows puromycin concentrations of less than 0.2 μg/ml 
resulted in 90-100% viable cells. At 0.5 μg/ml puromycin 50% of cells were viable, and 
concentrations above 1 μg/ml killed all cells. All further transfected cells were 
maintained in selection media containing 0.5 μg/ml puromycin. Once the optimal 
selection media had been ascertained and resistant cells begun to grow, cells were used 
experimentally for up to 4 weeks.  
 
γGCS protein expression was determined via Western blot on cell lysates. Figure 39 
shows γGCS protein to be reduced by 80% with construct 1 and 4, 95% with construct 2 
and 60% with construct 5 when compared to control cells. Construct number two 
consistently showed the greatest reduction and was therefore used for all future 
silencing experiments with γGCS pFIV siRNA. However, cells for which γGCS had 
been silenced were inherently unstable thus puromycin resistance was no longer a valid 
tool for selection.  
 
Chapter four: ROS-dependent HIF-1α stabilisation in normoxia 
 134
 
 
 
 
 
 
 
 
Figure 37 – Co-transfection of GFP with pFIV γGCS siRNA 
Cells co-transfected with GFP and γGCS construct sequence #2 to obtain visual confirmation of positive 
cell transfection. Phase contrast image (A), cells transfected with GFP (B), as shown by visible green 
fluorescence.  
 
 
 
 
 
 
 
 
 
 
(A) Phase contrast (B) GFP positive staining 
5 μm5 μm 
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Figure 38 – Puromycin dose-response 
Cells were grown in selection media containing 0-4 μg/ml puromycin. Cell viability was quantified using 
trypan blue exclusion. The values represent the mean + SEM from 3 independent experiments; * 
represents a significant difference (p < 0.05) from control. 
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Figure 39 – Transfection with γGCS siRNA decreases γGCS protein levels 
Cells were transfected with different γGCS siRNA constructs. Cell lysates were subject to SDS-PAGE 
and analysed by Western blot with an anti-γGCS antibody (A) and quantified by densitometry (B). The 
corresponding densitometry values were normalised with α-tubulin and results are shown relative to 
control. The values represent the mean + SEM from 3 independent experiments; * represents a significant 
difference (p < 0.05) from control. One representative blot is shown.  
 
Control γGCS #1 γGCS #2 γGCS #4 γGCS #5
γGCS 
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4.3.2 Inhibiting γGCS protein expression decreases cellular glutathione 
The next series of experiments were performed to investigate the functional 
consequence of γGCS protein knock-down. Firstly, measurements of GSH were made.  
 
Cells were transfected using the protocol described in 4.3.1. Scrambled (non-specific) 
control plasmid was used as a control in all experiments. Total cellular GSH was 
measured using a colorimetric assay GSH-400 kit (Oxis Research, refer to experimental 
procedures, 2.11.4). Figure 40 shows approximately a 40% decrease of GSH in cells 
transfected with γGCS pFIV siRNA, compared to both control (untreated) and 
scrambled control cells. 
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Figure 40 – Decreased glutathione in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence. Samples were analysed for GSH content using a GSH-400 kit (Oxis Research). Data 
was normalised to control. The values represent the mean + SEM from 3 independent experiments; * 
represents a significant difference (p < 0.05) from control. 
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4.3.3 Silencing γGCS increases cellular reactive oxygen species generation 
Experiments were then carried out to determine whether a decrease in GSH caused an 
effect on reactive oxygen species (ROS) generation in these cells.  
 
To measure ROS, cells previously transfected with γGCS were seeded in a black-edged 
96 well plate (Costa 3603) in phenol-free media, in quadruple wells and left overnight 
to adhere. Black plates were used to lower background fluorescence and to reduce cross 
talk between independent wells. γGCS silencing doubled DCF fluorescence (Figure 41). 
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Figure 41 – Increased DCF fluorescence in cells transfected with γGCS siRNA  
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence. Samples were analysed for ROS generation using 20 μM DCFH. Data was normalised 
to control. The values represent the mean + SEM from 3 independent experiments; * represents a 
significant difference (p < 0.05) from control. 
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4.3.4 Effect of γGCS knock-down on HIF-1α stabilisation at 21% oxygen 
Scrambled and γGCS transfected cells were treated with antioxidants (AO, NAC and 
ascorbic acid) for 4 h, sample lysates prepared and HIF-1α protein stabilisation was 
assessed by Western blot. Figure 42 shows cells transfected with a scrambled control do 
not stabilise HIF-1α. Silencing of γGCS stabilises HIF-1α in normoxia, yet this is 
prevented by treatment with AO.  
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Figure 42 – HIF-1α stabilisation in cells transfected with siRNA against γGCS at 21% oxygen 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence. Cobalt chloride (CoCl2, 160 μM) served as a positive control. Cell lysates were subject 
to SDS-PAGE and analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and expressed as a percentage to cells incubated with 
CoCl2. The values represent the mean + SEM from 3 independent experiments; * represents a significant 
difference (p < 0.05) from control, and ^ represents a significant difference from γGCS-transfected cells 
treated with AO. 
α-tubulin
HIF-1α 
Control           CoCl2 
Controls γGCS silencing Scrambled 
Control         AO Control         AO 
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4.4 Alternative strategy to promote a pro-oxidant environment 
Due to the difficulties incurred in maintaining a stable knock-down of γGCS protein 
expression whilst using the pFIV expression vector, we decided to develop a method in 
which these restrictions could be controlled. This was achieved by employing 
synthetically generated siRNA with anti-sense homology against γGCS. 
 
4.4.1 Validation of ON-TARGETplus SMARTpool siRNA against human γGCS 
In order to determine the time point in which to study the highest efficiency of siRNA 
silencing, cells were transfected with a scrambled, negative control siRNA (conjugated 
to Alexa Fluor 555) over a 72 h time course, and transfection efficiency determined. 
Maximum fluorescence was observed between 12 and 24 h post silencing (Figure 43). 
Next we determined mRNA, protein and GSH levels in cells transfected with siRNA 
against γGCS. Silencing γGCS causes a temporary decrease in γGCS protein (Figure 
44) and mRNA expression (Figure 45), which is associated with changes in GSH 
concentration (Figure 45). Transfection with scrambled siRNA had no effect (Figure 
44), remaining undistinguishable from control. There was also no difference in mRNA 
and GSH concentration in scrambled transfected cells (data not shown).  
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Figure 43 – Transfection efficiency of siRNA in HEK 293T cells 
Cells were treated with a negative control siRNA conjugated to Alexa Fluor 555 over a 72 h time course. 
Cell suspensions were made and fluorescence analysed using a Flow Cytometer (A). The data represent 
the mean + SEM from 3 independent experiments; * represents a significant difference (p < 0.05) from 0 
h (B). ns represents no significant difference from 0 h (B). One representative experiment is shown. 
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Figure 44 – Time course of γGCS protein expression in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence. Cell lysates were subjected to SDS-PAGE and analysed by Western blot (A) and 
quantified by densitometry (B). The corresponding densitometry values were normalised with α-tubulin 
and results are shown relative to control (0 h). Values are expressed as the mean + SEM from 3 
independent experiments; * represents a significant difference (p < 0.05) from the scrambled control. 
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Figure 45 – Time course of γGCS mRNA expression and GSH concentration in cells transfected with 
siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence over 72 h. Samples were analysed for GSH content (blue line). Data was normalised to 0 
h control and expressed as a percentage of control (A) and nmol GSH/ mg protein (B). Total RNA was 
obtained from cells, reverse transcribed into cDNA and mRNA copy numbers of γGCS were quantified 
by quantitative reverse transcriptase PCR and normalised against β-actin (bars) and expressed as a 
percentage of control (A).  The values represent the mean + SEM from 3 independent experiments; * 
represents a significant difference (p < 0.05) from control (0 h). 
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4.4.2 Effect of ON-TARGETplus SMARTpool γGCS silencing in HEK 293T cells 
on reactive oxygen species generation 
 
4.4.2.1 Detected using 2’-7’dichlorofluorescin (DCFH), a cell permanent 
indicator for reactive oxygen species 
Since γGCS silencing led to a decrease in glutathione after 24 h, experiments were done 
to measure ROS in these cells. Reactive oxygen species generation was determined 24 h 
post-silencing using 20 μM DCFH. Excitation and emission were measured at 490 nm 
and 520 nm, respectively. Silencing γGCS caused a two-fold increase in DCF 
fluorescence compared to the controls (untreated and scrambled) (Figure 46). 
 
4.4.2.2 Detected using a genetically encoded fluorescent indicator for hydrogen 
peroxide 
Using oxidant sensitive dyes such as DCFH to monitor ROS production has been met 
with contention as the use of these dyes in cells is problematic concerning sensitivity, 
specificity and auto-oxidation (Tampo et al., 2003). However, more recently a 
genetically encoded fluorescent indicator for intracellular hydrogen peroxide (H2O2) has 
been created to detect H2O2 inside living cells in real-time. The HyPer probe consists of 
yellow fluorescent protein (YFP) inserted into the regulatory domain of the prokaryotic 
H2O2-sensing protein, OxyR (Belousov et al., 2006). To further validate and compare 
the observed increase in DCF fluorescence, (Figure 46, indicative of ROS generation) 
the HyPer probe was used in γGCS transfected cells.  
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To characterise the sensitivity of HyPer in HEK 293T cells, cells were transfected with 
the plasmid carrying HyPer using Lipofectamine transfection reagent. HyPer-
transfected cells exhibiting YFP positive staining were then selected using fluorescence-
activated cell sorting (FACS), as the plasmid has no antibiotic selection in mammalian 
cells. Transfected cells were then treated with H2O2 (0-160 μM) and fluorescence 
detected immediately. The fluorescence of HyPer was detected by flow cytometry 
analysis at 488 nm. The HyPer probe exhibits a basal level of fluorescence intensity 
(approximately 40 a.u.) (Figure 47). Concentrations as low as 10 μM H2O2 led to 
increases in HyPer fluorescence, which was saturated at approximately 60 μM. This 
result shows that the HyPer probe can detect H2O2 in HEK 293T cells.  
 
To determine whether HyPer fluorescence following treatment with H2O2 was sensitive 
to antioxidants, HyPer-transfected cells were treated with 60 μM H2O2, followed by a 
bolus dose of NAC (1, 2 or 4 mM) immediately after the addition of H2O2. HyPer-
transfected cells demonstrate basal fluorescence intensity, as seen in Figure 47 and the 
addition of 60 μM H2O2 increases about 2.5 fold. Treatment with NAC caused a 
significant decrease in HyPer fluorescence. 4 mM NAC returned the fluorescence 
intensity back to that of the untreated control (Figure 48). 
 
Following the determination of HyPer sensitivity towards H2O2 and antioxidants, 
silencing experiments were performed using γGCS siRNA. Small interfering RNA was 
prepared, and plated into a 6 well plate. Sorted HyPer cells were then seeded on top in 
phenol-free, low serum media and left overnight to adhere. The fluorescence of HyPer 
24 h post γGCS silencing was detected by flow cytometry analysis. HyPer-transfected 
cells show basal fluorescence intensity as seen in the previous two figures. The 
fluorescence intensity increases significantly in γGCS-silenced cells and antioxidant 
treatment (NAC, 4 mM) immediately prior to analysis prevents this increase (Figure 
49). 
 
Similarly to the data collected using DCFH, the results obtained using the HyPer probe 
show that γGCS-silenced cells have exactly a 2-fold increase in ROS generation 
compared to control cells. 
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Figure 46 – Increased reactive oxygen species in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence. Samples were analysed for ROS using 20 μM DCFH. Data was normalised to control. 
The values represent the mean + SEM from 3 independent experiments; * represents a significant 
difference (p < 0.05) from control. 
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Figure 47 – Sensitivity of HyPer towards exogenously added H2O2  
Cells were transfected with HyPer and selected using fluorescence-activated cell sorting (FACS). Cell 
suspensions were made, treated with 0-160 μM H2O2 (shown in log scale of [H2O2], (A)) and 
fluorescence analysed immediately using a Flow Cytometer. Data represent the mean + SEM from 3 
independent experiments (B). 
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Figure 48 – Effect of NAC on H2O2-induced fluorescence in HEK 293T cells 
Cells were transfected with HyPer and selected using fluorescence-activated cell sorting (FACS). Cell 
suspensions were made, and then treated with 60 μM H2O2 followed by an immediate bolus dose of NAC 
(1, 2 or 4 mM) and fluorescence analysed using a Flow Cytometer. The values represent the mean + SEM 
from 3 independent experiments; * represents a significant difference (p < 0.05) from H2O2 treatment 
alone.  
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Figure 49 – HyPer fluorescence intensity in cells silenced with siRNA against γGCS 
Cells were transfected with HyPer and selected using fluorescence-activated cell sorting (FACS). Cells 
were then silenced with siRNA against γGCS for 24 h and treated with a bolus shot of NAC (4 mM) 
immediately prior to analysis. Cell suspensions were made and fluorescence analysed using a CyAN Flow 
Cytometer (DAKO). The values represent the mean + SEM from 3 independent experiments; * represents 
a significant difference (p < 0.05) from HyPer γGCS silenced cells.  
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4.4.3 Effect of γGCS silencing on HIF-1α mRNA and protein expression at 21% 
oxygen 
Since the use of synthetic siRNA against γGCS in HEK 293T cells decreased GSH and 
increased ROS in agreement with the data shown using pFIV expression vector, HIF-1α 
mRNA and protein were determined. Silencing γGCS causes a significant increase in 
HIF-1α mRNA gene expression (Figure 50) and protein stabilisation (Figure 51) 24 h 
post-silencing.  
 
The effect of antioxidant treatment on γGCS-silenced cells was then evaluated. Figure 
52 shows cells transfected with siRNA against γGCS, stabilise HIF-1α at 21% oxygen. 
Treatment with antioxidants (either NAC alone or a combination of NAC and ascorbic 
acid) significantly prevents HIF-1α stabilisation. 
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Figure 50 – HIF-1α mRNA expression in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
control sequence for 24 h. Total RNA was obtained from cells and reverse transcribed into cDNA. mRNA 
copy numbers of HIF-1α were quantified by quantitative reverse transcriptase PCR and normalised 
against β-actin and expressed relative to control. The values represent the mean + SEM from 3 
independent experiments; * represents a significant difference (p < 0.05) from control.  
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Figure 51 – HIF-1α protein stabilisation in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
(Scr). Cobalt chloride (CoCl2, 160 μM) served as a positive control. Cell lysates were subject to SDS-
PAGE and analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and results are shown as a percentage to CoCl2 
treated cells. The values represent the mean + SEM from 3 independent experiments; * represents a 
significant difference (p < 0.05) from scrambled control. One representative blot is shown. 
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Figure 52 – Effect of antioxidants on HIF-1α stabilisation in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS or treated with scrambled non-specific siRNA 
(Src) for 24 h, and treated with NAC (2.5 mM) alone or NAC (2.5 mM) and ascorbic acid (1 mM) for the 
final 4 h. Cobalt chloride (CoCl2, 160 μM) served as a positive control. Cell lysates were subject to SDS-
PAGE and analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and results are shown as a percentage to CoCl2 
treated cells. The values represent the mean + SEM from 3 independent experiments; * represents a 
significant difference (p < 0.05) from γGCS-silenced cells. One representative blot is shown. 
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4.4.4 Effect of γGCS silencing on other antioxidant systems and oxidant sensitive 
genes 
Next we investigated whether knocking-down γGCS and the associated increase in 
cellular ROS production had consequences for the expression of antioxidant genes. The 
results showed a 2- to 3-fold increase in the expression of catalase, manganese 
superoxide dismutase (MnSOD), nuclear factor-like 2 (Nrf2) and thioredoxin (Figure 
53). Since ROS production has been linked to the activation of NF-ĸB (Palacios-
Callender et al., 2004), a nuclear transcription factor, mRNA levels of NF-ĸB were also 
examined. The data show that there was a significant increase in mRNA expression in 
γGCS knock-down cells compared with control cells (Figure 54). 
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Figure 53 – Antioxidant mRNA expression in cells transfected with siRNA against γGCS 
Cells were transfected with siRNA against γGCS for 24 h. Total RNA was obtained from cells, reverse 
transcribed into cDNA and mRNA copy numbers of catalase, manganese superoxide dismutase 
(MnSOD), nuclear factor-like 2 (Nrf2) and thioredoxin were quantified by quantitative reverse 
transcriptase PCR and normalised against β-actin and expressed relative to control (0 h un-transfected 
cells). The values represent the mean + SEM from 3 independent experiments; * represents a significant 
difference (p < 0.05) from control (0 h un-transfected cells).  
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Figure 54 – NF-ĸB mRNA expression in cells transfected with siRNA against γGCS 
Cells were transfected with siRNA against γGCS for 24 h. Total RNA was obtained from cells, reverse 
transcribed into cDNA and mRNA copy numbers of NF-ĸB were quantified by quantitative reverse 
transcriptase PCR and normalised against β-actin and expressed relative to control. The values represent 
the mean + SEM from 3 independent experiments; * represents a significant difference (p < 0.05) from 
control. 
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4.5 Mechanism by which ROS stabilise HIF-1α in normoxia 
A number of mediators have been described to affect the HIF system including hypoxia 
(Wang and Semenza, 1993), NO (Quintero et al., 2006a), ROS ((Klimova and Chandel, 
2008), growth factors (Fukuda et al., 2002) and genetic mutations (Maxwell et al., 
1999). There are numerous potential mechanisms of these mediators, resulting in either 
the accumulation of HIF-1α or increased HIF-1 activity. These include inhibition of 
PHDs by Fe2+ chelation or activation of PI3K (Brune and Zhou, 2007), S-nitrosylation 
of HIF-1α (Li et al., 2007), inhibition of PHDs by reducing antioxidants, or direct 
oxidation of catalytic Fe2+ (Gerald et al., 2004) and NF-ĸB activation and HIF-1α 
mRNA up-regulation (Blouin et al., 2004;Frede et al., 2006;Jantsch et al., 2008).  
 
4.5.1 Detection of hydroxylated and ubiquitinated HIF-1α  
Since γGCS silencing stabilises HIF-1α at 21% oxygen, experiments underwent to 
investigate the potential mechanism of this stabilisation. At 21% oxygen, PHDs 
normally target HIF-1α for hydroxylation, which in turn mediates ubiquitination and 
proteosomal degradation. To test whether the PHDs were functioning, HEK 293T cells 
were treated with the proteosomal inhibitor MG132 (0-10 μM, 2 h). Cell lysates were 
prepared, separated by SDS-PAGE and analysed by Western blot. An antibody which 
specifically recognises hydroxylated HIF-1α was used during immunodetection. 
 
There is an accumulation of HIF-1α protein in MG132 treated cells, which is absent in 
untreated cells (Figure 55. Moreover, hydroxylated HIF-1α is detected in cells treated 
with 10 μM MG132 (Figure 55). Next, we investigated whether cells treated with 
siRNA against γGCS, which stabilise HIF-1α at 21% oxygen, have been targeted for 
hydroxylation by the PHDs. Figure 56 shows γGCS siRNA transfected HIF-1α have 
been hydroxylated. 
 
Given that HIF-1α is hydroxylated in γGCS siRNA transfected cells, we next tested 
whether HIF-1α was ubiquitinated by preparing IP with anti-ubiquitin. Figure 57 shows 
HIF-1α ubiquitination in cells treated with γGCS siRNA, at a level similar to control. 
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Figure 55 – HEK 293T cells treated with proteasomal inhibitor MG132  
Cells were treated with MG132 (0-100 μM) for 2 h at 21% oxygen. Cell lysates were subject to SDS-
PAGE and analysed by Western blot (A) and quantified by densitometry (B) HIF-1α (white bars) and 
hydroxylated HIF-1α (grey bars). The corresponding densitometry values were normalised with α-tubulin 
and results are shown relative to control. The values represent the mean + SEM from 3 independent 
experiments; * represents a significant difference (p < 0.05) from control. One representative blot is 
shown. 
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Figure 56 – Detection of hydroxylated HIF-1α in cells transfected with siRNA against γGCS 
Cells were either transfected with siRNA against γGCS for 24 h or treated with MG132 (10 μM, 2 h) at 
21% oxygen. Cell lysates were subject to SDS-PAGE and analysed by Western blot (A) and quantified by 
densitometry (B) HIF-1α (white bars) and hydroxylated HIF-1α (grey bars). The corresponding 
densitometry values were normalised with α-tubulin and results are shown relative to control. The values 
represent the mean + SEM from 3 independent experiments; * represents a significant difference (p < 
0.05) from control. One representative blot is shown. 
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Figure 57 – HIF-1α is targeted for ubiquitination in cells transfected with siRNA against γGCS  
HIF-1α protein was immunoprecipitated with an ubiquitin antibody from lysates of cells transfected with 
siRNA against γGCS or a non-specific control sequence (Scr) for 24 h. For controls, CoCl2 was used as a 
positive control for HIF-1α and to verify the stringency of immunoprecipitation, experiments included 
samples where immunoprecipitating antibody was omitted (Neg. Ctl). The immunoprecipitated proteins 
were subjected to Western blotting and detected with anti-HIF-1α. One representative blot is shown from 
3 independent experiments. 
   Ctl           Scr         γGCS     CoCl2    Neg. Ctl     
HIF-1α 
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4.6 Summary of key results 
γGlutamyl Cysteine Synthetase (γGCS), the rate limiting enzyme of GSH biosynthesis 
was successfully silenced in HEK 293T cells via two siRNA strategies. Silencing γGCS 
caused a significant decrease in cellular GSH thereby impairing the capacity of the cells 
to detoxify endogenously generated ROS, resulting in an increase in ROS. HIF-1α was 
stabilised at ambient [O2] in γGCS-silenced cells and this effect could be prevented by 
treatment with antioxidants. HIF-1α appears to remain hydroxylated and ubiquitinated 
in γGCS siRNA transfected cells. 
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Chapter five: Investigation into the origin of reactive oxygen 
species involved in HIF-1α stabilisation 
5.1 Introduction 
The findings presented in chapter four demonstrate ROS-induced HIF-1α stabilisation at 
ambient oxygen concentration. However, these data do not provide information 
concerning the possible origin of ROS contributing towards this normoxic stabilisation 
of HIF-1α. Therefore, experiments were conducted to establish the possible source of 
ROS involved in the stabilisation of HIF-1α in the γGCS silencing model, and to study 
the potential role of ROS in HIF-1α stabilisation at low [O2].  
 
HIF-1α stabilisation by free radicals has been previously demonstrated (Schroedl et al., 
2002;Wellman et al., 2003;Mansfield et al., 2005;Quintero et al., 2006a) yet the origin 
of free radical required for this effect remain controversial. Originally Chandel et al, 
(1998) reported that ROS generated by the mitochondria were able to trigger binding of 
HIF-1α to DNA and mRNA expression of erythropoietin (EPO) and vascular 
endothelial growth factor (VEGF) (downstream HIF-1α targets) in human hepatoma 
(Hep3B) cells. However, the generation of free radicals in hypoxia and their effect of 
stabilising HIF-1α remain contentious. 
 
Experiments were therefore conducted using the previously validated γGCS-silencing 
model to explore the hypothesis that ROS generated from the mitochondria stabilise 
HIF-1α. Initially, experiments were designed to characterise a genetic model in which to 
study the effects of HIF-1α stabilisation in cells with non-functional mitochondria 
(Rho0) and subsequently establish the consequence on ROS production. Alternative 
sources of ROS-induced HIF-1α stabilisation were also investigated.  
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5.2 Characterisation of mutated form of DNA polymerase gamma 
From the 5 isoforms (alpha, beta, gamma, delta, and epsilon) of DNA polymerase in 
human cells, DNA polymerase gamma (POLγ) is solely responsible for the replication 
of mitochondrial DNA (mtDNA). Studies by Wanrooij et al., 2007 showed the effects 
of expressing various catalytically deficient mutants of DNA POLγ. This led to a sharp 
decrease in mtDNA replication and a progressive decline in mtDNA copy number 
(Wanrooij et al., 2007). We investigated the consequence of the expression of mutated 
DNA POLγ on cellular ROS production and HIF-1α stabilisation.  
 
5.2.1 Effect of DNA POLγ mutation on respiration (VO2) and cytochrome aa3 
content 
HEK 293T cells stably transfected with an inducible catalytically deficient isoform of 
mitochondrial DNA POLγ (D890N) were kindly provided by Johannes Spelbrink, 
Institute of Medical Technology and Tampere University Hospital, Tampere, Finland. 
The expression of this mutated isoform is under the control of an inducible promoter 
that can be activated by the incubation of cells with doxycycline (DC). Cells were 
treated with DC (0-1500 ng/ml) for 0, 5 and 10 days and placed in the respiration 
chamber of the visible light spectroscopy (VLS) system (experimental procedures 
section 2.12) to monitor oxygen consumption (VO2) and redox changes in cytochrome 
aa3 of cytochrome c oxidase (CcO) during cellular respiration towards anoxia.  
 
Studies of the VO2 showed that control cells respire at ~ 15 μM O2/min/107cells. 
Incubation with DC led to both dose- and time-dependent decrease in VO2. After 5 
days, VO2 dropped by ~ 50% at concentration > 250 ng/ml. After 10 days, VO2 was 
decreased by incubation with DC as low as 50 ng/ml. At concentrations > 250 ng/ml, 
VO2 dropped to as little as 1 μM O2/min/107cells (Figure 58, A). The corresponding 
changes in the redox state of aa3 in terms of absolute concentration changes were also 
monitored (Figure 58, B). Incubation with DC (50-1500 ng/ml) for 5 days caused a 
significant reduction (> 50%) of cytochrome aa3. Incubation with DC (50-1500 ng/ml) 
for 10 days caused an even greater reduction of cytochrome aa3 to almost undetectable 
levels at concentrations > 250 ng/ml. Figure 58 shows incubation with 250 ng/ml DC 
caused the earliest significant response in mitochondrial functionality (VO2). Therefore 
all further experiments were performed using 250 ng/ml DC for 10 days.  
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5.2.2 Effect of DNA POLγ mutation on mtDNA content 
Next, mitochondrial DNA content was determined following a 10-day time course using 
250 ng/ml DC. Mitochondrial DNA was normalised to nuclear DNA and is represented 
in Figure 59 relative to non-induced cells. Figure 59 shows an early and steep decrease 
in mitochondrial DNA, with an EC50 of 8.9 hours. Mitochondrial DNA decreases by 
90% after 1 day DC incubation and remains at this level throughout the time course. 
 
5.2.3 Effect of DNA POLγ mutation on cytochrome c oxidase protein expression 
Following the previous results demonstrating functional defects in induced D890N and 
the loss of mitochondrial DNA, cytochrome c oxidase (CcO) protein expression was 
determined via Western blot. Cells were incubated with 250 ng/ml DC for 3, 5 and 10 
days and lysates prepared. Figure 60 shows non-induced cells to have a detectable level 
of CcO, which is not significantly affected after incubation with DC for 3 days. 
However, after 5 days incubation with DC, CcO protein concentration begins to decline, 
until at 10 days the protein is significantly reduced. 
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Figure 58 – Cellular respiration and cytochrome aa3 concentration monitored by VLS in DC treated cells 
D890N cells were incubated with 0-1500 ng/ml doxycycline (DC) for 5 or 10 days. Values of oxygen 
consumption (VO2) (A) and changes in the redox state of cytrochromes aa3 (B) were measured from 
intact cells during respiration towards anoxia using the VLS system. The values represent the mean + 
SEM from 3 independent experiments; * represents a significant difference (p < 0.05) from untreated 
cells (for 10 days incubation) and ^ represents a significant difference (p < 0.05) from untreated cells (for 
5 days incubation). 
(A) 
(B) 
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Figure 59 – Mitochondrial DNA content in induced D890N cells 
MtDNA copy number was determined by real time PCR of COX1 using 18S as a nuclear standard. The 
data shown represents the copy numbers for cells following doxycycline (DC) induction (250 ng/ml) for 
up to 10 days. The values represent the mean + SEM from 3 independent experiments; * represents a 
significant difference (p < 0.05) from untreated cells. 
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Figure 60 – Effect of DC treatment on cytochrome c oxidase protein expression 
Cells were treated with 250 ng/ml doxycycline (DC, 0-10 days). Cell lysates were subject to SDS-PAGE 
and analysed by Western blot (A) and quantified by densitometry (B). The corresponding densitometry 
values were normalised with α-tubulin and results are shown relative to control. The values represent the 
mean + SEM from 3 independent experiments; * represents a significant difference (p < 0.05) from 
control. One representative blot is shown. 
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5.2.4 Effect of DNA POLγ mutation on mitochondrial morphology 
We next examined whether the morphology of mitochondria were affected following 
DC induction (250 ng/ml, 10 days). Electron microscopy images of control cells show 
the structure of the mitochondria, with clearly identifiable cristae space (folding of the 
inner membrane) (Figure 61 (A), indicated by arrows). The structure of the 
mitochondria is still visible in induced cells, but the cristae are no longer uniform, and 
in some cases have been completely lost (Figure 61 (B), indicated by arrows).  
 
5.2.5 Mitochondrial membrane potential in induced D890N cells 
Next we investigated whether the membrane potential (ΔΨm) was maintained in induced 
cells, and to see if electrons are passed through the electron transport chain. After DC 
induction, cells were treated with rotenone (1 μM) to inhibit Complex I of the 
respiratory chain; followed by treatment with p-trifluoromethoxy carbonyl cyanide 
phenyl hydrazone (FCCP, 25 μM), an uncoupler of mitochondrial oxidative 
phosphorylation, while recording ΔΨm using time-lapse confocal microscopy.  
 
Treatment with rotenone causes the ΔΨm of control cells, as measured by tetramethyl 
rhodamine methyl ester (TMRM, 20 nM) fluorescence to be significantly reduced 
(Figure 62 (B); rotenone (Rot) addition). FCCP completely collapses ΔΨm. The ΔΨm of 
induced D890N cells is not affected by the addition of rotenone, but collapses 
completely upon treatment with FCCP (Figure 62 (D)).  
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Figure 61 – Electron microscopy of D890N control and induced cells 
Electron microscopy images of control (A) or induced ((B) 250 ng/ml DC, 10 days) D890N cells. Arrows 
depict mitochondrial structure, with cristae (A) or without cristae (B). (n = 3) One representative image 
for each is shown.  
(A) D890N Control (B) D890N Induced 
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Figure 62 – Mitochondrial membrane potential in control and induced D890N cells 
Control and induced (250 ng/ml DC, 10 days) D890N cells were treated with rotenone (1 μM) (Rot) 
followed by FCCP (25 μM), and TMRM fluorescence in whole-cells was monitored as an indicator of 
ΔΨm (B and D). FCCP completely abolished the TMRM fluorescence in control and induced cells. The 
values represent the mean + SEM from 3 independent experiments. One representative confocal image 
and trace of control (A) and DC induced (B) cells is shown, stained with 20 nM TMRM to indicate ΔΨm 
(red) and counterstained with 2 mg/ml Hoechst 33342 to identify the nuclei (blue). 
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D890N Induced 
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Rot
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5.3 Effect of DNA POLγ mutation on HIF-1α stabilisation  
Following the induction and characterisation of a Rho0 phenotype, defined as non-
respiring cells with no mitochondrial DNA, experiments proceeded to investigate the 
implications of Rho0 cells on ROS production and HIF-1α stabilisation.  
 
5.3.1 ROS production decreases in D890N Rho0 cells at ambient oxygen 
D890N HEK 293T cells were incubated with DC (250 ng/ml) for 9 days. Induced and 
control cells were then seeded in a black-edged 96 well plate in phenol free media, in 
quadruple wells and left overnight to adhere. Small interfering RNA against γGCS was 
also prepared, plated into the same 96 well plate and cells (control and induced) seeded 
on top. Reactive oxygen species generation was determined 24 h post silencing (10 day 
DC incubation) using 20 μM DCFH in the absence or presence of antioxidants.  
 
Figure 63 shows that there was a significant increase in DCF fluorescence in γGCS 
siRNA transfected cells compared to non-induced D890N cells. DCF fluorescence in 
induced D890N Rho0 cells was significantly less than non-induced cells and incubation 
with antioxidants had no effect. DCF fluorescence in induced D890N Rho0 cells 
transfected with siRNA against γGCS was also significantly less than non-induced cells 
and incubation with antioxidants had no effect. There was no difference observed 
between the DCF fluorescence of D890N Rho0 cells and D890N Rho0 cells transfected 
with γGCS siRNA. 
 
5.3.2 Loss of ROS in D890N Rho0 cells at low [O2] 
D890N cells were incubated with DC (250 ng/ml) for 10 days. Cells were then 
incubated at ambient (21%) or low [O2] (3%) concentration for 4 hours. Reactive 
oxygen species generation was determined using 20 μM DCFH and cells fixed with 
70% ethanol. The fluorescence of DCF was detected by flow cytometry. 
 
Figure 64 shows that there was a significant increase in DCF fluorescence at 3% oxygen 
in control D890N cells. However, this increase in DCF fluorescence was not observed 
in D890N Rho0 cells at 3% oxygen.  
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Figure 63 – Decrease in DCF fluorescence in Rho0 cells at 21% oxygen 
Cells were incubated with doxycycline (250 ng/ml) for 10 days. Cells were then treated with antioxidants 
(NAC 2.5 mM plus ascorbic acid 1 mM) for 4 h. Samples were analysed for ROS production using 20 
μM DCFH. Data was normalised to non-induced control data. The values represent the mean + SEM from 
3 independent experiments; * represents a significant difference (p < 0.05) from non-induced control. 
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Figure 64 – Decrease in DCF fluorescence in Rho0 cells in low [O2] 
Cells were incubated with doxycycline (250 ng/ml) for 10 days. Samples were analysed for ROS 
production using 20 μM DCFH. Fluorescence was analysed using a flow cytometer. Data was normalised 
to non-induced control data. The values represent the mean + SEM from 3 independent experiments; * 
represents a significant difference (p < 0.05) from non-induced control. 
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5.3.3 Inhibition of HIF-1α stabilisation in D890N Rho0 cells 
HIF-1α protein stabilisation was determined at 21% and 3% oxygen in Rho0 cells (250 
ng/ml, 10 days) and in Rho0 cells following transfection with γGCS siRNA. HIF-1α 
stabilisation was also determined in Rho0 cells at 0.5% oxygen.  
 
Figure 65 shows a significant increase in HIF-1α stabilisation in non-induced cells 
transfected with γGCS siRNA at 21% oxygen. However, silencing γGCS in Rhoo cells 
at 21% oxygen does not result in HIF-1α stabilisation. At 3% oxygen, HIF-1α is 
stabilised, and this stabilisation is significantly increased in γGCS siRNA transfected 
cells. However, HIF-1α stabilisation is prevented at 3% oxygen in Rhoo cells. HIF-1α 
stabilisation is not significantly different in γGCS siRNA transfected Rhoo cells at 3% 
oxygen. HIF-1α stabilisation is not altered in Rhoo cells at 0.5% oxygen.  
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Figure 65 – HIF-1α stabilisation in Rho0 cells and its sensitivity towards γGCS silencing 
Rho0 cells were transfected with siRNA against γGCS at 21% and 3% oxygen. Cell lysates were subject 
to SDS-PAGE and analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and results are shown as a percentage of the 0.5% 
oxygen control. The values represent the mean + SEM from 3 independent experiments; * represents a 
significant difference (p < 0.05). One representative blot is shown. 
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5.4 Role of mitochondrial ROS in HIF-1α stabilisation in human head 
and neck squamous carcinoma cells 
5.4.1 Effect of inhibiting a mitochondrial gene and protein expression on HIF-1α 
stabilisation 
Previous data had shown HIF-1α stabilisation in human head and neck squamous 
carcinoma (H157) cells at 21% oxygen, which can be prevented by incubation with 
antioxidants (Chapter 3, Figure 15), suggesting a role for ROS in this process. In order 
to establish if mitochondria were the source of ROS production, H157 cells were treated 
with ethidium bromide (EtBr) (0-500 ng/ml) for 7 days at 21% oxygen. Ethidium 
bromide was used since it is known to prevent the replication of mitochondrial DNA but 
not genomic DNA at low doses (Zylber et al., 1969;Nass, 1970;Nass, 1972). HIF-1α 
and COXI (a mitochondrial encoded gene) mRNA was determined. Figure 66 (A) 
shows HIF-1α mRNA is reduced in a dose-dependent manner, with a significant 
reduction observed at 200 ng/ml. Figure 66 (B) shows COXI mRNA is significantly 
reduced with all EtBr concentrations tested. 
 
Since HIF-1α mRNA was significantly reduced using 200 ng/ml EtBr, cells were then 
incubated with this concentration of EtBr for 0, 2, 5, 7 and 10 days at 21% oxygen. HIF-
1α and COX1 mRNA were determined. Figure 67 (A and B) shows HIF-1α and COXI 
mRNA to be significantly reduced from as early as 2 days after incubation with EtBr 
and over the entire experimental period. 
 
Figure 68 shows that HIF-1α is present at 21% oxygen in H157 cells, and incubation 
with EtBr results in loss of HIF-1α stabilisation in these cells. Cytochrome c oxidase is 
also detectable in these cells at 21% oxygen. Incubation with EtBr after 2 days causes 
complete loss of this protein, and this loss is maintained until the final collection at 10 
days.  
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Figure 66 – Dose response of HIF-1α and COX1 mRNA following EtBr treatment 
Cells were treated with ethidium bromide (0-500 ng/ml) for 7 days. Total RNA was obtained from cells, 
reverse transcribed into cDNA and mRNA copy numbers of HIF-1α (A) and COX1 (B) were quantified 
by quantitative reverse transcriptase PCR and normalised against β-actin and expressed relative to 
control. The values represent the mean + SEM from 3 independent experiments; * represents a significant 
difference (p < 0.05) from control.  
(A) 
(B) 
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Figure 67 – Time course of HIF-1α and COX1 mRNA after 200 ng/ml EtBr 
Cells were treated with 200 ng/ml ethidium bromide (EtBr) (0-10 days). Total RNA was obtained from 
cells, reverse transcribed into cDNA and mRNA copy numbers of HIF-1α (A) and COX1 (B) were 
quantified by quantitative reverse transcriptase PCR and normalised against β-actin and expressed relative 
to control. The values represent the mean + SEM from 3 independent experiments; * represents a 
significant difference (p < 0.05) from control.  
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Figure 68 – Effect of Ethidium bromide on HIF-1α and CcO protein expression 
Cells were treated with 200 ng/ml ethidium bromide (EtBr) for up to 10 days. Cell lysates were subject to 
SDS-PAGE and analysed by Western blot (A) and quantified by densitometry (B). The corresponding 
densitometry values were normalised with α-tubulin and results are shown relative to control. The values 
represent the mean + SEM from 3 independent experiments; * represents a significant difference (p < 
0.05) from HIF-1α control and ^ represents a significant difference (p < 0.05) from CcO control. One 
representative blot is shown. 
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5.4.2 Effect of ethidium bromide on respiration in H157 cells 
Cells were incubated with 200 ng/ml EtBr for 10 days and placed in the respiration 
chamber of the VLS system to monitor VO2 during cellular respiration to anoxia. 
Studies of the VO2 showed that control cells respire at ~ 18 μM O2/min/107cells. Cells 
treated with ethidium bromide respire at ~ 12 μM O2/min/107cells (Figure 69).  
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Figure 69 – Effect of Ethidium bromide on VO2 in H157 cancerous cells 
HI157 cells were incubated with 200 ng/ml ethidium bromide (EtBr) for 10 days. Values of VO2 were 
measured from intact cells during respiration to anoxia using the VLS system. The values represent the 
mean + SEM from 3 independent experiments; * represents a significant difference (p < 0.05) from 
control (non-treated cells). 
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5.4.3 Hypoxic HIF-1α stabilisation in ethidium bromide treated cells  
To confirm the inhibition of HIF-1α stabilisation was not due to a direct effect of EtBr 
treatment, cells were placed in hypoxia (0.5%) for 7 days and treated with 200 ng/ml 
EtBr. Stabilisation of HIF-1α was observed in both control and EtBr treated cells at 
0.5% oxygen (Figure 70). 
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Figure 70 – Effect of Ethidium bromide on HIF-1α stabilisation in hypoxia 
Cells were treated with 200 ng/ml ethidium bromide (EtBr) for 7 days. Cells were then incubated at 0.5% 
oxygen for 2 h. Cell lysates were subject to SDS-PAGE and analysed by Western blot (A) and quantified 
by densitometry (B). The corresponding densitometry values were normalised with α-tubulin and results 
are shown relative to control. The values represent the mean + SEM from 3 independent experiments; * 
represents a significant difference (p < 0.05) from control. One representative blot is shown. 
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5.5 Alternative source of ROS induced HIF-1α stabilisation 
The data above suggests HIF-1α can be stabilised by mitochondrial ROS, other ROS 
sources, however, may be responsible. Another major contributor to cellular ROS 
generation is the family of NADPH oxidases (NOX). Hypoxic up-regulation of a NOX 
and subsequent augmented ROS generation has been linked to HIF-1α accumulation 
(Goyal et al., 2004).  
 
To establish whether ROS generated from NOX stabilise HIF-1α, the expression of 
NOX in HEK 293T cells was evaluated. Isoforms NOX2 and NOX4 of NADPH 
oxidase are reportedly expressed in HEK 293T cells at an endogenous level (Anilkumar 
et al., 2008). Therefore, NOX2 and NOX4 protein expression was determined via 
Western blot in cell lysates. Figure 71 shows endogenous NOX2 can be detected in cell 
lysates. Endogenous NOX4 was not detectable in cell lysates (data not shown). 
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Figure 71 – Endogenous NOX2 protein expression in HEK 293T cells 
HEK 293T cell lysates were subject to SDS-PAGE and analysed by Western blot for endogenous NOX2 
protein expression. (n = 3). 
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5.5.1 NOX2 silencing in HEK 293T cells  
We next set out to silence NOX2 using siRNA. Previous data (section 4.4.1) 
demonstrated that optimal fluorescence for siRNA conjugated to Alexa Fluor 555 was 
between 12 and 24 h post silencing. A similar time frame was therefore used to study 
the silencing of NOX2 in cells. Small interfering RNA (scrambled and NOX2) was 
prepared, and plated into a 6 well plate. Cells were then seeded on top in low serum, 
antibiotic free media.  
 
To determine successful NOX2 silencing, NOX2 mRNA and protein was determined. 
In parallel, NOX1, NOX4 and NOX5 mRNA gene expression was also evaluated. 
Silencing NOX2 causes a time-dependent reversible decrease in NOX2 mRNA (Figure 
72) and protein (Figure 74). There was also a time-dependent reversible decrease in 
NOX1, NOX4 and NOX5 mRNA (Figure 73). There was no difference in mRNA and 
protein expression in scrambled transfected cells (data not shown). 
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Figure 72 – NOX2 mRNA expression in NOX2 silenced cells 
Cells were transfected with NOX2 siRNA at 21% oxygen for 24 h. Total RNA was obtained from cells, 
reverse transcribed into cDNA and mRNA copy numbers of NOX2 were quantified by quantitative 
reverse transcriptase PCR and normalised against β-actin and expressed relative to control. The values 
represent the mean + SEM from 3 independent experiments; * represents a significant difference (p < 
0.05) from control.  
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Figure 73 – NOX1, NOX4 and NOX5 mRNA expression in NOX2 silenced cells 
Cells were transfected with NOX2 siRNA at 21% oxygen for 24 h. Total RNA was obtained from cells, 
reverse transcribed into cDNA and mRNA copy numbers of NOX1, 4 and 5 were quantified by 
quantitative reverse transcriptase PCR and normalised against β-actin and expressed relative to control. 
The values represent the mean + SEM from 3 independent experiments; * represents a significant 
difference (p < 0.05) from control.  
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Figure 74 – NOX2 protein expression after NOX2 siRNA transfection 
Cells were transfected with NOX2 siRNA at 21% oxygen (0-48 h) and a non-targeting control siRNA 
sequence (Scr) for 24 h. Cell lysates were subject to SDS-PAGE and analysed by Western blot (A) and 
quantified by densitometry (B). The corresponding densitometry values were normalised with α-tubulin 
and results are shown relative to control. The values represent the mean + SEM from 3 independent 
experiments; * represents a significant difference (p < 0.05) from control. 
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5.5.2 Silencing NOX2 at 3% oxygen does not effect HIF-1α stabilisation 
Once successful silencing of NOX2 (and other NOX isoforms) had been confirmed, 
experiments were performed to investigate the effect this would have on HIF-1α 
stabilisation at low [O2]. To determine the effect of transfecting NOX2 siRNA in cells 
at 3% oxygen, NOX2 protein was determined. Figure 75 (A) and (B) shows NOX2 is 
silenced at 3% oxygen but there is no effect on HIF-1α stabilisation (Figure 75 (A) and 
(C)). 
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Figure 75 – HIF-1α stabilisation in cells transfected with NOX2 siRNA 
Cells were transfected with NOX2 siRNA at 21% and 3% oxygen (24 h) and a non-targeting control 
siRNA sequence (Scr) at 3% oxygen (24 h). Cell lysates were subject to SDS-PAGE and analysed by 
Western blot (A) and quantified by densitometry (B) NOX2 and (C) HIF-1α. The corresponding 
densitometry values were normalised with α-tubulin and results are shown relative to control. The values 
represent the mean + SEM from 3 independent experiments; * represents a significant difference (p < 
0.05) from control. 
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5.6 Summary of key results 
A Rho0 phenotype, defined as non-respiring cells with no mitochondrial DNA was 
successfully induced in HEK 293T cells. We were able to demonstrate that these cells 
produced less ROS compared to un-induced cells and cells transfected with γGCS 
siRNA at 21% oxygen. In addition, antioxidants had no effect. The level of ROS 
produced at 3% oxygen was also diminished to that of normoxic control cells. Crucially, 
Rho0 cells did not stabilise HIF-1α in response to treatment with γGCS siRNA or at 3% 
oxygen, with no effect observed at 0.5% oxygen. In another model of normoxic HIF-1α 
stabilisation, H157 carcinoma cells were successfully induced as Rho0 cells using 
ethidium bromide. In these cells, HIF-1α stabilisation was prevented at 21% oxygen, but 
remained stable at 0.5% oxygen. Silencing NOX2 (and the other isoforms) had no effect 
on HIF-1α stabilisation at 3% oxygen.  
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Chapter six: Discussion and conclusion 
 
6.1 Background and aim of current study 
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator that functions as a 
master regulator of the cellular response to decreases in oxygen concentration. The 
importance of HIF-1 in physiological processes is emphasised by the vast array of target 
genes that are controlled by HIF-1, including genes involved in erythropoiesis, glucose 
transport, glycolysis, iron transport and cell proliferation/survival. HIF-1 also plays key 
roles in critical aspects of tumour progression by promoting angiogenesis, cell survival, 
glucose metabolism and invasion. Tumour micro-environment and genetic mutations 
can lead to HIF-1α over-expression, and this is closely correlated with increased patient 
mortality in several cancer types (Semenza, 2009a).  
  
HIF-1 is a heterodimeric protein that consists of a constitutively expressed HIF-1β 
subunit and a HIF-1α subunit, the expression of which is highly regulated. The α-
subunit is degraded under normoxic oxygen conditions (21%) but is stabilised at low 
(3%), hypoxic (0.5%) and anoxic (0%) oxygen concentrations ([O2]). More recently, 
evidence from several groups has demonstrated that HIF-1α can be regulated by 
oxygen-independent mechanisms, and more specifically, by the generation of reactive 
oxygen species (ROS) at low [O2] (Chandel et al., 1998;Agani et al., 2000;Chandel et 
al., 2000a;Guzy et al., 2005;Quintero et al., 2006a). Stabilisation of the α-subunit by 
ROS has been shown to be a possible consequence of mitochondrial ROS production 
(Mansfield et al., 2005;Brunelle et al., 2005).  
 
The aim of this study was to investigate the effect of ROS on the stabilisation of HIF-
1α, both in normoxic and low [O2], and ultimately to determine the cellular source of 
free radicals involved in HIF-1α stabilisation. 
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6.2 Mechanisms of HIF-1α stabilisation 
Most organisms are dependent on a continuous supply of oxygen for survival. Sensing 
and responding to changes in oxygen partial pressure assures that the cellular oxygen 
supply is tightly controlled in order to balance the risk of oxidative damage vs. oxygen 
deficiency (Brune and Zhou, 2007). This delicate balance is disrupted in a variety of 
pathological conditions including heart disease and cancer (Semenza, 2000). A decrease 
in oxygen availability needs to be sensed in order to provoke appropriate changes that in 
turn circumvent hypoxic episodes, which are potentially harmful to cells, organs or the 
organism. A fundamental step in oxygen sensing involves a transcription factor named 
HIF-1 (Wang and Semenza, 1993). 
 
The intracellular oxygen concentration varies widely in different tissues due to the 
dynamic relationship between oxygen supply and demand, making hypoxia difficult to 
define. Many authors use the term ‘hypoxia’ to describe the oxygen concentration used 
in their study. However, little consistency exists between studies concerning the actual 
oxygen concentrations used, thus leading to confusing interpretation of results. For the 
purpose of this discussion, we have defined low [O2] as between 3% and 1.5%, and 
hypoxia as below 1.5% oxygen. 
 
HIF-1α can be stabilised through both oxygen-dependent and independent mechanisms. 
Indeed, a decrease in oxygen availability, as well as increases in nitric oxide (NO) and 
reactive oxygen species (ROS) have been described in the regulation of HIF-1α. This 
study has investigated the role of these different parameters in HIF-1α stabilisation. 
 
6.2.1 Oxygen-dependent stabilisation of HIF-1α 
6.2.1.1 HIF-1α stabilisation in hypoxia 
HIF-1 was first detected in nuclear extracts from Hep3B cells cultured in 1% oxygen, 
during studies investigating the hypoxia-dependent expression of erythropoietin (EPO) 
(Wang and Semenza, 1993). These authors also demonstrated HIF-1 DNA binding 
activity decayed rapidly when hypoxic cells were exposed to increased oxygen tension. 
It was later described that the expression of HIF-1α, and HIF-1 transcriptional activity 
increased exponentially as cellular oxygen concentrations decrease (Jiang et al., 1996). 
HIF expression is therefore most commonly associated with hypoxia. Hypoxia is a 
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fundamental physiological stimulus that occurs in response to tissue growth during 
normal development and in disease states such as anemia, haemorrhage, cardiovascular 
disease and cancer (Semenza, 2009b). When cells are subjected to acute hypoxia, the 
hydroxylation reactions, which prepare HIF-1α for proteasomal degradation, are 
inhibited as a result of substrate (O2) deprivation and/or, as we have now shown, 
mitochondrial ROS production (section 6.5). Loss of hydroxylase activity increases 
HIF-1α stability and transactivation function, leading to dimerisation with HIF-1β, 
translocation to the nucleus, binding of HIF-1 to its recognition sequence (HRE) and 
increased transcription of target genes. 
 
Initial experiments were therefore designed to test whether HIF-1α was stabilised in 
HEK 293T and H157 carcinoma cells following exposure to experimental normoxia 
(21% oxygen) through to hypoxia. As expected, oxygen deprivation results in a 
progressive increase in HIF-1α stabilisation, attributed to the decrease in PHD activity 
(Willam et al., 2004), as oxygen, the key substrate required for their hydroxylation 
activity becomes the limiting factor. 
 
6.2.1.2 HIF-1α stabilisation at low [O2] 
Originally, Chandel et al., 1998 suggested that ROS generated at low [O2] (1.5% 
oxygen) were responsible for stabilising HIF-1α, and in recent years further evidence 
has been produced (Sanjuan-Pla et al., 2005;Mansfield et al., 2005). 
 
In support of this, our data shows that HIF-1α stabilisation at low [O2], but not in 
hypoxia, is prevented by treatment with antioxidants (NAC plus ascorbate). It is worth 
noting that HIF-1α stabilisation is greater at 0.5% oxygen than at 3% oxygen. 
Therefore, the effect of antioxidants was compared when levels of HIF-1α stabilisation 
were similar (24 h 3% oxygen vs. 2 h 0.5% oxygen). This observation implies that in 
hypoxia HIF-1α stabilisation is oxygen-dependent, whereas at low [O2] HIF-1α 
stabilisation is dependent on free radicals. However, the addition of ascorbate has been 
suggested to enhance PHD activity (hence increasing hydroxylation reactions) rather 
than decreasing ROS via reduction of ferric iron to ferrous iron, thereby modulating 
HIF-1α protein accumulation (Pan et al., 2007). With this in mind, further experiments 
were performed using an alternative antioxidant, one that is not a co-factor for PHD 
activity. Glutathione (GSH) is the most abundant intracellular antioxidant. As native 
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GSH does not permeate the cell membrane, methylated GSH was used. Treatment of 
cells with methylated GSH at low [O2] prevented HIF-1α stabilisation in a dose-
dependent manner. This data provides further evidence to suggest that HIF-1α 
stabilisation is dependent on a free radical mechanism at low [O2] since it can be 
suppressed by antioxidants NAC plus ascorbate and GSH.  
 
We have also been able to demonstrate that H157 carcinoma cells incubated with either 
L-NMMA (a non-specific NOS inhibitor) or antioxidants at low [O2] show a reduction 
in the stabilisation of HIF-1α. However, in hypoxia this treatment has no effect. This 
supports data from Quintero et al., 2006 demonstrating that HIF-1α stabilisation was 
prevented at 3% oxygen in H157, H357 and B1CR6 oral squamous carcinoma cells by 
inhibition of NOS activity using L-NMMA and also by antioxidants, thus suggesting 
that the mechanism is dependent on a free radical reaction (Quintero et al., 2006a). 
Exposure of these cells to hypoxia however, resulted in HIF-1α stabilisation, which was 
not prevented by L-NMMA or antioxidants.  
 
From the observations made using HEK 293T and H157 carcinoma cells exposed to 
varying oxygen concentrations, our data suggests that at low [O2], but not in hypoxia, a 
ROS-dependent mechanism of HIF-1α stabilisation exists. It has also been shown by 
other authors that the addition or expression of antioxidants is sufficient to reverse HIF-
1α stabilisation at low [O2] (Sanjuan-Pla et al., 2005;Guzy et al., 2005). However, 
conflicting reports have demonstrated that enzymatically-generated superoxide actually 
reduces HIF-1α protein levels (Wellman et al., 2003) and a separate study has 
demonstrated that non-toxic levels of hydrogen peroxide did not result in HIF-1α 
stabilisation (Tuttle et al., 2007). Herein, further experiments were designed to study 
HIF-α stabilisation by both exogenous and endogenously released ROS. 
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6.3 ROS-dependent stabilisation of HIF-1α in normoxia 
Reactive oxygen species (ROS) have long been recognised as bona fide second 
messengers, having been suggested to activate a number of transcription factors, 
including nuclear factor kappa B (NF-ĸB), activator protein 1 (AP-1), specificity protein 
1 (Sp1), peroxisome proliferator-activated receptors (PPARs), among others (Lavrovsky 
et al., 2000). ROS have also been implicated in the regulation of HIF-1α stability 
(Chandel et al., 1998) 
 
6.3.1 Pharmacological agents 
Pharmacological agents such as cobalt chloride (CoCl2) have also been shown to 
regulate HIF-1α stability in normoxia via various mechanisms. These include increased 
ROS production (Chandel et al., 1998) and inhibition of the interaction between HIF-1α 
and the VHL protein (Yuan et al., 2003). We found that indeed, the addition of CoCl2 
stabilised HIF-1α in normoxia. In order to validate our experiments, we also used 
menadione, which has also been reported to release ROS (Criddle et al., 2006). Our 
own experiments showed that menadione did release ROS and we used it to investigate 
whether exogenous ROS stabilised HIF-1α. Both compounds stabilised HIF-1α in a 
dose-dependent manner. Treatment with antioxidants prevented the observed normoxic 
stabilisation of HIF-1α, further validating the role of ROS. Furthermore, both 
compounds have a synergistic effect on HIF-1α stabilisation in hypoxia. 
 
6.3.2 Carcinoma cells 
We were able to extend these findings by looking at HIF-1α stabilisation in H157 
carcinoma cells at 21% oxygen. These cells express HIF-1α and iNOS (Quintero et al., 
2006a) which make them ideal to investigate the role of ROS in HIF-1α stabilisation. 
Malignant tissue often produces free radicals (Szatrowski and Nathan, 1991;Bae et al., 
1997;Ha et al., 2000), thus in these cells, NO might be released in an environment 
favouring free radical reactions leading to peroxynitrite formation. Our results show that 
HIF-1α was present at 21% oxygen in these cells. Treatment with antioxidants, but not 
L-NMMA prevented normoxic stabilisation of HIF-1α, providing additional evidence 
towards a ROS-induced mechanism of HIF-1α stabilisation. 
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6.3.3 Macrophages 
It has recently been shown that bacterial infection and inflammatory sites, often 
characterised by low oxygen concentrations (Zinkernagel et al., 2007) stabilise HIF-1α 
in macrophages (MΦ) in a way that is independent of oxygen concentration 
(Peyssonnaux et al., 2005).  
 
It is well known that MΦ produce high concentrations of nitric oxide (NO) upon 
activation (Stuehr and Nathan, 1989;Garedew and Moncada, 2008) and hence 
investigations proceeded to explore the role of NO in HIF-1α stabilisation in activated 
murine MΦ. Upon activation, nitrite concentrations increased suggesting an increase in 
iNOS activity, as this is the major source of NO in these cells (Garedew and Moncada, 
2008). Nitrite accumulation was abolished in activated MΦ when co-treated with 
SEITU, a specific iNOS inhibitor. In these experiments, we also found that HIF-1α was 
stabilised after MΦ activation in a biphasic manner. The early stabilisation observed 
after 1.5 h was insensitive to treatment with SEITU but sensitive to antioxidants. It was 
not surprising that SEITU had no effect on HIF-1α stabilisation at 1.5 h post-activation 
since nitrite accumulation was not observed until 6 h activation. The later stabilisation, 
however, was dependent on the generation of NO as it could be abolished by treatment 
with SEITU. Treatment with antioxidants did not prevent HIF-1α stabilisation in the 
latter time points, initially suggesting this was entirely NO-dependent. However, in a 
situation where there is a lot of free radicals and NO (as in the case of activated MΦ), 
HIF-1α may be stabilised by possible peroxynitrite formation. Thus perhaps, in these 
conditions the antioxidants used were not enough to detoxify the ROS produced. 
Therefore, the latter stabilisation could still be ROS-dependent rather than exclusively 
NO-dependent.  
 
Our data is in agreement with Peyssonnaux et al., 2005. These authors show that the 
loss of HIF-1α-/- in MΦ attenuates iNOS induction in response to bacterial stimulation 
(Peyssonnaux et al., 2005). During inflammation HIF-1 is critically involved in iNOS 
up-regulation, while reduced NO production as seen in HIF-1α-/- cells, impairs MΦ 
TNF-α production and bactericidal activity (Peyssonnaux et al., 2005). 
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6.3.4 Genetically-induced pro-oxidant environment 
With conflicting data in the literature, we wanted to tackle the issue of ROS-induced 
HIF-1α stabilisation in normoxia (initially) without the addition of pharmacological 
agents. We decided to decrease the biosynthesis of glutathione (GSH) (an important 
cellular antioxidant) (Krzywanski et al., 2004) using an in vitro model previously 
employed by Diaz-Hernandez et al., 2007. These authors showed that impairment of 
GSH biosynthesis in primary cortical neurons induced ROS production and triggered 
apoptotic death (Diaz-Hernandez et al., 2007). This demonstrates the importance of 
GSH biosynthesis in protecting cells from the harmful effects of excessive ROS 
production.  
 
We used RNA interference (RNAi) to selectively knock down the catalytic subunit of γ-
glutamyl cysteine synthetase (γGCS), the rate-limiting enzyme in GSH biosynthesis. 
Using small interfering RNA (siRNA) sequences against human γGCS, we observed a 
reduction in the expression of the protein higher than 80%. This correlated with a ~ 40% 
decrease in total cellular GSH levels. Furthermore, our own data has showed that 
silencing the catalytic subunit of γGCS results in a 2-fold increase in ROS production at 
21% oxygen, accompanied by an increase in HIF-1α protein stabilisation. Treatment 
with antioxidants abolished this enhanced stabilisation of HIF-1α, further suggesting a 
role of ROS in the observed stabilisation of HIF-1α. Previously, it has been shown in a 
B cell lymphoma cell line that administration of L-buthionine sulfoximine (L-BSO); a 
competitive inhibitor of γGCS activity, resulted in apoptosis, which correlated with 
depleted GSH levels and an increase in ROS production (Armstrong et al., 2002). These 
data further extend our findings, which demonstrate that genetic inhibition of γGCS in 
HEK 293T cells was sufficient to cause a decrease in GSH concentrations, as well as 
increases in ROS production.  
 
We also decided to confirm these results using an alternative method to achieve GCS 
silencing. We used synthetic double-stranded siRNA molecules which can be 
introduced into cells to suppress gene expression transiently. We silenced the catalytic 
subunit of γGCS, both at the mRNA and protein levels (approximately 90% and 80% 
reduction respectively). We confirmed the functional silencing of γGCS by analysing 
the cellular GSH levels and observed a marked decrease (approximately 60% decrease) 
when compared with control (mock-transfected) cells. We also found that as previously 
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observed, there was a 2-fold increase in DCF fluorescence in cells where γGCS had 
been silenced. Thus, we achieved two independent genetic models in which the desired 
phenotype was attained.   
 
There are concerns, however, that the detection of ROS using DCFH may be unreliable 
due to superoxide formation during the conversion of DCFH to the fluorescent dye DCF 
or upon exposure to light (Rota et al., 1999). In addition, DCFH and related 
compounds/dyes are sensitive to multiple types of ROS, including ROS and RNS 
species (Droge, 2002) and cannot be targeted to specific intracellular components. Thus, 
there are multiple shortcomings to detection and visualisation of ROS with DCFH, 
which may result in false positive or over amplified signals (Belousov et al., 2006). 
Alternative methods to measure the formation of ROS and RNS include fluorometric 
and spectrophotometric methods, chemiluminescence and electron paramagnetic 
resonance (Chance et al., 1979;Pou et al., 1989;Tarpey and Fridovich, 2001). These 
methods rely on the redox properties of specific ROS and RNS, and therefore are prone 
to artefacts (as with DCFH) caused by species of similar reactivity or by reactive 
intermediates produced by the probe itself (Picker and Fridovich, 1984;Faulkner and 
Fridovich, 1993;Liochev and Fridovich, 1995;Liochev and Fridovich, 1998). 
 
To address the weakness of DCFH (and other such ROS indicators) as a probe to 
measure ROS, we proceeded to utilise a new class of ROS sensor. To overcome the 
disadvantages of existing methods for detecting ROS, Belousov et al., 2006 developed a 
genetically encoded biosensor for hydrogen peroxide (H2O2). This sensor consists of 
yellow fluorescent protein (YFP) inserted into the regulatory domain of Escherichia coli 
OxyR (OxyR-RD). The indicator, named HyPer (from hydrogen peroxide) demonstrates 
sub-micromolar reactivity to H2O2, and at the same time it is insensitive to other 
oxidants (Belousov et al., 2006). Based on these characteristics, HyPer can be used as 
an accurate monitor of intracellular H2O2 levels. Using HyPer transfected HEK 293T 
cells, where γGCS has been silenced, we observed that H2O2 levels were twice that of 
the control. Additionally, treatment with an antioxidant abolished this increase. These 
data corroborate our previous DCFH-based observations that ROS accumulation occurs 
in cells where γGCS is silenced. Since there was a two-fold increase in HyPer 
fluorescence it would strongly suggest that the vast majority of ROS produced in this 
silencing model is H2O2. 
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Following confirmation of increased ROS production in our γGCS-silencing model, 
HIF-1α stabilisation was also observed. Moreover, antioxidants reversed this normoxic 
stabilisation confirming our previous observations showing stabilisation of HIF-1α in 
normoxic conditions by ROS.  
 
We also observed a two-fold increase in catalase and Nrf2 and a three-fold increase in 
manganese superoxide dismutase and thioredoxin, suggesting that when γGCS has been 
disrupted, cells attempt to compensate for the increase in ROS by increasing the 
expression of other antioxidant genes (Colombo and Moncada, 2009). ROS production 
has also been linked to the activation of the nuclear factor kappa B (NF-ĸB) (Palacios-
Callender et al., 2004). Our experiments show that down-regulation of γGCS caused an 
increase in ROS which correlated with an increase in NF-ĸB expression.  
 
6.4 Mechanism of ROS-induced HIF-1α stabilisation 
Our findings add to an increasing body of evidence that suggests ROS stabilise HIF-1α 
in both normoxia and at low [O2]. The mechanism by which ROS stabilise HIF-1α has 
yet to be fully clarified. It has been proposed to occur through modifications in the 
PHDs, such as nitrosylation (Metzen et al., 2003) or changes in the redox state of their 
ferrous iron (Gerald et al., 2004).  
 
The immediate regulators of HIF-1α stability are the prolyl hydroxylases (PHD), a 
family of oxidases involved in the post-translational modification that signals HIF-1α 
for degradation (Epstein et al., 2001;Berra et al., 2003). PHD use 2-oxoglutarate and 
oxygen as substrates and require ferrous iron (Fe2+) as a cofactor. Chemical inhibitors 
that block the activity of PHD, such as iron chelators that deprive the enzyme of Fe2+ 
(desferoxamine), or which consequently competes with 2-oxoglutarate for binding at the 
hydroxylase (DMOG), prevent HIF-1α proline hydroxylation and cause accumulation of 
HIF-1α as well as activation of HIF-dependent gene expression (Ivan et al., 2002).  
 
Cells cultured under low [O2] stabilise HIF-1α; however, recent studies, including our 
own, have found that such accumulation is dependent on functional mitochondria 
(section 6.5) (Chandel et al., 2000a;Mansfield et al., 2005). Questions remain 
concerning the signalling pathway linking mitochondrial ROS production to the 
inhibition of PHD activity. ROS may regulate the redox state of iron through the Fenton 
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reaction. Therefore, low oxygen levels may inhibit PHD activity because ROS decrease 
the availability of the PHD cofactor Fe2+ (Gerald et al., 2004) rendering the enzyme 
inactive. It has been shown however that low-level ROS formation increased PHD 
activity in both normoxia and hypoxia (Callapina et al., 2005).  
 
In both our genetic models, we have observed HIF-1α stabilisation, implying an 
inhibition of PHD activity (since the observed stabilisation was in normoxic 
conditions). Exogenous hydrogen peroxide has been shown to stabilise HIF-1α at 
ambient oxygen concentrations (Simon, 2006;Bell et al., 2007), implying ROS inhibit 
the hydroxylation reaction. To investigate this further, we used a proteasomal inhibitor 
(MG132) to detect hydroxylated HIF-1α protein at 21% oxygen. Prelimary results 
showed that HIF-1α was hydroxylated in our ROS-induced HIF-1α model, suggesting it 
had been targeted for hydroxylation and therefore the PHD were not inhibited by 
enhanced ROS production. We went on to show that HIF-1α appeared to be 
ubiquitinated and thus possibly being targeted for proteasomal degradation. How then is 
it that HIF-1α is stabilised in our model? Our data shows that the gene expression of 
HIF-1α was increased 2-fold in our ROS-induced model of HIF-1α stabilisation. This 
preliminary data suggests that HIF1-α is stabilised by ROS increasing its synthesis 
(transcription), rather than ROS inhibiting PHD activity and ultimately preventing HIF-
1α degradation. Indeed, Yuan et al., 2008 demonstrate that ROS generated by NADPH 
oxidase was required for HIF-1α accumulation by intermittent hypoxia (IH) in PC12 
cells. HIF-1α levels in cells exposed to IH with cyclohexamide (an inhibitor of protein 
synthesis) were similar to those exposed to IH alone, suggesting that increased HIF-1α 
accumulation in the absence of cyclohexamide was at least in part due to new synthesis 
of HIF-1α protein (Yuan et al., 2008).  
 
However, to confirm this hypothesis, further studies would be required using 
cyclohexamide and treatment with actinomycin D (a transcription inhibitor). Also, 
questions remain as to which signal transduction pathways lead to HIF-1α synthesis. In 
the case of intermittent hypoxia (IH)- induced HIF-1α stabilisation are known to involve 
NADPH oxidase-dependent ROS production that, through a signalling cascade 
involving inostitol 1,4, 5- triphosphate (IP3), diacylglycerol (DAG), calcium-
calmodulin kinase (Ca/CAMK) and protein kinase C (PKC), stimulate mTOR-
dependent HIF-1α synthesis. 
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Furthermore, recent data demonstrates that there is no evidence for hydrogen peroxide 
dependent inhibition of PHD activity (Chua et al., 2010). This confirms our own results 
that ROS do not regulate PHD activity directly.  
 
6.5 Mitochondrial ROS-induced HIF-1α stabilisation 
Studies investigating the involvement of the electron transport chain in oxygen sensing 
revealed that a functional mitochondrial chain was required for HIF-1α stabilisation. 
This observation was made during studies using electron transport chain inhibitors, 
since rotenone (an inhibitor of the distal end of Complex I), myxothiazol and 
stigmatellin (inhibitors of the upstream end of Complex III), were capable of preventing 
HIF-1α stabilisation at low [O2] (Chandel et al., 1998;Agani et al., 2000;Guzy et al., 
2005). However, these studies relied heavily on the use of pharmacological agents, 
which may have non-specific effects on the cell. Furthermore, the role of ROS in the 
stabilisation of HIF-1α at low [O2] has not been completely clarified, since data has 
challenged these findings (Vaux et al., 2001;Srinivas et al., 2001). However, our own 
data has demonstrated that ROS play a role in the stabilisation of HIF-1α in normoxia 
and at low [O2]. Therefore, we next investigated the cellular source of ROS involved in 
HIF-1α stabilisation. 
 
Mitochondria and NADPH oxidases are a major cellular source of ROS. Both 
mitochondrial derived ROS (Chandel et al., 1998;Chandel et al., 2000a;Schroedl et al., 
2002) and NOX derived ROS (Hirota and Semenza, 2001;Goyal et al., 2004;Mekhail et 
al., 2004) have been previously implicated in HIF-1α stabilisation. Thus we decided to 
investigate the role of these ROS sources in HIF-1α stabilisation. 
 
6.5.1 Mitochondrial ROS 
Mitochondria contain their own DNA (mtDNA), which encodes 13 genes that are 
essential for the assembly of a functional electron transport chain. Mitochondrial DNA 
(mtDNA) is replicated by an assembly of proteins and enzymes including DNA 
polymerase γ (POLγ) and its accessory protein, mitochondrial single stranded DNA 
binding protein (mtSSB) and mtDNA helicase (Twinkle). DNA POLγ is the only known 
DNA POLγ in human mitochondria and is essential for mitochondrial DNA replication. 
It is well established that defects in mtDNA replication lead to mitochondrial 
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dysfunction and disease. Wanrooij et al., 2007 characterised the inducible expression of 
mutant POLγ in cultured human cells. The expression of the mutated form D890N 
(representing an amino acid change from an aspartate residue (D) to an asparagine 
residue (N)) was under the control of an inducible promoter activated by incubation of 
cells with doxycycline (DC). Over-expressed catalytically-inactive mutant POLγ out 
competes with the endogenous wild type POLγ for binding to mtDNA, thus preventing 
the cell to replicate mtDNA (Wanrooij et al., 2007) and eventually  producing non-
functional respiratory mitochondria. HEK 293T cells stably transfected with an 
inducible mutated isoform of mitochondrial DNA POLγ (D890N) were kindly provided 
by Johannes Spelbrink, Institute of Medical Technology and Tampere University 
Hospital, Tampere, Finland, and were further characterised for use in our studies for use 
as Rho0 cells (cells without respiratory functionality and mtDNA). 
 
Our results show that mutating DNA POLγ over a period of 5-10 days depletes the cell 
of its mtDNA. DC induction also decreases the expression of cytochrome c oxidase, a 
partially mitochondrial-encoded protein. We also show that mutating DNA POLγ 
results in the inhibition of cellular respiration and a decrease in cytochrome aa3 content.  
 
It has been estimated that 1-3% of oxygen consumed by the mitochondria is converted 
to ROS (Boveris and Chance, 1973). The rate of ROS production is strongly linked to 
the mitochondrial membrane potential (ΔΨm), which is generated by protons in the 
intermembrane space. Mild uncoupling of mitochondria strongly reduces ROS 
production (Brand et al., 2004). We observed in our Rho0 cells that the ΔΨm was not 
affected by the addition of rotenone, which inhibits Complex I (by preventing the 
transfer of electrons from Complex I to ubiquinone), suggesting the absence of electron 
transport along the ETC in these cells. Indeed, ROS production in DC induced Rho0 
cells were significantly less than that of non-induced cells. Knocking-down γGCS in 
HEK 293T cells has previously demonstrated a 2-fold increase in ROS production. 
However, this increased ROS production is not observed in our Rho0 cells in which 
γGCS has been knocked down. Treatment with antioxidants in both cases has no further 
effect on ROS production. This data suggests that the vast majority of ROS produced in 
our Rho0 cells is of mitochondrial origin since even when γGCS has been silenced, no 
increase in ROS is observed. A study utilising the mitochondrial-targeted antioxidant, 
Mito-Q has provided further evidence towards the role for ROS in mitochondrial 
signalling to the HIF pathway at low [O2] (Bell et al., 2007).  
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ROS production at 3% oxygen was next to be examined in these cells especially since it 
has been well documented that low [O2] increase ROS production (Chandel et al., 
1998;Vanden Hoek et al., 1998;Waypa and Schumacker, 2002). Our data confirm 
results of Chandel et al., 1998. At 3% oxygen we demonstrate a clear increase in ROS 
production compared to cells cultured in normoxia. This increase in ROS is absent in 
our Rho0 cells, suggesting that mitochondria are responsible for ROS production at low 
[O2]. Elimination of ROS in both our normoxic model of HIF-1α stabilisation and at 3% 
oxygen, resulted in the prevention of HIF-1α stabilisation in these cells. In both 
however, HIF-1α was stabilised at 0.5% oxygen.  
 
Due to the central role of HIF in the adaptive response to decreased oxygen tension, the 
HIF pathway has become an area of intense investigation as a therapeutic target in 
ischaemic disease and cancer, since hypoxia plays a significant role in disease 
development (Poellinger and Johnson, 2004;Semenza, 2006). In our studies we have 
demonstrated that HIF-1α stabilisation in human head and neck squamous carcinoma 
(H157) cells is dependent on ROS generation at 21% and 3% oxygen. Upon induction 
of a Rho0 phenotype in these cells, HIF-1α stabilisation is inhibited in normoxia but not 
in hypoxia. These data provide further evidence for the role of mitochondrial-derived 
ROS in HIF-1α stabilisation, since in the absence of functional mitochondria, ROS 
production decreases. 
 
The integrity of the mitochondrial electron transport chain in HIF-1α stabilisation is 
confirmed in our own data and is in agreement with the work by several other groups. 
Initial observations by Chandel et al., 1998 and Agani et al., 2000 which concluded a 
role of the electron transport chain in HIF-1α stabilisation were made using 
pharmacological agents that may have had non-specific effects on cells and in turn the 
mitochondria. Thus these authors went on to utilise an alternative method to study the 
role of the electron transport chain in HIF-1α stabilisation. They too utilised cells that 
had been depleted of their mitochondrial DNA. First they induced mitochondria-
depleted cells using ethidium bromide. Ethidium bromide interferes with DNA 
replication and caused a progressive decline in mtDNA. This results in a loss of electron 
transport in the mitochondria and was subsequently associated with an absence in HIF-
1α stabilisation at low [O2] (Chandel et al., 1998;Chandel et al., 2000a). More recently, 
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genetic approaches have been developed to investigate the requirement of functional 
mitochondria in hypoxic HIF-1α stabilisation.  
 
One study knocked out cytochrome c (Mansfield et al., 2005) which carries electrons 
from Complex III to Complex IV. Murine embryonic cells lacking cytochrome c fail to 
stabilise HIF-1α at low [O2] (Mansfield et al., 2005). Two further studies demonstrated 
that inhibiting Complex III function by knocking- down the Rieske iron-sulphur protein 
inhibits the ability of multiple cell lines to stabilise HIF-1α at low [O2] (Guzy et al., 
2005;Brunelle et al., 2005). 
 
6.5.2 NADPH oxidase ROS 
The NADPH oxidase (NOX) family of superoxide and hydrogen peroxide producing 
proteins have emerged as an important source of ROS in signal transduction. ROS 
produced by NOX proteins NOX1-5 and DUOX1 /2 play essential roles in the 
physiology of the brain, the immune system, the vasculature, and the digestive tract as 
well as in hormone synthesis (Brown and Griendling, 2009).  
 
Early in vitro studies showed that NOX enzymes were less active in hypoxia than 
normoxia (Gabig et al., 1979). However there is evidence for (He et al., 2002) and 
against (Chang et al., 2005) NOX-derived ROS in HIF-1α stabilisation. There is a 
report showing that stimulation of human umbilical vein cells (HUVEC) with 
prostacyclin stabilised HIF-1α under prolonged hypoxia, by attenuating NOX-derived 
ROS production due to suppressed Rac1 and p47phox expression (Chang et al., 2005). To 
the contrary, other groups have not confirmed the inhibitory effect of NADPH oxidase 
signalling on HIF but instead report that ROS production by renal NOX4 is essential for 
HIF-2α expression and vascular endothelial growth actor (VEGF) or glucose transporter 
1 (Glut-1) expression in renal tumour cells (Mekhail et al., 2004). Furthermore, the 
GTPase Rac1, which stimulates NOX activity, was stimulated by hypoxia and a 
dominant-negative Rac1 repressed hypoxia-dependent HIF-1α accumulation (Hirota and 
Semenza, 2001). In A549, a human epithelial cell line, hypoxia increased NOX1 mRNA 
and protein expression, which was accompanied by enhanced ROS production and 
activation of HIF-1-dependent target gene expression (Goyal et al., 2004).  
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Conflicting reports have been published on whether NOX-derived ROS stabilise HIF-
1α, we therefore investigated the role of NOX-derived ROS in HIF-1α stabilisation in 
our own experiments. We found that NOX2 was expressed most abundantly, and 
preceded to silence NOX2 gene expression in our cells (HEK 293T). Upon silencing 
NOX2, it became apparent that this also resulted in the concomitant decrease of the 
other NOX isoforms, NOX1, 4 and 5, possibly because of sequence conservation 
amongst the isoforms. Exposure of the cells to a low [O2] (3%) did not up-regulate 
NOX2. Furthermore, silencing NOX2 gene expression did not effect HIF-1α 
stabilisation at 3% oxygen. This data therefore suggests that ROS necessary to stabilise 
HIF-1α do not come from NOX at low [O2]. It has been demonstrated that during 
hypoxia, increased mitochondrial ROS generation leads to activation of NOX1 by 
protein kinase C (PKC), thereby augmenting ROS production, and thus the elevation 
intracellular Ca2+ concentrations, and pulmonary artery smooth muscle cell (PASMC) 
shortening (Rathore et al., 2008). This could imply a positive feedback pathway for 
ROS generation (Ward, 2008). However, since in our model there is no effect on HIF-
1α stabilisation in cells where NOX2 has been silenced, this may be either a cell 
specific mechanism or dependent on the duration of hypoxia and/or re-oxygenation 
episodes, though further investigations would be required. 
 
Taken together, our data provide evidence for participation of mitochondrial-derived 
ROS in HIF-1α stabilisation. In our Rho0 models (POLγ mutant in HEK and ethidium 
bromide treatment in H157), HIF-1α stabilisation is prevented. First in normoxia when 
γGCS has been silenced, secondly at 3% oxygen where HIF-1α is consistently stable 
and thirdly in cancerous cells that have previously demonstrated normoxic stabilisation. 
To support this further, we have shown that upon silencing γGCS in Rho0 cells, ROS 
production does not increase indicative that the main source of ROS in these cells is 
indeed mitochondrial. NF-ĸB has also been shown to be up-regulated in our normoxic 
model of HIF-1α stabilisation, and several studies have linked the production of 
mitochondrial ROS to the activation of NF-ĸB (Chandel et al., 2000b;Pearlstein et al., 
2002;Palacios-Callender et al., 2004). 
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6.6 Mitochondrial ROS production at low [O2] 
The mitochondria are considered a likely site of oxygen sensing, and it has been 
proposed that the electron transport chain acts as an oxygen sensor by releasing ROS in 
response to ‘hypoxia’. The ROS released during ‘hypoxia’ act as signalling agents that 
trigger diverse responses, including the stabilisation of HIF-1α (Guzy and Schumacker, 
2006).  
 
The paradoxical generation of mitochondrial ROS at low [O2] may exist due to the 
influence of oxygen concentration on the activity of cytochrome c oxidase (CcO). NO 
may bind and inhibit CcO, resulting in an increase in its Km for oxygen and an increased 
reduction of electron carriers located upstream from the terminal oxidase (Cooper and 
Davies, 2000), favouring superoxide formation at low [O2] (Palacios-Callender et al., 
2004). Thus, in normoxic oxygen conditions, the enzyme (CcO) is predominately in an 
oxidised state, it consumes oxygen and metabolises NO. At low [O2], when the enzyme 
is predominately in a reduced state, oxygen and NO compete for binding to the enzyme 
and NO is not metabolised. Allowing for the possibility that, as oxygen concentration 
falls, there lies a ‘window’ in which the mitochondria are able to produce free radicals 
which is not a direct affect of low [O2] but is instead due to the reduction of the electron 
transport chain via NO (Palacios-Callender et al., 2004). When the enzyme is fully 
reduced in hypoxia, there is not enough oxygen consumed by the electron transport 
chain to yield the production of ROS (Figure 76). 
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Figure 76 – A model summarising ROS production at low [O2] 
As the oxygen concentration ([O2]) decreases from normoxia to hypoxia, the cytochrome c oxidase 
changes from an oxidised state to a reduced state. Between ~ 3% and 1.5% oxygen (low [O2]) lies a 
‘window’ in which the production of ROS is favoured.  
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6.7 Conclusion and future work 
The results from the current study indicate that reactive oxygen species (ROS) stabilise 
HIF-1α in both normoxia (21%) and at a low [O2] (3%). We have also provided 
preliminary data to suggest that ROS do not inhibit the hydroxylation or ubiquitination 
of HIF-1α but instead ROS enhance the synthesis of HIF-1α.  
 
Furthermore, we have been able to demonstrate that the source of ROS involved in HIF-
1α stabilisation in HEK 293T and oral squamous carcinoma cells is of mitochondrial 
origin. Our results also indicate that as oxygen concentrations decrease (without 
reaching hypoxia or anoxia), mitochondria produce more free radicals. Additionally, our 
work has demonstrated that two distinct mechanisms of HIF-1α stabilisation exist 
within the cell depending on the oxygen concentration. At low [O2], HIF-1α 
stabilisation is dependent of the formation of ROS, yet in hypoxic conditions, oxygen 
becomes the limiting factor.  
 
To further this study it would be of interest to clearly demonstrate the mechanism of 
action by which reactive oxygen species result in HIF-1α stabilisation. Prolyl 
hydroxylases (PHD) mediate hydroxylation and degradation of HIF-1α at 21% oxygen. 
PHD should be active in normoxia yet HIF-1α is stable in our γGCS knock-down 
model. Thus, it would be important to investigate further whether ROS affect the 
activity of PHD in this model. We have provided preliminary data suggesting that PHD 
are active and that HIF-1α is targeted for hydroxylation. However, the method used in 
this study does not demonstrate this clearly. In order to investigate this further, PHD 
activity could be measured in cells where γGCS has been silenced at 21% using a HIF-
1α-pVHL binding assay. This assay is based on the knowledge that only hydroxylated 
HIF-1α is capable of binding pVHL, thus reflecting PHD activity. 
 
Hypoxia plays an important role in determining disease progression in a vast array of 
pathologies, including vascular disease, cancer and chronic inflammation. However, as 
observed in this study, not just low or hypoxic oxygen conditions results in HIF-1α 
stabilisation. This study could provide means of therapeutic intervention in the 
treatment of inflammatory diseases and cancer.  
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